ADVANCES IN
Applied Microbiology VOLUME 27
CONTRIBUTORS TO THIS VOLUME
A. M. Cundell Robert J. Fleischaker John C. ...
152 downloads
1698 Views
11MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
ADVANCES IN
Applied Microbiology VOLUME 27
CONTRIBUTORS TO THIS VOLUME
A. M. Cundell Robert J. Fleischaker John C. Godfrey
A. Hurst
L. S. McClung Vedpal Singh Malik Anthony J. Sinskey James C. Weaver
ADVANCES IN
Applied Microbiology Edited by D. PERLMAN School of Pharmacy The University of Wisconsin Madison, Wisconsin
and Allen I. Laskin Exxon Research and Engineering Company Linden, New Jersey
VOLUME 27
@
1981
ACADEMIC PRESS A Subsidiary of Harcourt Brace Jovanovich, Publishers
New York London Toronto Sydney San Francisco
COPYRIGHT @ 1981, BY ACADEMIC PRESS, INC. ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM O R BY ANY MEANS, ELECTRONIC OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT PERMISSION IN WRITING FROM THE PUBLISHER.
ACADEMIC PRESS,INC.
111 Fifth Avenue, New York, New York 10003
United Kingdom Edition published by ACADEMIC PRESS, INC. (LONDON) LTD. 24/28 Oval Road, London N W l 7 D X
LIBRARY OF CONGRESS CATALOG CARDNUMBER:59-13823
ISBN 0-12-002627-9 PRINTED IN THE UNITED STATES OF AMERICA 81828384
9 8 7 6 5 4 3 2 1
CONTENTS LJST
OF
CONTRIBUTORS., .............................
................
ix
Recombinant DNA Technology
VEDPALSINGHMALIK I . Introduction ........................................................
I1. Plasmid DNA Purification
111.
.
IV V. VI . VII . VIII .
............................................ Isolation of Genes ................................................... Making Recombinant DNA Molecules in Vitro .......................... Transformation ...................................................... Host-Vector Systems ................................................ UtiEity of New Technology ............................................ A Postscript ........................................................ References .........................................................
2 3 4 22 31 32 47 64 67
Nisin
A . HURST I . Introduction ........................................................ I1. Biology ............................................................
.
111
IV . V.
Chemistry .......................................................... Biosynthesis ........................................................ Use of Nisin ........................................................ References .........................................................
85 87 98 105 108 119
The Coumermycins: Developments in the Late 970s JOHN
C . GODFREY
......... ......... 111. Biological Developments ............................................. IV. Conclusion ......................................................... References ......................................................... I . Introduction .............................................. I1. Chemical Developments. 1972-1979 .........................
V
125 125 128 133 133
vi
CONTENTS
Instrumentation for Process Control in Cell Culture
ROBERTJ . FLEISCHAKER. JAMES C. WEAVER.AND ANTHONYJ . SINSKEY I . Introduction
........................................................ ........................ Microcarriers ....................................................... Generalized Model of Cell Growth ..................................... Evaluation of Instrumental Methods ................................... Temperature ........................................................ Mixing and Viscosity ................................................. pH ......................... ................................ Ionic Strength ......................................................
I1. Comparison between Animal and Microbial Cells
I11. IV. V. VI . VII . VIII . IX. X. Dialyzable Components: Carbohydrates. Organic Acids. Amino Acids. Salts. and Other Nutrient Components ...................................... XI * Oxygen ............................................................ XI1. Carbon Dioxide ..................................................... XI11. NAD+-NADH ...................................................... XIV. Oxidation-Reduction Potential ......................................... xv. ATP .......................... ................................. XVI. Cytofluoremetry ..................................................... XVII . Conclusion ......................................................... References ...................... ..............................
137 138 139 140 142 145 146 148 149 152 153 156 159 162 163 163 165 165
Rapid Counting Methods for Coliform Bacteria
A . M . CUNDELL I. I1. 111. IV. V.
Introduction .................................................... Criteria for a Rapid Coliform-Counting Procedure ........................ Review of Rapid Coliform-Counting Procedures ......................... Potential for Future Development ..................................... Summary ........................................................... References .........................................................
169 170 171 179 180 180
Training in Microbiology at Indiana University-Bloomington
L. S . MCCLUNG ........................................................
I. Introduction I1 The Early Period .................................................... 111 The Modem Period ..................................................
. .
185 187 187
CONTENTS
vii
IV . Faculty and Research ................................................ V . Physical Facilities ................................................... Appendix: List of Ph.D. Recipients. 1949-1979 .......................... References .........................................................
191 197 201 205
INDEX .................................................................... CONTENTS OF PREVIOUS VOLUMES ...........................................
207 211
This Page Intentionally Left Blank
LIST OF CONTRIBUTORS Numbers in parentheses indicate the pages on which the authors’ contributions begin.
A. M. CUNDELL,Flow Laboratories, Znc., 25 Lumber Road, Roslyn, New York 11576 (169) ROBERTJ . FLEISCHAKER, Department of Nutrition and Food Science, Massachusetts Znstitute of Technology, Cambridge, Massachusetts 02139 (137)
C. GODFREY,Godfrey Science and Design, Znc., 282 Soundview Avenue, White Plains, New York 10606 (125)
JOHN
A. HURST, Microbiology Research Division, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada KIA O D (85)
L. S. MCCLUNG, Department of Biology, Zndiana University, Bloomington, Zndiana 47405 (185) VEDPALSINGHMALIK,The Upjohn Company, Kalamanoo, Michigan 49008 (1) ANTHONYJ. SINSKEY,Department of Nutrition and Food Science, Massachusetts Znstitute of Technology, Cambridge, Massachusetts 02139 (137) C. WEAVER,Haruard-MZT Division of Health Sciences and Technology, Cambridge, Massachusetts 02139 (137)
JAMES
ix
This Page Intentionally Left Blank
Recombinant DNA Technology
VEDPAL SINGH MALIK The Upjohn Company, Kalamazoo, Michigan
I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111. Isolation of Genes
,
. .. .. ... .. .
A. Selection for Function.
....
..................... ...............
............. B. Ligation of Restriction Fragments V. Transformation. . .
,.........
C. Streptomycetes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Yeast . . . . . F. Mammalian Cells.. . . . . . ..................... VII. Utility of New Technology. . . A. Merodiploids Constructio ............ B. Operon Fusions . . . . . . . . . . . . . C. Directed Secretion of Proteins . . . . . . . . . . . . . . . . . . . . . . D. I n Vitro Localized Mutagenesis . . . . . . . . . . . . . . . . . . . . . . . E. Genome Organization . . . . .... F. Origin (On) of Replication. . . .............. .............. G. Human Proteins.. . . . . . . . . . . ............. H. Vaccines . . . . . . . . . . . I. Improvement of Industrial .......,......... J. Vanishing Organisms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Resource Recovery and Waste Disposal. . . . . . . . . . . . . . . . L. Improved Crops.. . . . . . . . . . VIII. A Postscript . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . .
.
.. . .
.
.
2 3 4 5 9 13 18 19 22 23 2.3 27 29 31 32 34 38 39
43 44 45 47 48 48 50 50 51 53 54
55 56 61 61 61 64
67
1 ADVANCES IN APPLIED MICROBIOLOGY. VOLUME 27 Copyright @ I 1881 by Academic Press. Inc. Au rights of reproduction in any bnn reserved. ISBN 0-13-0026e7-9
I
2
VEDPAL SINGH MALIK
I. Introduction Where ignorance of local manners-and languagehas led me astray, I ask due pardon from the local proprietors. J. D. B u ’ L ~ ~(1966) K
.
Read not to contradict and confute, nor to believe and take for granted. . but to weigh and consider. FRANCIS BACON(1597)
This article is addressed to those biologists who have knowledge of molecular genetics but would like to be familiar with the literature dealing with the rapidly advancing forefront of recombinant DNA technology. Genetic recombination that results from the breaking and rejoining of DNA molecules is subject to strong taxonomic constraints in viuo. Exchange of genetic material rarely occurs between unrelated organisms, and even similar bacterial species may not exchange chromosomal genes. Plasmids and viruses can incorporate small pieces of host DNA in their own chromosomes and act as vectors for transference of these genes to closely related bacterial species. These vectors bearing chromosomal genes can either become integrated into the chromosome of the recipient cell or exist as independently replicating units in the cytoplasm. A certain degree of DNA sequence homology is a prerequisite for genetic recombination in viuo. However, recombination between DNA molecules in uitro is not subject to these taxonomic restrictions. Consequently, genetic material from organisms of quite diverse origins with little DNA sequence homology can now be attached into an appropriate vector and introduced into a host cell for propagation and expression. The possibility of cloning DNA of higher organisms into a genetically well-characterized haploid microbe such as Escherichiu coli is an important recent development in applied microbiology, This new technology has paved the way for the propagation of lines of organisms that are genetically alike and that all contain identical recombinant DNA molecules. A variety of novel genetic combinations in microorganisms can thus be created. This new technology also makes it possible to isolate defined genes and to prepare large quantities of homogeneous fractions of DNA from organisms whose genetics and biochemistry are not well known. Microorganisms that have been used to benefit man for centuries can now be genetically modified by implanting foreign genes into them. Furthermore, mammalian proteins and other useful products can be synthesized through the use of microorganisms genetically modified by the implantation of foreign genes. Ultimately, this new technology will surely accelerate the understanding of the regulatory biology of the organisms that have thus far been refractory to in uitro methods of genetic analysis (Dawid and Wahli, 1979;Sinsheimer, 1977; Setlow and Hollaender, 1979; Maniatis, 1980). Recombinant DNA technology generally involves several steps:
RECOMBINANT DNA TECHNOLOGY
3
1. DNA fragments coding for proteins of interest are synthesized chemically or isolated from an organism. 2. These DNA fragments are inserted in a restriction endonuclease cleavage site of the vector that does not inactivate any gene required for the vector’s maintenance and selective marker. 3. The recombinant DNA molecules are then introduced into a host to replicate using the replication origin of the vector. 4. Recipient host cells that have acquired the recombinant DNA are selected. Selection pressure is applied to enrich bacteria with a selectable marker. 5. Desired clones are then characterized to ensure that they maintain true copies of the DNA segment that was originally cloned.
II. Plasmid DNA Purification Plasmids are widely used as vectors and methods of their isolation can vary depending upon the host organism. In E. coli, many methods are used for isolating plasmid DNA free from chromosomal DNA. Plasmid-harboring E. cold is grown in any rich medium such as Typticase Soy broth or a minimal salt solution supplemented with casamino acids. In certain plasmid isolations, such as ColE1 derivatives, where protein synthesis is not required to initiate plasmid DNA replication, 300 &ml of chloramphenicol is added in the log phase of growth. This selectively inhibits chromosome duplication and allows amplification of plasmid DNA so that 45%of total cellular DNA is plasmid (Clewell, 1972). Cells are centrifuged and suspended in 50 mM Tris buffer containing 25%sucrose. Lysozyme in the presence of EDTA is added to hydrolyze the peptidoglycan layer of the cell wall. Protoplasts thus formed are then lysed by addition of the anionic detergent sodium dodecyl sulfate so that the chromosome remains attached to the cell envelope. Sodium chloride is added to 1 M concentration to precipitate chromosomal DNA and cell debris. After centrifugation, the supernatant containing plasmid DNA is removed (Guerry et al., 1973).Usually, phenol or pronase and ribonuclease are used to remove protein and RNA. The plasmid DNA is subsequently precipitated with ethanol or with polyethylene glycol (Johnson and Gunsalus, 1977).The DNA is then purified by CsCl density-gradient centrifugation in the presence of ethidium bromide (Martens and Clayton, 1977). Other procedures are now available for isolating plasmids from E. coli (Ohlsson et al., 1978; Colman et al., 1979), pseudomonads (Johnson and Gunsalus, 1977; Palchaudhuri and Chakrabarty, 1976; Hansen and Olsen, 1978); Bacillus subtilis (Gryczan and Dubnau, 1978); Serratia murcescem (Timmis and Winkler, 1973); Streptococcus (Clewell et al., 1974); Streptomyces (Bibb et al., 1978; Malik, 1977, 1978; Schrempf et d.,1975; Yagisawa et al., 1978), Agrobacterium (Currier and Nester, 1976); yeast
4
VEDPAL SINGH MALIK
(Zakian et al., 1979);and other eukaryotic cells (Shoyab and Sen, 1978). It is extremely important that DNA be free from contaminating nucleases and RNA species. Sometimes DNA has to be purified by polyacrylamide gel electrophoresis, sucrose gradient centrifugation, or column chromatography before it can be hrther used (Hardies and Wells, 1976, 1979; Hardies et al., 1979).
Ill. Isolation of Genes Chromosomal location of DNA sequences of a gene affects the ease with which the genes are isolated. On the basis of phenotypic effect and organization in the chromosomes, genes can be subdivided into the following groups: 1. Simple genes. Their product is a single polypeptide or single RNA (e.g., ribosomal RNA, tRNA, insulin, histone, ovalbumin, or monomeric enzymes). Such genes are the easiest ones to isolate. 2. Complex genes. Many multimeric proteins are aggregates of several nonidentical polypeptide subunits. Some require cytochromes and specific cofactors for their biological activity. All of these genes coding for the various parts of the hnctional enzyme aggregate may not be clustered together on the chromosome, e.g., the genes that code for the tryptophan synthetase, fatty acid synthetase, mixed-function oxidase, hydroxylases, and enzymes that oxidize drugs but require cytochrome P-450. 3. Operons. Many genes specifying degradative and biosynthetic pathways are clustered adjacent to each other on the chromosome, and these gene clusters are called operons. Examples are lac operon and histidine operon (Miller and Reznikoff, 1978). 4. Regulon. Certain genes specifying a biosynthetic function such as arginine biosynthesis are organized in several minioperons widely scattered on chromosomes. However, all such genes are regulated coordinately and have been called regulons. 5. Multiple regulons. Many products, e.g., antibiotics, are assembled from precursors derived from several different pathways. For example, L-cysteine, L-valine, and L-a-aminoadipate are involved in the biosynthesis of P-lactam antibiotics (Malik, 1980). Multiple regulons participating in the synthesis and regulation of the biosynthesis of such complex molecules are probably scattered all over the chromosome. Isolation of all genes involved in antibiotic synthesis can therefore be a difficult task. Since genes are composed of DNA stretches, to isolate genes one must first isolate DNA. Purified cytoplasmic organelles such as mitochondria and chloroplasts can be used to obtain their DNA. However, isolation of specific genes from total DNA is difficult and many properties of genes are used to advantage to isolate the genes. Human genome contains about lo' globin gene-sized DNA sequences, of which approximately 60% occur in one or a
RECOMBINANT DNA TECHNOLOGY
5
few copies. To increase the probability of success in cloning a particular gene from such a highly complex genome, it helps to enrich DNA sequences before cloning into a vector. A combination of several methods could yield an enrichment of several thousandfold. Genes located on plasmids or phages are greatly enriched by purifying the plasmid or-phage DNA. Many genes involved in aromatic and sterol metabolism (Chakrabarty, 1978), heavy metal transformations, and drug resistance are located on plasmids. Genes for the insecticide toxin produced by Bacillus thuringiemis may be located on a bacteriophage (Perlak et al., 1979; Templeton et al., 1979). After preparations that have been enriched for a desired gene, recombinant DNA technology is used to isolate the genes from such preparations.
A.
SELECTION FOR
FUNCTION
Many genes can be selected by their function if mutants of a host organism lacking that function are available. Cohen and Chang (1973)were the first to take advantage of the fact that certain genes determining resistance to antibiotics were located on plasmids. These genes were enriched by purd$ng plasmid DNA. Their isolation was therefore made easier by selecting clones that harbored genes responsible for resistance to antibiotics. These authors reported the in vitro construction of DNA molecules that combined genetic information from two different E. coli plasmids carrying drug-resistance markers. These recombined plasmids were inserted by transformation into drug-sensitive E . coli. The transformant clones were selected by directly plating cells on nutrient agar plates supplemented with antibiotics. On such media, only cells that acquired recombinant plasmids survived since the host was killed by antibiotic. Cohen and Chang were also the first to insert the penicillinase gene from a gram-positive bacterium Staphylococcus plasmid into an E. coli plasmid. The penicillinase gene was expressed and maintained when the chimeric plasmid was introduced into E. coli. A thymidylate synthetase gene from the B. subtilis bacteriophage 43T has also been cloned and expressed in E. coli. Phage $3T DNA was digested with Eco RI and ligated to an EcoRI-digested pMB9 plasmid of E. coli. This recombinant DNA was used to transform a thy- E. coli. The desired transformants had a thy+ tet phenotype (Ehrlich et al., 1976). These recombinant plasmids replicated in E. coli, utilizing the origin of DNA replication of the E. coli vector plasmid. Such experiments did not tell whether genes of gram-positive organisms were being transcribed in E. coli from a promoter of the vector or from their own promoter. Base sequences of regulatory elements, e.g., promoters, could be very different in different organisms. The level of gene expression in a given organism could vary depending upon the efficiency of interaction between regulatory sequences and corresponding protein molecules.
6
VEDPAL SINCH MALIK
1 . Genome Library
Techniques for the construction and screening of a complete library of clones for any genome is a practical starting point for ampllfying specific genes (Wensink et al., 1974;Benton and Davis, 1977; Sternberg et al., 1977; Maniatis et al., 1978; Dodgson et al., 1979; Gergen et al., 1979).A complete library of genome fragments is a set of independent clones that, statistically, contains the entire genome among the recombinant DNA molecules (Clarke and Carbon, 1976). Complete sets of DNAs can be maintained if no segment is disruptive to the vector or host. If every DNA segment is transformed and maintained with equal efficiency, then the probability (P) of the presence of a desired DNA sequence in a genome bank is as follows:
P
= 1 - [(l
-+)4"
where x = length of desired segment of DNA, L = average length of DNA fragment cloned, F = fraction of genome represented by an average fragment, and N = number of transformant colonies containing cloned DNA. Clarke and Carbon calculated that 720 transformed colonies will give a probability of 0.90 that one E. coli gene was cloned with an average molecular weight of 8.5 X lo6. However, the probability increases to 0.99 with a genome bank of twice this size. A library of soybean genome (Breiner et al., 1979) and chicken genome has been constructed in the vector A charon 4A (Maniatis et al., 1978). Chicken DNA was partialky digested with restriction enzymes HaeIII and AZuI. Fragments of 14-22 kb were purified by sucrose gradient fractionation. This DNA was methylated by EcoRI methylase, ligated to synthetic dodecameric linkers, digested with EcoRI restriction enzyme, and refractionated on sucrose gradients. These fragments were then ligated to purified charon 4A left and right arms joined at the A cohesive end site. The ligated concatemeric DNA was treated with the in uitro packaging extracts. Packaged phages were purified by cesium chloride centrifugation. These phages were amplified by growth on plates at subconfluent densities. Several independent globin gene-containing recombinants were selected from the chicken genome library by screening with adult and embryonic globin cDNA as a probe (Dodgson et al., 1979).
2 . Screening of Genome Library a. Auxotrophic Complementation. Many genes have been identified by transforming auxotrophs with recombinant molecules. For making genomic banks in E. coli, the recipient is usually F+. This allows transfer of recom-
RECOMBINANT DNA TECHNOLOGY
7
binant plasmids to other E. coli auxotrophs (Miller, 1972) and provides a rapid method for identifying a recombinant plasmid containing a specific gene from a genome bank of randomly cloned genome fragments (Clarke and Carbon, 1976; Latrou et al., 1980). Whenever applicable, this procedure is extremely rapid, since a large number of colonies from a genome bank can be screened with little effort. Many individual colonies from the genome library can be grown in a grid on a master plate and replicated to a lawn of recipient auxotroph cells on the appropriate selective media. However, the only genes selected by this method are those for which a bacterial mutation exists and that are expressed in the bacterial host. The expression of the desired gene can vary depending on the vector, cloning site, and host cell; and such a selection may not produce the gene of interest even though the source of a gene is a bacterium related to the host organism. Methods have been developed for the selection of DNA sequences that complement metabolic mutations and structural defects such as those involved in mutant flagellar genes (Silverman and Simon, 1977; Schell and Wilson, 1979; Walz et al., 1978; Moore and James, 1979; Vapnek et al., 1977; Chinault and Carbon, 1979; Gardner, 1979; Struhl et al., 1976). Recombinant molecules carrying specific genes have been selected directly by using appropriate E. coli auxotrophs as host. Restrictionless strains of E. coli that are transformed with high efficiency are usually used as recipients. Genes that complement trp, gal, lop, l a d , ara, thyA, leu, bio, and many others have been identified in this manner (Clarke and Carbon, 1976; Hershfield et aZ., 1974; Berg et al., 1976; Collins et aZ., 1976; Cohen et al., 1978). A Saccharomyces cerevisiae DNA segment of 4700 base pairs containing the galactokinase gene (gal-])has been cloned in pBR322 (Hind111 site) and maintained in an E. coli strain that carries a deletion in its own galactokinase gene (galK). The yeast gene was shown to be present (1) by complementation of the E. co2i galactokinase deletion, (2) by hybridization of the cloned DNA fragment to the restriction enzyme digest of total yeast DNA, and (3) by demonstration of yeast galactokinase, a monomeric protein, in cell-free extracts of the E. coli harboring the plasmic that contains the yeast galactokinase gene. The yeast galactokinase activity in E. coli extracts is 0.7%of the bacterial galactokinase activity present in wild-type E. coli cells fully induced with fucose. E. coli cells lacking a functional galactokinase gene but harboring the yeast galactokinase gene grow slowly in minimal medium containing galactose as the sole carbon source. Such cells have a generation time of 14.3 hours (Citron et al., 1979). The replication of pBR322 is under relaxed control and 50-100 copies per cell of the hybrid plasmid containing the yeast galactokinasegene could be expected. These multiple copies of the gene per cell should allow production of galactbkinase enzyme in sufficient
8
VEDPAL SINGH MALIK
amount for good growth of the host, considering that turnover numbers in vivo of the E . coli and yeast galactokinase enzymes are similar. The yeast galactokinase gene is expressed in E. coli very poorly. This decreased expression of yeast gene in E. coli could be due to inefficient transcription, translation, posttranscriptional or posttranslational modification of galactokinase, or a combination of all. St. John and Davis (1979) have also reported the cloning in E. coli of yeast galactose-inducible sequences selected by another technique. The similarity between sequences cloned by St. John and Davis (1979) and Citron et al. (1979) cannot be assessed by the data given. Saccharomyces cerevisiae genes coding for P-galactosidase (Dickson and Martin, 1978) and several genes involved in other biosynthetic pathways (Struhl et al., 1976; Carbon et al., 1977; Ratzkin and Carbon, 1977; Struhl and Davis, 1977; Clark and Carbon, 1978; Bach et al., 1979) are expressed when cloned in E. coli. Several yeast genes, for example, leu-2, his-3, ura-3, trpG, and adh-2, have been isolated by complementation test (Williamson et al., 1980). Yeast cells carrying an ampR gene of E . coli plasmid ligated to a yeast replicon produce penicillinase (Chevallier and Aigle, 1979).
b. In Situ Hybridization. Colonies or phage plaques with the desired gene can be identified in situ by hybridization to a radioactively labeled RNA probe complementary to the desired gene (Grunstein and Hogness, 1975). This procedure is used when the desired clones cannot be assayed for the function of the gene of interest. Under such circumstances, DNA sequences for the gene of interest are detected by taking advantage of the complimentarity of the RNA or DNA probe. For each screening of the library, petri dishes (150 mm) with up to 10 plaque-forming units (PFU) or colonies per plate can be used. From each petri plate, viral plaque DNA or colonies are fued to the nitrocellulose filters and lysed, and the DNA is denaturated by alkali treatment (Benton and Davis, 1977). Colonies or plaques that hybridize with 32P-labeledprobe RNA or cDNA of the genes of interest are located by autoradiography or fluorography. Duplicate positive plaques or clones can be purified through several further platings at low plaque density. Colony hybridization has been used widely. Similar procedures have been developed for SV40 plaques (Villarreal and Berg, 1977), and have been used to isolate Drosophila tRNA genes (Dunn et al., 1979) and ribosomal DNA of B. subtilis (Moran and Bott, 1979), soybean (Breiner et al., 1979), and Dictyostelium (Maizels, 1976) c. In Situ Immunoassays. Radioisotopes such as lz5Ihave been used for many years as labels for monitoring the distribution of reagents in immunological assay systems. Nonradioactive labels such as bacteriophages, enzymes, stable free radicals, and fluorescent and chemiluminescent groups
RECOMBINANT DNA TECHNOLOGY
9
have also been used (Simpson et al., 1979; O’Sullivan et al., 1979; Harris et al., 1979). Radioimmunoassays have been used to identlfy genes for which E. coli mutants do not exist (Henning et al., 1979). The method depends on the presence of the gene product and requires expression of the cloned gene in the host. Both viral and phage vectors can be used, since the technique is applicable to phage plaques as well as colonies. Broome and Gilbert (1978) developed a very sensitive solid-phase radioimmunoassay capable of detecting picograms of specific antigens. This pioneering methodology was first used to select E. coli clones that synthesized rat proinsulin (Villa-Komaroff et al., 1978). Such assay can be used to screen clones for the presence and expression of specific gene sequences. Because of the extreme sensitivity of this assay, it can detect even the very low level of expression resulting in the synthesis of only a few molecules per cell. Hybridoma technology can be used to make specific monoclonal antibody (F. Melchers et al., 1978). The combination of radioimmunoassayswith gel electrophoresis can be used to characterize immunoreactive proteins (Secher and Berke, 1980). Enzymes involved in the biosynthesis of peptide antibiotics have been purified to homogeneity (Kleinkauf and Koischvitz, 1980). Such pure enzymes could now be used to make specific antibodies needed for a radioimmunoassay to isolate the genes involved in peptide antibiotic synthesis.
d . Sib Selection. This method can be used to isolate clones from a genome library. The whole genome library is divided into pools, each containing many different clones. Each pool is tested by the pertinent assay procedure for the presence of a desired gene. That pool containing the gene of interest is subdivided and retested until the individual clone is identified. Sea urchin histone genes and human interferon genes have been isolated in this way (Kedes et al., 1975; Bylinsky, 1980; Gilbert and Villa-Komaroff, 1980). B. PHYSICAL DIFFERENCES 1 . Density
If the gene differs significantly in base composition from the total cellular DNA and is present in multiple copies per genome, then the repeated sequences band in CsCl gradient as a satellite in addition to the main chromosomal band. Ag+ or Hg+ increases such density differences. Ribosomal RNA genes of Xenopus laeuis were isolated on the basis of density differences and were the first eukaryotic genes to be cloned in E. coli (Morrow et al., 1974).
10
VEDPAL SINCH MALIK
Amplified rRNA genes of Tetrahymenu are free from chromosomes in the macronucleus of Tetrahymenu (Din and Engberg, 1979) and can be easily separated on sucrose gradient or by agarose gel electrophoresis. An EcoRI-generated fragment of plasmid pSC122 was purified by equilibrium centrifugation in cesium chloride (Timmis et al., 1975). This fragment coding for ampicillin resistance had a buoyant density of 1.692 gm/cm3 whereas the remaining DNA fragment banded at a buoyant density of 1.710 gm/cm3. Firtell et al. (1976) enriched recombinant DNA molecules of Dictyosteliurn dwcoideum (22% GC) and pSClOl (50% GC) by fractionation on a CsCl density gradient. The region between 30 and 40% GC yielded about 85%hybrid molecules, whereas the initial population contained 2 4 % hybrids. The approach used by Firtell et aZ. (1976)could be used to enrich recombinant molecules with pieces of Streptmyces genome (70% GC) if they could be ligated with homopolymer (dGidC) tailing into a vector with low GC content. 2 . Size Many enrichment procedures utilize information about the size of the DNA fragment required for the desired gene. a. Gel Electrophoresis. Restriction enzyme-generated fragments are separated according to size by gel electrophoresis (Southern, 1979a). Bands containing a gene can be designated (Helling et al., 1974)when the fragment order of a simple genome such as that of a plasmid or phage is known (Table I). For organisms with a high efficiency of transformation, the bands of endonuclease-digested DNA can be isolated after electrophoresis and correlated with specific genes after transformation (Young et al., 1977; Brown and Carlton, 1980; Mazza and Zalizzi, 1978). Gel electrophoresis is routinely used for determining the fragment composition of recombinant DNA molecules constructed by ligation of cohesive ends generated by restriction enzymes. Digestion by the same restriction enzyme regenerates the original DNA fragments and such fragments are easily identified by gel electrophoresis. As little as 10 pg of DNA per band can be visualized by staining the gel with ethidium bromide, which fluoresces under UV light (Helling et al., 1974). DNA can be extracted from these resolved bands and used for further analysis with various restriction enzymes, nucleotide sequencing, or transformation. Agarose gel electrophoresis is best suited for characterizing fragments above 1.5 kb. For smaller fragments, polyacrylamide gels are used. Standards of A and 4x174 DNA already cleaved with restriction enzymes are commercially available
11
RECOMBINANT DNA TECHNOLOGY
TABLE I FRAGMENT SIZES' PRODUCED BY b S T l U C r I O N
ENDONUCLEASE DIGESTION OF A AND 4x174 GENOMES
A Fragment number
Hind111
EcoRI
1 2 3 4 5 6 7 8 9 10 11
23,720 9,460 6,670 4,260 2,250 1,960 590 100
21,800 7,550 5,930 5,540 4,800 3,380
4x174 BamHI
HaeIII
HaeII
TaqI
17,400 7,300 6,760 6,470 5,540 5,510
1,353 1,078 872 603 310 281 271 234 194 118 72
2,314 1,565 783 269 185 123 93
2,914 1,175 404 327 231 141 87
54
54
33 20
'In base pairs. and can be used as markers for determining size of unknown DNA fragments. Digestion of E. coli DNA with EcoRI restriction enzyme yields about 500-600 fragments differing in molecular weight, base composition, and sequence. When this digest is examined by agarose gel electrophoresis, a featureless pattern is obtained. However, Fischer and Lerman (1979) have developed a two-dimensional electrophoretic method that resolves the large number of components of an EcoRI-digested E. coli chromosome into 350 discernible spots. The significance of this technique is demonstrated by the detection of four spots unique to a digest of E. coli lysogenized by A. These four spots were not observed in uninfected E. coli, but two of these spots were due to A phage DNA alone. Creighton (1979)used a similar procedure in a study of protein denaturation. Rapid and sensitive procedures for detecting plasmids by agarose gel electrophoresis have been developed (LeBlanc and Lee, 1979).Plasmids present in one copy per cell with a molecular weight of up to 1.5 x 108 can be identified. One colony is sufficient to obtain a fragment pattern of a recombinant plasmid after restriction endonuclease cleavage (Eckhardt, 1978; Klein et al., 1980). Southern (1975)developed the technology for studying gene arrangement directly. High-molecular-weight DNA is cleaved with a restriction enzyme and separated into fragments by agarose gel electrophoresis. The DNA is
12
VEDPAL SINGH MALIK
then denatured and transferred from the gel onto a cellulose nitrate strip. The cellulose nitrate strip is hrther baked to ensure binding of DNA to the paper and is then hybridized with a specific labeled RNA, DNA, or cDNA probe. The probe hybridizes only to its complementary partner and can be localized by autoradiography. The size of the gene sequence localized as a radioactive band can be determined by comparing with DNA standards electrophoresed on the same dilute agarose gel. Using the Southern hybridization technique, physical maps of restriction endonuclease cleavage sites in several structural genes and in the DNA region flanking the genes have been constructed. Comparison of the size of the restriction fragments of structural genes and cDNA has revealed that many genes are not contiguous in the DNA but have noncoding inserts. Such noncoding inserted sequences have been found in the rabbit P-globin gene, chick ovalbumin (Kourilisky and Chambon, 1978; Catterall et al., 1979), mouse P-globin (Tilghman et al., 1978), mouse immunoglobulin light chain (Brack and Tonegawa, 1977), Drosophiln ribosomal genes (Glover and Hogness, 1977), and yeast mitochondria1 tRNA (Goodman et al., 1977). Southern (1979b) has designed a gene machine in which DNA is electrophoresed from the outside to the center of a 2% agarose cylinder. DNA is collected on a dialysis membrane when it reaches the center and is eluted at intervals. The high capacity of the gene machine makes it an ideal first fractionation device. Approximately 200300 fractions are separated, of which only a few contain the desired gene fragment. In this manner, up to 50-fold enrichment of a specific gene sequence can be achieved.
b. Electron Microscopy. The most accurate and reliable method for determining the size of DNA is electron microscopy. Heteroduplex analysis is used to build the map of A DNA digested with EcoRI. Such maps of plasmid and phage genomes as well as other DNA segments are routine these days and can be confirmed by comparing the electrophoretic pattern of DNA fragments obtained by restriction cleavage of recombinant molecules differing by deletion or by the addition of DNA from other genomes. New methods for visualizing RNA-DNA hybrids by electron microscopy permit precise localization of individual genes (Thomas et al., 1976; Miwa el al., 1979). c. Genetic Methods. DNA coding sequences for yeast tyrosine transfer RNA have been located on eight digerent EcoRI restriction fragments. There is significant natural variation among various yeast strains in the sizes of EcoRI and Hind111fragmentsthat hybridize with tyrosine tRNA. Restriction fragments of various sizes hybridizing with the same tRNA genes occupy genetically homologous chromosomal sites. These size variants of EcoRI-HindIII
RECOMBINANT DNA TECHNOLOGY
13
restriction fragment behave as Mendelian traits. Olson et al. (1979) associated six of the eight tyrosine tRNA loci with specific restriction fragments by establishing genetic linkage between the suppressor tRNA and a size variant of the respective restriction fragment. Even though all eight genes code for suppressor tyrosine tRNA, pronounced differences in phenotype exist between different suppressors. Now, cloned DNA sequences can be correlated with the corresponding genetic loci by transforming into appropriate strains of yeast and testing for functional expression of the suppressor. Restriction fragment size variants have been used to analyze inheritance of plant and animal mitochondrial DNA (Levings and Pring, 1976), rDNA, and 2 pm plasmid sequences of yeast (Petes, 1979; Livingston, 1977; Fonty et al., 1978), and Drosophila mitochondrial DNA (Shaw and Langley, 1979). Widespread Occurrence of restriction fragment size variants can have an impact on molecular genetics similar to that of electrophoretic variants on proteins and may speed up the genetics of eukaryotes (Birky, 1978). C.
COMPLEMENTARY RNA
1 . cDNA
Many eukaryotic genes are split. The mRNA coding sequences (exons)are interrupted by intervening sequences (introns) of unknown function. These split genes are transcribed into an RNA precursor that matures into mRNA by a splicing mechanism (Abelson, 1979). Since split genes are not found in bacteria, they are not expressed in E. coli (Puijalon and Kourilsky, 1979). Therefore, cDNA made in vitro has been used to get expression of several mammalian proteins in E. coli. This method of gene isolation is possible only if mRNA species that code for a certain protein can be sufficiently enriched. Several methods for isolating biologically active ribonucleic acid from various sources have been described (Chirgwin et al., 1979; Mansson et al., 1979; Payvar and Schimke, 1979; Brandt and Ingversen, 1978). Total RNA containing poly(A) tails is sometimes translated in a cell-free system and the polysomes precipitated by the purified antibody. The enriched RNA is further purified by affinity chromatography on an oligo(dT)column. RNA-dependent DNA polymerase from avian myeloblastosis virus is used for the synthesis of complementary DNA (cDNA) strand from RNA. This enzyme is also called reverse transcriptase and generates a hairpin structure with a short double-stranded region at the 3’-terminal of cDNA. Escherichia coli DNA polymerase I is used to synthesize a second DNA strand of this self-priming cDNA with a 3’-terminal hook. The hairpin loop connecting the two complementary
14
VEDPAL SINGH MALIK
strands is digested by S1 nuclease and the RNA is hydrolyzed by alkali treatment. The desired species of cDNA is identified by restriction enzyme analysis and size determination of the DNA fragment as determined by gel electrophoresis. The cDNA can be cloned into a vector by homopolymer tailing, blunt-end ligation, or utilization of linkers. After restriction endonuclease digestion, a distinct fragment pattern is obtained from cDNA synthesized from an enriched mRNA species. This effect has made it possible to clone rat insulin cDNA (Ullrich et al., 1977), human growth hormone (Goeddel et al., 1979a; Roskam and Rougeon, 1979), human chorionic gonadotropin (Shine et al., 1977), and rat growth hormone (Seeburg et al., 1978b). Ullrich et al. (1977) developed ingenious methods for obtaining DNA sequences coding for insulin. Purified rat insulin mRNA, which could have been used as a probe, was not available at that time. Total polyadenylated mRNA was used to make cDNA from specialized pancreatic cells that synthesize insulin. Restriction endonuclease digestion with Hue111 of the cDNA produced major fragments of 180 and 80 nucleotides. These two fragments were present in an undigested species of cDNA of about 450 nucleotides. This 450-nucleotide-long cDNA was joined to Hind111 synthetic linkers before insertion into a plasmid vector. The recyclization of the vector PMBQ was prevented by removing phosphate groups with alkaline phosphatase. In this way, only plasmids that annealed to cDNA with terminal 5'-phosphates were ligated by ligase. Hue111 digests of plasmid DNA from transformed cells were used to identify clones that carried 450, 180, and 80 nucleotide fragments characteristic of the major species of cDNA. Direct sequencing of cDNA showed that it carried information for coding known amino acid sequences for rat insulin. The recombinant plasmids isolated by Ullrich et al. (1977)contained the whole of the proinsulin coding sequence and part of the N-terminal prepeptide. Even though the recombinant plasmid-bearing strain did not produce any insulin, these pioneering experiments opened the way for obtaining gene sequences that utilized the size of cDNA and size of its characteristic restriction fragments to select the correct DNA sequence that codes for the polypeptide of interest. Recently, Bell et al. (1979) have isolated and sequenced a cDNA clone encoding human preproinsulin. Double-stranded cDNA, prepared from unfractionated mRNA isolated from human insulinoma, was inserted into PstI endonuclease site of P-lactamase gene of pBR322 using poly(dG)-poly(dC) homopolymer extensions. This DNA was used to transform E. coli, and 525 tetracycline-resistant transformants were obtained. These were replicaplated and screened for insulin sequences by colony hybridization using nick-translated cloned rat preproinsulin I cDNA as a probe. Autoradiography revealed that 2 out of 525 colonies hybridized with the probe. Both
RECOMBINANT DNA TECHNOLOGY
15
colonies were ampicillin-sensitive and contained inserts of about 250 and 500 base pairs. Since the two sequences were in different reading frames, fused P-lactamase human preproinsulin polypeptide was not synthesized by either one of these clones. However, isolation of these human preproinsulin sequences is a step toward microbial production of human insulin. Fiddes and Goodman (1979) isolated sequenced and cloned cDNA for the a-subunit of human chorionic gonadotropin (HCG). Polyadenylated mRNA from first trimester placenta was enriched for human chorionic gonadotropin-specific mRNA. These RNA samples were translated in a wheat germ cell-freetranslation system with [ 35SJmethionine, and the synthesized proteins were characterized on an SDS-15% polyacrylamide gel after imnoprecipitation by an antiserum against human chorionic gonadotropin. This polyadenylated RNA was used to synthesize cDNA, which was restricted with AZuI or HpaII. With both enzymes, a specific band pattern variable with the RNA used to make cDNA was observed. The 340-base pair cDNA fragment obtained from full-term mRNA is present in human chorionic somatomammotropin cDNA and is present only in minute amounts in first trimester cDNA (Shine et al., 1977). However, AZuI digestion of first trimester cDNA yields segments of 230 and 80 base pairs as major fragments that correspond to either cx- or P-HCG cDNA. The full length cDNA in the size range of 600-750 base pairs was ligated to synthetic HindIII linkers and then cloned into the HindIII site of pBR322. DNA from 22 transformants was analyzed by restriction enzyme cleavage. One recombinant had a 620-base pair-long Hind111 insert, which corresponds to the major cDNA species and contains AluI and HpaII fragments similar to those observed in the first trimester cDNA. Sequencing of this cDNA showed that the entire coding region, including the 24 amino acid presequence and most of the untranslated region, was present in the fragment. In eukaryotes, a precursor polypeptide is generally the immediate product of mRNA translation. The precursor polypeptide is often processed to produce a functional product. Precise posttranslational processing will probably not be accomplished by E. coli. Therefore, in vitro manipulation of primary translational products may have to be carried out for producing certain eukaryotic proteins in bacteria. Nakanishi et al. (1979) have reported the nucleotide sequence of a 1091base pair cloned cDNA insert. This fragment encodes bovine corticotropin-&lipotropin precursor mRNA. DNA sequencing has been reduced to a routine exercise owing to the advances in methodology (Maxam and Gilbert, 1977; Sanger et al., 1977a,b; Weissman, 1979) and has been used to confirm the identity of many DNA sequences that code for eukaryotic proteins. Nucleotide sequences for insulin, rat growth hormone, and human somatomammotropin have been identifed by direct sequencing of
16
VEDPAL SINGH MALIK
cloned DNA segments and comparison of the nucleotide sequence with that predicted by the amino acid sequence of its protein product (Ullrich et aZ., 1977; Seeburg et al., 1978b; Shine et al., 1977). Recombinant DNA technology has made possible the examination of DNA from eukaryotes in genetically and biochemically well-characterized microbes such as E . coli. Genetic and biochemical analyses that were possible only for E. coli genes are now possible for many cloned genes. Fritsch et al. (1979) have already taken initial steps toward localizing sequences that are involved in controlling the switch from fetal to adult fi-globin-like gene expression in man. They used complementary DNA and genomic DNA fragments as probes in Southern hybridization experiments to map the end points of deletions in DNA from individuals with hereditary persistence of fetal hemoglobin and GB-thalassemia. The possibilities of cloning eukaryotic genes in an organism amenable to genetic analysis may allow selection for metabolic mutants of eukaryotic genes and the testing of the regulatory effect and function of the mutant genes. 2 . Complementary RNA as a Probe Development of gene-specific probes allows the selection of the recombinants containing the sequences of interest. A gene-specific probe functions by specific hybridization; for 'example, ribosomal RNA labeled to a high specific activity with lZsI hybridizes to ribosomal genes and is therefore a specific probe. Ribosomal RNA has been iodinated (Commerford, 1971)and successfully used as a probe to detect ribosomal gene sequences in mouse (Amheim, 1979), Dictyostelium discoideum (Cockburn et al., 1976), Bacillus thuringiensis (Klier et al., 1979; Taylor, 1979), Euglena gracilis (Graf et al., 1980). New affinity chromatography, using cDNA containing recombinant plasmid DNA as probe and reverse phase chromatography, allows enrichment so that single mammalian genes together with adjacent sequences can be cloned (McFarland and Borer, 1978; Miura et al., 1979; Persson et al., 1979; Sodja and Davidson, 1978; Shih and Martin, 1974; Taylor, 1979). Affinity columns of nucleic acids bound to cellulose can be used to fish out complementary nucleic acid strands. Column effluent denaturing and recycling through the column yields high efficiency of hybridization. Column-bound RNA can be used as a probe to isolate a complementary DNA, which can then be used to isolate the other complementary DNA strand. Annealing of separately purified complementary strands produces DNA duplexes (Woo et al., 1977a). The 3'-poly(A) tail on most eukaryotic mRNAs can be hybridized to column-bound poly(U) or poly(aT). The enzymes A exonuclease and E. coli exonuclease I11 are used to digest DNA from the 5'-end and 3'-end, respec-
RECOMBINANT DNA TECHNOLOGY
17
tively, exposing the beginning and end of a coding strand. The middle of a gene can be hydrolyzed by pancreatic deoxyribonuclease and exonuclease 111. These single-stranded DNA segments are hybridized with mRNA and isolated. A specific DNA fragment hybridized with mercuriated RNA binds to sulfhydryl agarose. It can be eluted with mercaptoethanol bound to POly(U) agarose and subsequently eluted with ribonuclease (Dale and Ward, 1975; Longacre and Mach, 1979; Longacre et al., 1977; Brown and Balmain, 1979; Beebee and Carty, 1980). Ricciardi et al. (1979) have documented methods for isolating specific mRNAs and for mapping them to the complementary DNA sequences. Total cytoplasmic RNA is hybridized to DNA restriction fragments that have been immobilized on nitrocellulose filters after fractionation on agarose gels. The RNA species that are so selected by Southern hybridization are eluted and their products identified by translation in a cell-free system. This procedure permits preparative purification of mRNAs that are further defined by their ability to direct the synthesis of specific polypeptides (Zubay, 1977). Liu et al. (1979) have developed a microinjection method for detecting translation products from small amounts of mRNA. They were able to detect the synthesis of human fibroblast interferon thymidine kinase, hypoxanthine phosphoribosyl transferase, adenine phosphoribosyl transferase, and propionyl-CoA carboxylase in response to mRNA injected into eukaryotic cells. Using this method, these authors followed the purification of interferon mRNA sequences on sucrose density gradients. This method should aid in isolation of those mRNA sequences for which a biological, immunological, autoradiographic, or selective assay exists. This sensitive assay requires extremely small amounts of material and time. 3. Hybridization Arrest of Complementary RNA Translation In uitro cell-free protein-synthesizing systems using wheat germ embryos can be used to translate mRNA into proteins. The proteins are identified by urea polyacrylamide gel electrophoresis and specific antibody reaction. A bank of clones containing cDNA is generated. Their recombinant plasmid DNA is sonicated, denatured, and hybridized to the enriched mRNA mixture to be translated. The recombinant plasmid DNA that will arrest the translation of one of the mRNAs into the desired protein is further characterized with respect to its DNA sequences and can be further used as a probe for purifying more mRNA or DNA. When a specific mRNA cannot be purified sufficiently for it to be used as a probe, hybridization arrest of RNA translation can be employed to select specific DNA sequences (Patterson et al., 1977). Kronenberg et al. (1979) inserted a DNA copy of mRNA coding for bovine preparathyroid hormone into the PstI site of plasmid pBR322 by
18
VEDPAL SINCH MALIK
using the poly(dG)-poly(dC) homopolymer extension tails. Recombinant plasmids coding for preparathyroid hormone were identified by the ability of the specific plasmid DNA to arrest the translation of preparathyroid hormone mRNA. 4 . R-loop Hybridization
RNA can hybridize to double-stranded DNA in the presence of formamide by displacing the identical DNA strand (Thomas et al., 1976). The threestranded complex so formed is called an R-loop and can be separated by CsCl density gradient centrifugation. Using this method in combination with preparative agarose gel electrophoresis, Tonegawa et aZ. (1977) obtained a 350-fold enrichment of the immunoglobin gene coding for a mouse A chain variable region. This enriched DNA was cloned into a phage vector. Cech and Rio (1979) used R-loop hybridization and electron microscopy to map RNA transcription products of the extrachromosomal ribosomal RNA genes of Tetrahymena thermophila. In order to obtain an efficient rate of RNA-DNA hybridization, the reaction's conditions must be near to or above the melting temperature of the DNA sequences that will hybridize with RNA. White and Rosbash (1979) have constructed a vector containing a sequence high in G C content. This vector with a high strand-separation melting temperature has been designed for gene isolation by forming R-loops. When heated to a temperature at which the majority of DNA sequences are fully denatured, recombinant molecules stay together, owing to high G + C content of the vector. However, RNA is annealed to denatured regions and is retained in the form of an R-loop when the temperature is lowered. DNA molecules containing R-loops can be further fractionated by chromatography on poly(U)Sepharose columns, or on anti-RNA-DNA antibody columns (Rudkin and Stollar, 1977; Wittig and Wittig, 1979).
+
D. SYNTHETIC NUCLEOTIDE PRIMERS When poly(A)-RNA isolated from rat insulinoma is translated in a wheat germ cell-free system, about 25% of the synthesized protein is immunoprecipitated with anti-insulin sera (Villa-Komaroffet aZ., 1978; P. T. Chan et al., 1979). However, restriction endonuclease Hue111 analysis of the dscDNA prepared from total poly(A)-RNA suggests that not more than 2% of the cDNA represents insulin-coding sequences. To overcome the difficulties of obtaining bacterial clones containing full-length insulin cDNA inserts, P. T. Chan et al. (1979)constructed a highly specific cDNA probe corresponding in sequence to the 5'-region of rat insulin mRNA. This was achieved by using a specific deoxydecanucleotide as a primer for the reverse transcription
RECOMBINANT DNA TECHNOLOGY
19
of total rat insulinoma poly(A)-RNA. The synthetic decanucleotide primer d(C-C-T-C-C-A-G-C-A-G)corresponded in sequence to the region coding for amino acids 11-13 plus the first nucleotide of the codon for residue 14 of the insulin B chain as documented by Ullrich et al. (1977).Colony hybridization with decanucleotide-primed cDNA was used to identify seven clones coding for rat insulin I mRNA and nine to rat insulin I1 mRNA. Mevarech et al. (1979)have used a similar approach to isolate an mRNA species that is present at less than 1%concentration in poly(A)-containing tissue fractions. They utilized synthetic nucleotide primers to detect and selectively transcribe gastrin mRNA into cDNA (Noyes et al., 1979). Short oligonucleotide primer could be synthesized because of the knowledge of the amino acid sequence of gastrin. This method has wide applications and provides a new strategy for identifying important genes whose mRNA is less abundant. The method is applicable also for isolating chromosomal genes.
E. CHEMICAL SYNTHESISOF GENES Work on the chemical-enzymatic synthesis of bihelical DNA began in the middle 1960s (Khorana, 1978). The total synthesis of the biologically functional tyrosine suppressor transfer RNA gene of E . coli is an achievement of unparalleled importance in the history of biology and chemistry (Khorana et al., 1976). The total synthesis of the 207 base pair-long DNA included the control elements, as well as the EcoRI restriction endonuclease-specific sequences at both ends (Ryan et al., 1979a). This synthetic gene had amber suppressor activity in vivo when introduced into a suitable E. coli host after being inserted into a double amber mutant of bacteriophage A (Khorana, 1979). During the last decade, Narang and his associates have developed the triester method for the unambiguous chemical synthesis of short deoxyribooligonucleotideswith defined sequences of bases (Narang et al., 1979; Itakura et al., 1973). The simplicity, efficiency, and speed of this method have already enabled the synthesis of many biologically useful nucleotide sequences such as lac operator DNA (Bahl et al., 1977, 1978),linkers containing restriction sites of endonucleases (Bahl et al., 1976a), somatostatin gene (Itakura et al., 1977), tridecadeoxyoligonucleotideinhibitor of Rous sarcoma virus (Zamecnik and Stephenson, 1978), and human insulin gene (Hsiung et al., 1979; Goeddel et al., 1979a; Sung et al., 1979).These results indeed establish the possibility of gene synthesis if the amino acid sequence of the protein product is known and the size of the gene is not extremely large. The mammalian hormone somatostatin, which could be useful in treating acute pancreatitis and insulin-dependent diabetes, consists of 14 amino
20
VEDPAL SINGH MALIK
EcoR1,HwX pwify 77 bp fragment from gal
m
FIG.1. Construction of a plasmid (pHGH107) for the bacterial expression of human growth hormone. pHGH3 (10 pg) was cleaved with EcoRI and HaeIII restriction endonucleases and the 77 base pair (bp) fragment containing coding sequences for HGH amino acids 1-23 was isolated from an 8% polyacrylamide gel. The plasmic pHGH31 (-5 pg) was cleaved with HaeIII. The 551 bp HGH sequence and a comigrating 540 bp HaeIII fragment of pBR322 were, purified by gel electrophoresis. Subsequent treatment with XmaI cleaved only the HGH sequence, removing 39 base pairs from the 3’-noncoding region. The resulting 512 bp fragment was purified from the 540 bp pBR322 HaeIII piece by electrophoresis on a 6% polyacrylamide gel. Next, 0.3 p g of the 77 bp EcoRI-HaeIII fragment and 0.3 p g of the 512 bp HahIII-Xmul fragment were polymerized with T4DNA ligase in a 16 p1 reaction for 14 hours at 4°C. The mixture was heated at 70°C for 5 minntes to inactivate the ligase, then treated with EcoRI (to
RECOMBINANT DNA TECHNOLOGY
21
acids. Somatostatin is produced in the hypothalamus at the base of the brain and inhibits the secretion of several hormones including growth hormone, insulin, and glucagon. Somatostatin was originally obtained in milligram quantities by extracting the brain tissue of a half million sheep. The synthesis of milligram quantities of somatostatin by a few liters of E. coli implanted with synthetic gene was the first demonstration of the utility of recombinant DNA technology for producing human peptides in E. coli (Itakura et al., 1977). The DNA sequence for somatostatin could be chemically synthesized because of the knowledge of the amino acid sequence of somatostatin. This synthetic somatostatin gene was inserted at the carboxy-terminal end of the P-galactosidase gene of a plasmid vector. The carrier P-galactosidase was purified from E. coli cells carrying the synthetic somatostatin gene. Somatostatin was recovered from the carrier protein by treating the hybrid molecules with cyanogen bromide, which cleaves the peptide bond at a methionine residue. The residue has been inserted preceding the first amino acid in the somatostatin peptide. The tertiary structure of Pgalactosidase-somatostatin-fused protein prevented proteolytic degradation of the somatostatin. Achievement of the microbial synthesis of a polypeptide with the size and immunological properties characteristic of mature human growth hormone is a fine example of the sophistication that recombinant DNA technology has already reached (Goeddel et al., 1979a). Human growth hormone (HGH) consists of 191 amino acids. A precursor consisting of a signal peptide attached to the N-terminus of growth hormone is produced in the anterior lobe of the pituitary. Genentech scientists used the knowledge of the restriction endonuclease map and sequence of cDNA of HGH to tailor a bacterial plasmid that directs synthesis of mature HGH in an E. coli cell (Fig. 1). cleave fragments that had dimerized through their EcoRI sites) and with SmaI (to cleave X m I dimers), yielding a 591 bp fragment with an EcoRI “sticky”end and a SmaI “blunt” end. After purification on a 6% polyacrylamide gel, approximately 30 ng of this fragment were obtained. The expression plasmid pGH6, containing tandem lac UV-5 promoters, was treated successively with HindIII, nuclease S1, and EcoRI; then purified by gel electrophoresis, which removes most of the promoter sequence of the tcRgene, but leaves the structural gene intact. A portion (So ng) of the resulting vector, which had one EcoRI “sticky” end and one “blunt” end, was ligated to 10 ng of the 591 bp HGH DNA. The ligation mixture was used to transform x’’’~. Colonies were selected for growth on tetracycline (12.5 gmlml). Since the tcR promoter is no longer functional, tetracycline resistance is dependent upon transcription from the lac promoters reading through the HGH gene sequence into the tcRgene. Approximately 400 transformants were obtained. Colony screening by the filter hybridization procedure identified 12 colonies containing HGH sequences. The plasmids isolated from three of these colonies gave the restriction patterns expected for the correctly assembled gene when cleaved with HaeIII, PouII, and PstI. The DNA sequence of one clone, pHGH107, was determined. Reproduced with permission from Goeddel et al. (197913).
22
VEDPAL SINGH MALIK
Sequence coding for amino acids 23 and 24 as well as the 3'-noncoding region of HGH contains Hue111 sites. Restriction digestion of HGH cDNA with HaeIII yields a 551-base pair fragment, which codes for amino acids 24-191 of HGH. Genentech scientists constructed DNA sequences coding for HGH by fusing a 551-base pair cDNA fragment with a chemically synthesized DNA fragment containing an ATG initiation codon and a coding sequence for amino acids 1-23 of HGH. This synthetic-natural hybrid gene was transcribed in E. coli from a lac promoter (see Fig. 1).Since most E. coli proteins do not contain N-terminal methionine, the formyl-methionine was removed, yielding 2.4 mglliter of human growth hormone that was stable and could be recovered by breaking cells open. Martial et al. (1979) also cloned and sequenced cDNA containing the entire coding and some of the noncoding portion of HGH mRNA. The desired mRNA was isolated from acromegalic tumors. The polyadenylated RNA from tumors that had the most HGH mRNA, as determined by translation assay in the wheat germ protein synthesizing system, were used to synthesize cDNA. This cDNA, highly enriched in full-length copies of HGH mRNA as judged by molecular weight and restriction enzyme analysis, was inserted in pBR322. For growth hormone expression, the cDNA was placed under the control of t r p regulatory elements by inserting it into a vector that contains the regulatory region, the first structural gene (WE)and 15%of the second gene (trpD)of the E . coli trp operon. A fusion protein containing the amino-terminal region of the trpD protein, amino acids coded by the 5'untranslated portion of HGH mRNA, the 26 amino acids of the signal peptide, and all of the amino acids of the growth hormone constitute 3%of total bacterial protein when cells are derepressed for trp transcription (Martial et al., 1979). Several fused proteins such as P-lactamase rat proinsulin (Villa-Komaroff et al., 1978), P-lactamase rat pregrowth hormone (Seeburg et al., 1978a), and P-galactosidase-chickenovalbumin (Fraser and Bruce, 1978) have been expressed by cloning cDNA. The fused proteins are still recognized by specific antibody but they have not yet been processed to yield natural product. However, cloning of A repressor (Backman et al., 1976)and mouse dihydrofolate reductase (Chang et al., 1978; Alt et al., 1978) yielded natural gene product. These proteins are probably initiated at the initiation codon of the mRNA derived from their specific genes.
IV. Making Recombinant DNA Molecules in Vitro In all the productions of nature or of art, what already exists potentially is brought into being only by what exists actually.
ARIST~TLE(FOURTHCENTURY BC)
RECOMBINANT DNA TECHNOLOGY
23
A. HOMOPOLYMER TAILING
In 1970, H. Gobind Khorana and co-workers discovered that DNA ligase produced by E. co2i virus T4catalyzes end-to-end linkage of DNA (Lehman, 1974). Khorana’s laboratory exploited T4 ligase to link short synthetic sequences of nucleotides with single-strand projections into longer DNA pieces. Now using C02+as a cofactor, flush-ended DNA or DNA with 5’sticky ends works as a primer for terminal transferase (Roychoudhury et al., 1976a,b). DNA of various sources can also be treated with A exonuclease to remove a small number of nucleotides from the 5’-end. Deoxynucleotidyl transferase is then used for stepwise addition of a series of identical nucleotides at 3’-OH ends of a DNA strand. A block of identical nucleotides is added to one population of DNA and a block of complementary nucleotides is added to DNA from another source. The two preparations of DNA are then annealed by hydrogen bonding and covalently linked by the combined action of exonuclease 111, DNA polymerase I, and DNA ligase. If the homopolymer tails are longer than 40 nucleotides, the joint is stable, so the hybrid molecule can be transformed without in vitro ligation. This method will join any two species of DNA irrespective of their size and base sequences of their ends, and has been successfully used for cloning DNA (Jackson et aZ., 1972; Lobban and Kaiser, 1973; Bollum, 1974, 1978; Clarke and Carbon, 1976; Wensink et al., 1974). DNA joining is only intermolecular, since intramolecular circularization is prevented by the homopolymer tailing. The original starting material can be recovered with altered ends only (Hofstetter et aZ., 1976; Roberts, 1978; Backman et al., 1976). However, addition of poly(dG) tails to SmaI- or PstI-cleared DNA regenerates the recognition sequence of the enzyme originally used. Single-strand breaks incurred during DNA preparation can also be a starting point for terminal nucleotidyl transferase, and cloning of such DNA could yield deletions, additions, or replacement at the break point. B. LIGATIONOF RESTRICTIONFRAGMENTS Bacteria possess a unique combination of the two enzyme activities to prevent replication of invading DNA. The cell is able to methylate its own DNA at specific adenine sites. The specific action of cellular enzymes recognizes and degrades any DNA that is not modified by a species-specific methylation pattern. The restriction endonucleases cleave the foreign DNA at specific base sequences that are protected by methylation in the host DNA. These enzymes are widely distributed in bacteria and are of two kinds. Class I enzymes are nonspecific in cleavage and require ATP, magnesium,
24
VEDPAL SINGH MALIK
and S -adenosylmethionine as cofactors for activity. They recognize specific sites on DNA but make a limited number of double-stranded random cuts away from recognition sites. The state of methylation at the restriction site determines the subsequent enzyme action (Smith, 1979). Most class I1 restriction endonucleases recognize and cleave a specific sequence of base pairs in DNA duplex and require only magnesium. These are used for DNA sequencing, isolation, physical mapping, cloning, and structural analysis of highly repetitive satellite DNAs and eukaryotic genomes (Fonty et aZ., 1979). These enzymes have also been used to study site-specific interaction of DNA with protein molecules such as RNA and DNA polymerase, transcriptional repressors, and activators (Nathans, 1979). A majority of enzymes classified as restriction 11 endonucleases are not associated with the restriction-modification system (Roberts, 1976) and many enzymes from taxonomically different organisms recognize the same sequence. Roberts (1976) coined the name of isoschizomers for such enzymes. However, isolation of isoschizomers is no reflection of genetic relatedness since similar isoschizomers occur in gram-negative Hemophilus and gram-positive Cwynebacterium. Several enzymes cleave both double- and single-stranded DNA. It is possible that such enzymes recognize and cleave small DNA duplex regions generated by secondary loops within second-stranded DNA. Some enzymes produce fragments with 5’-single-strand extensions (HpaII, HinI, EcoRI, EcoRII), 3’-single-strand extensions (PstI, HhaI), and flush ends (HaeIII). Enzymes of general use are produced commercially (Table 11). Another method of making cohesive termini for joining DNA molecules depends on the ability of restriction endonucleases to cleave DNA into complementary-ended fragments. The cleavage is at or near an axis of two fold rotational symmetry; a palindrome, where nucleotide sequence on one DNA strand is read 5’ to 3’, is the same as the sequence on the complementary strand read in the 3’ to 5’ direction. Because of the symmetrical palindromic arrangement of nucleotides in the vicinity of the cleavage point, the restriction enzymes produce DNA molecules with cohesive ends. During DNA isolation, most DNA is sheared randomly to molecular weights ranging from 1to 40 x lo6. However, by controlled random shearing of large DNA, fragments of a size suitable for cloning can be obtained (Adam and Zimm, 1977). In this case, a large number of restriction endonucleases cleave DNA at defined points and generate a unique set of discrete fragments that are ideal far cloning. If the restriction site is within the gene, then partially digested DNA or digestion in presence of distamycin can be used (Nosikov et al., 1976). A different restriction enzyme that does not cleave within the gene is another choice. Hybrid molecules cloned in this
TABLE I1
SOME USEFUL RESTRICTIONENZYMES Restriction endonuclease
Sequence recognized
Microorganism
AluI
5‘-A GJC T-3‘ 3‘-T C t G A-5’
Arthrobacter luteus
BamHI
5 ‘ d G A T C C-3’ 3’-C C T A GtG-5’
BociUus amybliquefaciens H
BglI
5’. . G c c N N N NJN G G c . . 3’ 3‘. . C G G NtN N N N C C G . . 5‘ 5 f . .A ~ A cT T . . 3’ 3‘. T C T AGTA.. 5’
BglII
5 ’ d A A T T cat 3’-C T T A AtG-5’
EcoRI
BaciUus globigii B. gbbigii E. coli RY 13 canying plasmid RI
EcoRII
5’- C C A G G-3’ 3‘-G G T C C t - 5 ‘
E. coli RK 22
HaeII
5’-G G k C-3’ 3’-C C t G G-5’
Hemophilus aegyptius
HaeIII
5’-Pu G C G CIPy-3’ 3’-PytC G C G Pu-5’
H. aegyptius
Hincll
5’. . G T PyiPu A C . . 3’ 3’..CAPu?PyTG..5’
Hemophilus influenzae &
Hind111
5 ’ . . A J A G C T T . . 3’ 3’. . T T C G A t A . . 5’
H. influenzae R,, com-’Q
Hinfl
5t.. c..3‘ 3’..C TNAfG..5’
H. influenzae Rf
5’.. G A C G C N N N N N
1 . . . . . . . . . 3‘
HemPhilus gallinamm
3‘..C T G C G N N N N N
N N N N N t...5’
HgaI
ANT
(Continued )
TABLE I1 (Continued ) Restriction endonuclease
Sequence recognized
Microorganism
HhaI
5‘-G c GJC . . 3’ 3‘-CtG c c . .5’
Henwphilus hemolyhcus
HhaII
5’.. G J A N T C . . 3 ‘ 3’..C TNAtG..5’
H. hemolyticus
HpaI
5’-G T TJA A c-3’ 3’-C A AtT T G 5 ’
Henwphilus parainfluenure
HpaII
5t-CJC G G-3’ 3 ‘ 4 G CtC-5’
H. parainjluenzae
MboI
5’.. 3.C A T C . . 3’ 3‘..C T A Gt..5’
MorareUo boois
MboII PstI
S’.. G A A C A N N N N N N N 3’..CTTCTNNNNNNN
N J . . 3’ . ..5‘
5’-cT G c A J G - ~ ~
M. boois
Prwidencia stuartii
3 ’ 9 A C G T C5’ 5’.. GJT C G A C . . 3‘ 3 ’ . . C A C G T t G . . 5‘
Streptomyces albus
CCCJGGG
Smatiu wcescens S,
5‘. . T k G A . . 3’ 3‘. . A G C t T . . 5’
Thennus aquatinrs
XbaI
5 ’ - T k T A G A-3’ 3‘-A G A T CtT-5‘
Xanthrrmonas badrii
XhOI
5’-C.l?. C G A C 3 ’ 3’-G A G C T t C 5 ’
Xanthomonas hulcicolu
SalI
RECOMBINANT DNA TECHNOLOGY
27
way can be digested later by the same enzyme to recover the original DNA segment. Enzymes that make staggered cuts are especially useful. The enzyme DNA ligase is used to covalently link the 3’-OH terminus of one strand to the 5’-phosphate end of a second strand. Thus the enzyme can repair singlestrand breaks such as those present in hydrogen-bonded sticky ends of two DNA preparations that have been cleaved with the same restriction enzyme. DNA ligase from E. coli requires NAD as cofactor, while DNA ligase from T4 and higher organisms utilizes ATP as cofactor. In addition to repairing single-stranded breaks as does E. coli enzyme, T4 ligase can link RNA and DNA strands aligned on a complementary DNA template. Another enzyme RNA ligase joins two single-stranded DNA, or two RNA molecules, or RNA molecule to single-stranded DNA molecules (Sugino et al., 1977). During the course of the ligation reaction, most often the vector anneals back to the original form, which decreases the percentage of real recombinant molecules formed. However, advantage can be taken of the identical cohesive termini produced by BglII and BamHI cleavage. When two various DNAs are ligated in the presence of these two enzymes, 100% of the recombinant molecules are obtained (Blakesley, 1980; Rao and Rogers, 1978). Some vectors contain sites where insertion of foreign DNA leads to loss of antibiotic resistance. The kanamycin determinant of Pkc, is inactivated by insertion at the BglII site. Similarly, pBR322 contains several sites where insertion of foreign DNA inactivates genes for resistance to ampicillin or tetracycline (Boliver et al., 1977; Sutcliff, 1978a). Alkaline phosphatase treatment of the vector prevents self-ligation and consequently increases the proportion of recombinant plasmids (Ullrich et al., 1977). Linkage of two different DNA molecules is favored by a high concentration of DNA molecules. Therefore, after ligation of DNA segments at high concentrations of DNA, the mixture is sometimes diluted so that circularization occurs preferentially (Goff and Berg, 1978, 1979). However, .the rate of circularization decreases as the length of the DNA segment increases. Owing to this effect and to high transformation efficiency with small plasmids, short DNA segments are cloned more efficiently than long ones.
C. BLUNT-END LIGATION Sgaramella et al. (1970) discovered that T4ligase enzyme can join (bluntended) fully base-paired DNA duplexes. Even though blunt-end joining occurs at a much slower rate compared to sealing of single-stranded nicks, it is of considerable importance for joining DNA molecules that lack cohesive ends (Mottes et al., 1977). Any DNA segments obtained by shear, by using two different restriction enzymes or by using restriction enzymes that pro-
28
VEDPAL SINGH MALIK
duce blunt ends, can be joined without adding homopolymer tails (Sgaramella, 1971). DNA polymerase can be used to fill out non-flush-ended DNA duplexes. Blunt-end ligation of longer molecules obtained by shearing DNA at random rather than at specific sequences offers the possibility of cloning intact genes, since the DNA should appear on some fragment. Chemically synthesized DNA sequences can also be linked by this procedure, where it is necessary not to add additional bases, e.g., in cloning of promoters or specific restriction enzyme recognition sequence. However, blunt-end ligation does not allow the recovery of the cloned fragment after the recombinant DNA has been propagated. Backman et al. (1976) used flush-end fusion techniques involving no sequence overlap to construct a plasmid carrying the repressor gene of bacteriophage A fused to the promoter of lac operon. In some cases, the abutting of DNA fragments generated by different restriction endonucleases creates a sequence at the junction that is cleaved by one of the restriction endonuclease (Table 111). These findings expand the spectrum of utility of TABLE 111
USE OF
THE
Restriction endonuclease
EcoRl
FILLING-INMETHOD WITH VAFUOUSRESTRICTION ENDONUCLEASES~,~
Recognition sequence
GJAATTC
Requirement for site regeneration 5‘C
Subsite recognition sequence
Subsite
J AATT
EcoRJ
TTAAf
CTTAAtC EcoRII
JCCAGG
None
JCCACG
EcoRII
GCTCC f Hind111
A~AGCTT
GCTCCt 5‘T
Alu I
GJCATCC CCTACtG
5’C
MboI
AJGATCT
5’T
AGJCT TCtCA
TTCCAtA
Barn1 BgZII
JGATC CTAGf
MboI
JGATC
CTAC?
TCTACtA ~~~
~
Several endonncleases that produce 5’-protruding ends are listed with the DNA sequence they recognize. After filling in these ends with DNA polymerase I, the original recognition sequence can be regenerated by joining the filled-in end to a flush-ended DN molecule that meets the requirement listed in the third column. When joined to a flush-ended fragment not meeting that requirement, the filled-in end generates a subspecificity, described in the fourth and fifth columns. The top line of each recognition sequence reads from the 5’- to the 3’end; the bottom line reads in the opposite direction. Reproduced with permission from Backman et al. (1976).
RECOMBINANT DNA TECHNOLOGY
29
endonucleases and allow recovery of fragments that have been inserted by blunt-end ligation. D. DNA LINKERS
1. Blunt-End Linkers Restriction site DNA linkers for manipulating DNAs that lack cohesive ends (sheared DNA, synthetic DNA, cDNA) are commercially available. The decanucleotide d(C-C-G-G-A-T-C-C-G-G) contains recognition sequences of BamHI, HpaII, and HapII. When joined to blunt-ended DNA by polynucleotide ligase, this linker adds the recognition sequences of these restriction enzymes to both ends of the DNA fragment, which can be inserted into a vehicle by using the restriction enzyme cohesive termini. If the DNA fragment is not flush-ended, it can be first digested with the Aspergillus nuclease S1 to produce even ends (Ghangas and Wu, 1975), since this one linker can be used with several restriction enzymes. An enzyme that does not cleave the DNA fragment to be cloned can be used. The high number of G-C base pairs in this self-complementary restriction site linker gives double-stranded DNA great stability. However, a large DNA fragment is likely to contain many restriction sites and therefore cannot be cloned this way. The improved phosphotriester method has been used (Bahl et al., 197613; Scheller et aZ., 1977) to synthesize the linker sequence for BamHI d(C-C-G-G-A-T-C-C-G-G),EcoRI (C-C-G-A-A-T-T-C-G-G),and HindIII.
2. Preformed Adaptors Such linkers do not require cleavage with restriction enzymes for generating cohesive ends and have a blunt end and a single-stranded cohesive end corresponding to one of the restriction enzyme recognition sites. The adaptor will join to DNA only at the blunt end if the cohesive end lacks 5’phosphate. The DNA joined to the adaptor is phosphorylated before ligating to the vector. Adaptors with a six-nucleotide-longduplex region have been synthesized to contain the recognition sequence for XmaI and S m I and cohesive ends for BamHI (Norris et al., 1979).
3. Conversion Adaptor When a DNA fragment obtained by digestion with one restriction enzyme is inserted into a different restriction site in the vector, conversion adaptors are used. For example, using such an adaptor, an EcoRI-cleaved piece of DNA can be inserted into the BamHI site of the vector. There are two methods of preparing conversion adaptor: (1) blunt-end ligation of two different types of preformed adaptors and (2) synthesis of two
30
VEDPAL SINGH MALIK
different single-stranded decadeoxynucleotides, each containing a sequence of four nucleotides at the 5’-end corresponding to the central part of the recognition sequence of two restriction enzymes, and a six-nucleotide-long d(C-C-C-G-G-G) self-complementary sequence at the 3’-end. Annealing these two decadeoxynucleotides causes a conversion linker to form with a BamHI sticky terminus on one side and an EcoRI, 5’-sticky terminus on the other (Narang et al., 1977). This adaptor can be used to clone a DNA segment that has an EcoRI recognition sequence at one end and a BamHI sequence at the other. Such an adaptor was ligated to the lac operator fragment carrying EcoRI cohesive ends. The lac operator DNA, now car?ing BamHI sticky ends, was ligated to BamHI-cleaved pBR322 plasmid DNA and transformed into E . coli (Marians et al., 1976; Bahl et al., 1976b). The transformed cells were plated on nutrient agar plates containing X-gal (5-bromo-4-chloro-3indolyl-P-D-galactoside). The transformants produced a large amount of 4-galactosidase, which hydrolyzed X-gal and released blue dye 5-bromo-4-chloro indigo. Escherichia coli transformants containing lac operator ligated to the multicopy plasmid pBR322 have all lac repressor bound to the cloned operator and thereby derepress lac operon. 4. Single-stranded Adaptors
Such adaptors can be used to clone a DNA fragment with 3’-protruding ends (PstI-digested DNA into the BamHI, or EcoRI-digested vector with 5’-protruding ends). These linkers are single-stranded decadeoxynucleotides containing a five nucleotide sequence complementary to the 3’-protruding end and the other pentanucleotide sequence complementary to the 5’cohesive end. Two such linkers, the EcoRI-PstI (5’-A-A-T-T-C-C-T-G-CA-3’) and the EcoRI-Hue11 (5’-A-A-T-T-C-G-G-C-G-C-3‘)adaptors, have been synthesized by the triester method. Bahl et al. (1976b) ligated BamHI decamer to a 21-base pair-long synthetic lac operator. Duplex DNA cleavage of this large fragment with BamHI produced a lac operator flanked by BamHI-generated cohesive ends. This operator was then inserted into plasmid pMB9 in the Bum HI restriction site (Rodriquez et al., 1976). Sadler et al. (1977) synthesized single-stranded fragments of the lac operator that, upon annealing, produced a central piece of lac operator flanked by singlestrand sequences similar to those yielded by EcoRI endonuclease digestion. This synthetic lac operator was then spliced into the EcoRI site of pMB9 and transformed into E. coli. About 10% of the tetracycline-resistant transformants had functional lac operator. Functional lac operator has been cloned independently by five groups (Marians et al., 1976; Bahl et al., 1976b; Heyneker et al., 1976; Sadler et al., 1977; and Scheller et al., 1977). Linker molecules have to be so designed that, after linking, triplets are
RECOMBINANT DNA TECHNOLOGY
31
introduced on either side of the DNA to be cloned. This would leave the reading frame for protein synthesis unchanged. A variety of linkers may be available commercially in the near future. These may offer promoters, operators, new restriction sites, ribosome binding sites, chain initiation, and termination sites flanked by restriction enzyme recognition sequences.
V. Transformation Transformation is the process of introducing in uitro-constructed recombinant DNA molecules into the cytoplasm of an organism (venema, 1979). Even though transformation is not common among most bacteria, it occurs naturally in Streptococcus, Azotobacter, Pneunwcoccus, Bacillus, Henwphilus, Neisseria, Acinetobacter, and Thermoactinomyces vulgaris (Deddish and Ravin, 1979; Page and Tigerstorm, 1979; Sisco and Smith, 1979; Morrison and Mannarelli, 1979; Morrison and Baker, 1979; Fuchs and Dobrzanski, 1978). Mandel and Higa (1970) discovered that treatment of E . coli cells with calcium chloride enables them to take up viral DNA. Cohen et aZ. (1972) and Cosloy and Oishi (1973) found that a similar treatment made E . coli cells permeable to purified R factor DNA. This method has been critical for the use of plasmids as cloning vectors and has been used with SalmneZZa (Lederberg and Cohen, 1974), Enterobacter (Taketa, 1972; Momson, 1977), Staphylococcus (Lofdahl et aZ., 1978a,b), and Pseudomonas (Chakrabarty, 1976). Taketa (1972) found that Ca2+-inducedtransformation of E . coli allowed uptake of RNA and single- and double-stranded DNA. Heterologous duplex DNA but not RNA or single-stranded DNA inhibited the transformation by duplex viral DNA. Ca2+could not be substituted for any other cation, but Mg2+ doubled the number of Ca2+-inducedtransformants. Zn2+ severely inhibited transformation. Cells from the exponential growth phase were best for transformation. Different growth media had no effect on transformation, but temperature did. Efficiency of transformation was decreased if cells were grown below 32°C. No transformation occurred if the Ca2+treatment was performed at 3TC, suggesting that lower temperature was necessary for the Ca2+-mediatedbinding of DNA to cell surfxe. Most DNA molecules can transform cells successfully, but only rare cells are competent to take up DNA. Individual competent cells can be transformed by more than one plasmid simultaneously, which allows indirect selection of a cryptic plasmid if transformation is carried out with a mixture of a cryptic plasmid and a small selectable plasmid. High cotransduction fiequencies (80%)with a small cryptic plasmid and pSCl01 have been obtained
32
VEDPAL SINGH MALIK
(Kretschmer et al., 1975). A temperature-sensitive mutant (pSC205) that is eliminated from the cotransformed cells leaves the cryptic plasmic behind for further experimentation. The nature of transforming nucleic acid in calcium-treated E . coli has been studied by Strike et al. (1979). Many alterations of the initial transformation procedure of Higa and Mandel have yielded very high transformation rates (Norgard et al., 1978; Kushner, 1978). Mutants lacking exonuclease and restriction endonucleases are used as recipients to prevent the degradation of incoming foreign DNA. Mutants altered in the cell envelope are also transformed at a high rate. Prolonged incubation of E . coli cells in calcium chloride improves the competence, and 2 x lo' transformants per microgram of pBR322 DNA can be obtained routinely (Dagert and Ehrlich, 1979; Molholt and Doskocil, 1978; Norgard
et al., 1979). Liposomes can be used for introducing specific DNA sequences into cells. Fraley et al. (1979) describe the entrapment of plasmic pBR322 within liposomes and then transfer to E . coli by standard transformation procedure at a frequency of 1% of the control. This frequency was unaffected by the addition of DNAase to the incubation mixture. Procedures for high-frequency transformation of protoplasts of B . subtilis (Tanaka, 1979; Chang and Cohen, 1979; Mottes et al., 1979), Streptomyces (Bibb et al., 1978; Thompson et al., 1980; Suarez and Chater, 1980), Spirillum lipoferum (Mishra et al., 1979), Neurospura crassa (Case et al., 1979; Mishra, 1979), and yeast (Hinnen et al., 1978; Gafner and Philippsen, 1980; Petes, 1980) have now been developed and can be routinely used to introduce recombinant DNA molecules into these organisms. Even though procedures for transformation of industrial strains may differ, base line information is now available to make a start in the direction of introducing foreign genes into commercially important microbes.
VI. Host-Vector Systems Most segments of DNA do not have an inherent capacity for selfreplication and should be linked to DNA sequences that are self-replicating. Genetic signals required for replication are host-specific. If foreign DNA is to be replicated in an organism, it should be ligated to a suitable DNA fragment (vector)that can replicate in that organism. The recombinant DNA molecules consisting of the desired foreign DNA and the vector can be introduced into the host, and cells that have received the DNA chimeras can then be identified. The yield and purity of cloned genes and efficiency of ligation and transformation are greater with small vectors. However, origin of replication, gene insertion sites, and genes useful for selection in trans-
RECOMBINANT DNA TECHNOLOGY
33
formation determine the minimum size of the vector. For easy recovery of the recombinants, an insertion site in a vector gene whose function is easily identifiable is a good attribute (Fig. 2). Then clones containing a plasmid with inserted DNA that inactivates the gene can be selected easily from clones with wild plasmid phenotype. Another desirable property of the vector is its role as a promoter site for initiating transcription across the inserted fragment. Foreign genes can be transcribed from this vector promoter if their normal promoters are not recognized by the host transcription machinery. Promoters can be followed by the ribosome binding sites, initiation codon, and then a restriction site to insert the DNA for obtaining expression.
nRPQ33
FIG.2. Plasmid pBR322. pBR322 is obtained from pBR313 and has a molecular weight of 2.6 x los. pBR322 contains a single PstI restriction site, located within the ampicillin-resistant gene. There are also single sites for the restriction endonucleases EcoRI, HindIII, BamHI, and SalI, all located within the tetracycline-resistant gene. Reproduced with permission from Bethesda Research Laboratories, Inc., Rockville, Maryland.
34
VEDPAL SINGH MALIK
A. Escherichia coli 1. Plasmids Cohen et al. (1973) were the first to construct a small plasmid-cloning vector (pSC101). It carried the DNA sequences essential for replication in E. coli, a selectable gene conferring tetracycline resistance and a single site for EcoRI that was outside regions determining replication of the vector and selectable gene of tetracycline. Plasmid pSClOl was used to clone ribosomal genes from Xenopus laevis (Morrow et al., 1974), histone genes from sea urchin (Kedes et al., 1975), and mouse mitochondrial DNA (Chang et al., 1975). Now, many derivatives (pBM9, pBR322) of plasmid ColE1 have been developed as vectors for cloning foreign DNA into E. coli (Bastia, 1978;Tait and Boyer, 1978; Sutcliffe, 1978b; Helinski, 1979).These plasmid vectors are present as 3 0 5 0 copies per E. coli cell under normal conditions of growth. Their DNA can be amplified to about 45% of total cellular DNA if the E. coli is grown in the presence of chloramphenicol. Consequently, very high yields of both plasmid DNA and any DNA segment inserted into the plasmid can be obtained (Chakrabarty, 1978; Norgard et al., 1979). Rao and Rogers (1978) constructed another plasmid vector, pKC7, by replacement of the HindIII-BamHI fragment of pBR322 with 1.8 kb HindIII-BamHI Tn5 segment derived from A. This vector normally replicates by the plasmid system, but amplification of the vector is induced by thermal induction of the A replication system. This vector confers resistance to ampicillin (100 mg/ml) and kanamycin (100mg/ml) but not to tetracycline. Plasmid vector pKC7 contains several new unique restriction sites in addition to most that are in pBR322 (Rao and Rogers, 1979). Depending on the orientation of insertion of DNA segments in the single BglII site, both kanamycin-sensitive and kanamycin-resistant clones are produced. Similar results have been obtained when DNA is inserted in the HindIII site of pBR322 (Widera et al., 1978). Some pBR322 recombinants carrying DNA inserts in the HindIII site are resistant to tetracycline and others are sensitive, because the BgIII site in pKC7 and HindIII site in pBR322 are in the beginning of the promoter for the kanamycin and tetracyline genes, respectively. Backman et al. (1976) constructed plasmid vectors that carry the bacteriophage A c1 gene and confer immunity to A infection on host bacteria. Using the same plasmid pKB158 selection for tetracycline resistance was about twice as efficient as selection for immunity. Bernard et al. (1979) have constructed a plasmid vector (pHUB4) into which restriction fragments can be inserted so that they are transcribed from
RECOMBINANT DNA TECHNOLOGY
35
the A PL promoters, and the A N gene product stimulates reading through transcription terminators downstream from A PL. A hundredfold increase relative to the wild-type E. coli in w aporepressor level was obtained when a 1.3 kb BamHI restriction fragment containing entire trpR gene was cloned in pHUB4. Uhlin et a2. (1979) derived a vector that has lost the control of its replication above 35°C. This vector replicates without copy number control and its DNA could amount to 75% of the total cellular DNA. During the vector amplification, growth and protein synthesis continue at a normal rate. Final gene dosage decreases with increasing weight of the recombinant plasmid. Degree of amplification is limited by the total amount of plasmid DNA rather than the number of plasmid copies. P-Lactamase was amplified up to 400fold when cloned into this vector. Construction of E. coli plasmid vectors that can be used to isolate promoter active DNA fragments has been reported (An and Friesen, 1979; West et al., 1979). These “promoter-probe” plasmids select for promotercontaining DNA fragments by insertional activation of the tetracycline resistance gene that has an inactive promoter.
2. Cosmids Cosmids are plasmids usable as gene-cloning vectors in an in vitro packaging system by coliphage A (Collins, 1979; Collins and Hahn, 1978; Collins and Bruning, 1978). These plasmids carry the A bacteriophage COS site, which allows the plasmid, including large inserted DNA fragments, to be packaged as pseudobacteriophage A particles. Such particles adsorb to recipient E. coli and introduce the large recombinant DNA into the host. Original cosmids are very small and therefore are not packaged as bacteriophage A particles, which allows selection of recombinant molecules of a certain size only. Since the average size of the cloned fragment is comparatively large (10 megadaltons), fewer recipient clones are screened for the desired gene without a selective marker (Mayer et al., 1979).
3. Bacteriophage A Phage A (Fig. 3) has been well characterized physically, genetically, and chemically (Szybalski and Szybalski, 1979). Most A vectors are unable to lysogenize, since they have deletions for att+, int+, or c 1genes essential for lysogeny. Bacteriophage A unable to establish lysogeny can be converted into the plasmid state at a low frequency. Furthermore, A deleted for int+ and att+ genes can lysogenize E. coli at secondary sites at low frequency. However, about one-third of phage A can be replaced without any impairment of the lytic cycle. The upper limit of DNA that can be packaged into the phage head is about 105% of the normal A genome. The lower limit is
36
VEDPAL SINGH MALIK
c0.L
LEFT ARM
m Nu1
J
MATURE PHAGE
0.a'
b mqion
attP
5'G
RIGHT ARM oosR
N cI OP
R
r!~'
3'
CO.
.
c!. .o.ttL b.0'
N
CI
OP
R
cos Nu1
J
b region
attR I....
PROPHAGE
bio I .
o'b'
FIG.3. A simplified genetic and physical map of the bacteriophage h genome. The heavy lines represent the complementary 1 arid r DNA strands. The genome is presented in the form of an open circle obtained by bending downward the left and right termini of the linear A DNA molecule (drafted above the circle), according to the convention. Strand 1 is transcribed leftward (counterclockwise) and has a 5 ' 4 at its left cohesive terminus, m. Strand r is transcribed rightward (clockwise) and has a 5'-A at its right cohesive terminus, n'.Strand r displays a higher density in the CsC1-poly(U,G)gradient and a lower density in the alkaline CsCl gradient than strand 1. The shaded arrows represent the various leftward and rightward transcripts, always placed next to the complementary coding strand. The prophage map (drawn at the bottom) is a circular permutation of the linear map of mature DNA (drawn at the top). The RNA polymerase binding sites are represented by small black circles near the center of the drawing. The approximate positions of the ribosomal binding sites (short radial bars near the center) were determined only for the exo-m' portion of A. Reproduced with permission from Szybalski and Szybalski (1979).
RECOMBINANT DNA TECHNOLOGY
37
about 80%. Therefore, a A vector with deletion of 20% of its own DNA can accept an insertion amounting to 25% of the total length of A DNA, which is about 50,000 base pairs. Phage A vectors usually lack a restriction endonuclease target in the essential part of the genome and have one restriction site in the dispensable region. Certain A vectors have two restriction sites in the nonessential region. This, then, permits insertion of foreign DNA by replacement of A DNA. Plaque type of these recombinant phage is altered which can be visually screened (Murray et al., 1977). Foreign DNA can also be inserted into A vectors so that its expression is from the very efficient A leftward promoter PL. In such recombinants, phage A N gene product allows RNA polymerase to override transcriptional stop signals. Regulatory mutants in A gene Q can be used to prevent cell lysis and expression of the late A genes. Following infection of E. coli, a A phage carrying tryptophan synthetase gene, constructed by such reasoning, produced tryptophan synthetase as a very high proportion of total cell protein (Moir and Bremmar, cited in Murray, 1976; Crawford and Stauffer, 1980; Guarente et al., 1980). Phage A vectors in which the inserted DNA fragment is transcribed from A PL or lac promoter have been constructed by Blattner et al. (1977).These A vectors are named after Charon, the mythological boatman of the River Styx. Some of these phages (charons 8 and 9) can be used to clone up to 25,000 base pairs of DNA fragments produced by EcoRI, Hind111 and PstI. Other charon phages have restriction sites for two enzymes and can be used to insert DNA digested with pairs of enzymes, which prevents self-cyclization of heterogenously terminated vectors and fragments. Some charon vectors can be converted into viable phage only by incorporating foreign DNA, and formation of a plaque suggests successful cloning. Following insertion, charons 6 and 7 produce clear rather than turbid plaques. Charon 12 is unable to plaque on pol A strains of E. coli if foreign DNA is inserted into the A red gene. When DNA is inserted into 2acZ gene of A lac-5 derivative charons (2 and 16), colorless rather than colored plaques are produced on lac-indicator bacteria. Several other A vectors have been constructed (Skalka, 1978; Enquist et al., 1976; Donoghue and Sharp, 1978). 4 . Filamentous Single-Stranded Phages
Since the length of the virus particle is determined by the length of virus DNA, these viruses can accommodate almost any size of inserted DNA. Such recombinant viruses may or may not be defective. Furthermore, the rapid DNA-sequencing technique of Sanger and Coulson (1975) utilizes single-separated DNA strands. A new class of cloning vector, the singlestranded bacteriophage M13, can be used as a ready source of single-strand
38
VEDPAL SINGH MALIK
DNA of target DNA sequence (Denhardt et al., 1979). Barnes (1979) has constructed a M 13-histidine transducing cloning phage, known as M 13Hog, which has a single EcoRI site and amarker (hisD)for auxotrophic selection. Gronenborn and Messing (1978) have constructed an M13 lac cloning vehicle that has a single EcoRI site in the ffih codon of the P-galactosidase gene. Two hundred copies per cell of the replicative form of this vector occur as double-stranded DNA (Buchel et al., 1980). Cells never lyse but excrete many copies of phage single-stranded DNA. DNA sequences inserted in the EcoRI site are transcribed from lac promoter and translated when in phase. If inserted DNA has its own promoter, then fusion products to the N-terminal 130 residue of P-galactosidase are produced. These can be assayed by in vitro complementation with inactive mutant A-M15 P-galactosidase (Langley et al., 1975).
B. Bacillus subtilis Bacillus species produce a variety of different enzymes and antibiotics and are therefore important in the fermentation industry (Yoneda et al., 1979). Unlike E . coli, Bacillus lack endotoxins in their architecture. Genetic manipulation of Bacillus can be achieved by high-frequency transformation. Several generalized transducing phages of B . subtilis are also known. It has about 200 genes well mapped on its chromosome (Hoch, 1976). Plasmids
Several Bacillus species harbor small cryptic plasmids, (Lovett and Burdick, 1973; Bernhard et al., 1978; Bingham et al., 1979; Gonzalez and Carlton, 1980). Furthermore, many drug resistance plasmids of Staphylococcus aureus can replicate and express their drug resistance genes in B . subtilis (Ehrlich, 1977, 1978; Iordanescu, 1975; Gryczan et al., 1978; Gryczan and Dubnau, 1978; Chi et al., 1978; Canosi et al., 1978; Murphy and Novick, 1979). Development of the S . aureus plasmid as vectors now allows cloning of DNA sequences in B . subtilis. Specific segments of B . subtilis chromosome can thus be maintained in an extrachromosomal state. This will allow gene purification and complementation of regions of B. subtilis chromosomes not amenable previously to such analysis (Haldenwangand Losick, 1979; Segall and Losick, 1977). A colony bank of E . coli containing hybrid plasmids representative of the B . subtilis genome has been constructed (Rapoport et al., 1979). The initial cloning of B . subtilis chromosomal fragments in B . subtilis used 3-megadalton neomycin-resistance plasmid pUBllO as vector. Keggins et al. (1979) used plasmid pUBllO as a vector to clone fragments of Bacillus
RECOMBINANT DNA TECHNOLOGY
39
DNA that complement trp mutations in B. subtilis. The levels of the plasmid-specified trp enzymes in B. subtilis were higher than the repressed level of chromosomally specified trp enzymes. Certain cloned trp fragments had a single HindIII restriction site. Insertion of HindIII-generated DNA sequences into such plasmids abolished trpC complementing activity and reduced by tenfold the plasmid-specified trpF product. These results suggest that tryptophan cluster in B. subtilis is transcribed as a unit in the direction of trpE trpA. Gene cloning was used to determine polarity of an operon by Crabeel et al. (1980). C. STREPTOMYCETES A change must sometimes be made to things one is not accustomed to.
HIPPOCRATES (FIFTHCENTURY, BC)
Antibiotics are the best known examples of secondary metabolites produced by streptomycetes. Since some of them are toxic to their producers, the producers have evolved mechanisms that protect them against this toxic effect. The formation of secondary metabolites is usually repressed during logarithmic growth and is depressed during the stationary phase. In organisms that produce secondary metabolites, certain primary pathways are not well regulated and the overall metabolism lacks coordination, which results in the accumulation of intermediates and end products of primary metabolism. To prevent this accumulation, many regulatory mechanisms have evolved among microorganisms. For example, E. coli switches off its operons if the concentration of intercellular metabolites exceeds certain levels. Industrial organisms, such as streptomycetes, lack coordinated regultion of metabolism but have evolved an alternative strategy. They developed subsidiary pathways to dispose of intracellularly accumulated toxic levels of metabolites. Genes determining such subsidiary pathways are superimposed on growth and their expression is overridden by a growth-linked regulatory mechanism (Malik, 1979a). It is only during the suboptimal or stationary growth phase when the growth-linked overriding regulatory mechanism is abolished that the expression of genes involved in the antibiotic synthesis commences. The molecular nature of this overriding mechanism and the induction process involved in antibiotic synthesis are not understood. In spite of the production of many metabolites of commercial value, the genetics and biochemistry of streptomycetes have been poorly studied. However, the development of a cloning system into streptomycetes could increase the understanding of the regulatory biology of these industrially important organisms. Once the regulatory mechanisms that control antibiotic production are understood, this knowledge can be used to derepress
40
VEDPAL SINGH MALIK
biosynthetic pathways determining antibiotic biosynthesis instead of the present trial-and-error approach by media manipulation. As a result, many potential producers of antibiotics (and other secondary metabolites) are discarded as nonproducers because they were grown in media that do not allow transcription of genes involved in antibiotic production. If regulatory elements, e.g., operators, involved in pathways coding for antibiotic synthesis can be cloned, then these elements can be introduced back into the parent organism on a multicopy plasmid so that the repressor that prevents transcription of antibiotic-synthesizing genes will be neutralized and the corresponding genes will be expressed. Such operators can also be ligated to ribosomal RNA genes and inserted into the chromosome at many locations, since many copies of ribosomal RNA genes are present per haploid genome. Ribosomal RNA genes provide the DNA homology necessary for recombination and integration into the chromosome. In B . subtilis and E . coli, ribosomal genes are near the origin of replication and are amplified during the growth phase, when many replicating forks of chromosome are present. Many genes that regulate growth are present in the vicinity of the ribosomal genes. Since antibiotic production is inversely related to growth rate, study of the genes of the ribosomal cluster could provide clues to the regulation of antibiotic synthesis. It is, therefore, very timely that the gene clusters that determine ribosome synthesis in streptomycetes be isolated, sequenced, and further studied. 1 . Plasmids
Any streptomycete plasmid or actinophage may probably be used as a vector to clone genes in streptomycetes. Unfortunately, all streptomycete plasmids isolated to date are cryptic, and hence have no selectable marker. Once a streptomycete gene has been identified, it can be prepared in large amounts and used to transform streptomycetes after ligation to DNA fragments of actinophage or plasmid that can replicate in streptomycete. Streptomyces erythreus contains a ribosomal RNA methylase that may be another marker conferring resistance to erythromycin, lincomycin, and streptogramin B type antibiotics. Eventually, such a gene can be used as a selective marker to isolate the origin of replication of a streptomycete plasmid or phage. The origin of replication of actinophage or streptomycete plasmid ligated to the ribosomal RNA genes and the DNA sequence-complementing auxotrophs may be a suitable vector for cloning genes in streptomycetes. Numerous cryptic plasmids have been isolated from streptomyces (Malik, 1977, 1979b; Hayakawa et al., 1979; Nojiri et al., 1980; Okanishi et al., 1980). The SCP2 is a self-transmissible plasmid of the 20 X 106daltons that promotes chromosomal recombination in Streptomyces coelicolor and regulates production of and resistance to antibacterial substances (Troost et al.,
RECOMBINANT DNA TECHNOLOGY
41
1979).This plasmid can replicate stably in Streptmyces parvulus and Streptomyces lividans. The latter also harbors several plasmids (SLP,-SLP6) that have a molecular weight of more than 6.25 x lo6. Streptomyces lividans plasmids are primed with host genome sequences of various lengths. Purified DNA of SCP2* and SLP can be introduced in the protoplasts of plasmidless strains of S . coelicolor, S . lividans, and S . parvulus ATCC 12434. The transformants are detected after segregation of polyethylene glycol-treated protoplasts (Ochi et al., 1979; Bibb et al., 1978). Plasmidcontaining clones produce a zone of growth inhibition due to antibiotic production active against plasmid-free cells, a trait exhibited by SCP2* and SLP, into S . coelicolor, S . parvulus, and S . lividans (Troost et al., 1979). Foreign DNA sequences can now be cloned in these industrially important organisms. Plasmids (SLP1-SLP6) have BamHI and PstI restriction sites where foreign DNA can be inserted without inactivating the lethal zygosis property or replication functions (Suarez and Chater, 1980; Thompson, et al., 1980). With the knowledge of such restriction sites, cloning of foreign genes into streptomycetes using these plasmids as vectors can now proceed. Several vectors that can be used to clone genes in streptomyces have recently been developed. Fragments of S . coelicolor genome carrying methylenomycin resistance (M. Bibb, personal communication) and various prototrophic alleles (D. A. Hopwood, personal communication), have already been cloned, using SCP2* as a vector and S . coelicolor as a host. Such clones are highly unstable but can be stabilized if a fragment of SCP2* that carries a specific plasmid segregation function is included in the recombinant plasmid. In another series of experiments, Hopwood and his co-workers shotgun-cloned antibiotic resistance genes from Streptomyces j-adiae and Streptomyces azureus into S . lividans. The S . lividans plasmid SLP1.2 was used as a vector to clone neomycin-3-phosphotranseferase gene and neomycin-3-acetyltransferase gene from S , fradiae into S . lividuns. Using the same vector, thiostrepton resistance and erythromycin resistance from S . azureus and S . erythreus have also been cloned in S . lividans. These antibiotic resistance markers can now be inserted into other vectors or combined to build vectors with multiple resistances to generate a genetransporting vehicle analogous to E . coli-cloning vector pBR322.
2 . Actinophages Various actinophages that grow on Streptomyces have been described (Chater and Carter, 1978, 1979; Hranueli et al., 1979; Klaus et al., 1978, 1979; Sladkova et al., 1979; Lomovskaya et al., 1980).Vectors with repressor gene of actinophages ligated to streptomyces plasmid could be worth constructing. Transformants could be selected by virtue of their resistance to
42
VEDPAL SINGH MALIK
lysis by actinophages, and commercial large-scale fermentations with Streptomyces harboring such plasmid-actinophage repressor vectors could be resistant to lysis by actinophages. The temperature actinophage, (31, has been developed as a suitable Streptomyces cloning vector (K. Chater, personal communication). Like all known Streptomyces temperate phages in size and morphology, this actinophage resembles E . coli phage A and contains sticky ends. A 20-gene linkage map has been constructed by using temperature-sensitive plaque morphology and host range mutants. Heteroduplex analysis, denaturation, and restriction enzyme digestion have been used to align the linkage map with the physical map of the linear 39 kb DNA of C31. Repressor gene (C) is located in the middle of the genome and many genes for essential functions are located to the left of the C gene. Actinophages that are resistant to chelating agents have deletions in the center of the genome-removing repressor gene or in the rightmost 25% of the molecule-removing phage attachment site to the chromosome. Partial EcoRI digests of E . coli plasmid pBR322 and actinophage deletion mutant C31Cts 23 were ligated and transfected in S. lividans. Transfectants were selected by hybridizing clones to radioactive pBR322 DNA. The resulting C31-pBR322 recombinant molecule replicates as a phage in Streptomyces and as a stable plasmid in E . coli. Further modifications have produced a vector that has single restriction sites for BamHI and PstI and can be used to clone up to 7 kb of foreign DNA. A C31-pBR322 hybrid is restricted by Streptomyces albus P and does not form plaques on R-m+ S. albus G mutants if part of pBR322 is inserted in C31. The latter effect may be used to select deletion mutants. Ampicillin- and tetracycline-resistancegenes of pBR322 may be expressed in Streptomyces if inserted in such a manner that they are transcribed from an actinophage promoter. Chloramphenicol acetyl transferase gene from E . coli has also been cloned in S. Zividam using S . lividans plasmid SLP1.2 as a vector. This enteric bacterial gene is expressed in S. Ziuidans and its transcription may initiate from the promoter of Streptomyces vector plasmid (M. Bibb, personal communication). These cloned antibiotic resistance genes provide a good selective marker for cloning DNA sequences in Streptomyces. The convenient assay of chloramphenicol acetyltransferase and P-lactamase can be further used to understand the molecular biology of Streptomyces promoters. As a consequence, the time has finally arrived when systematic study of the molecular biology of Streptomyces can be exploited to generate hybrid antibiotics, to introduce useful genes for utilization of cheap carbon sources (e.g., cellulose degradation), and for production of valuable human metabolites (e.g., insulin, interferon). Multicopy vectors with highly efficient constitutive promoters will soon be available to amplify and express genes of
RECOMBINANT DNA TECHNOLOGY
43
interest in Streptomyces, making them very attractive for producing valuable metabolites. Certain thermophilic Streptomyces that grow to a very high cell mass on cheap carbon sources are another promising host for producing valuable metabolites (e.g., amino acids, organic acids, vitamins, enzymes, antibiotics, coloring pigments) at a reduced cost.
D. YEAST Several hybrid vectors that replicate in both E. coli and yeast are now available (Broach et al., 1979; Farabaugh and Fink, 1980). Hinnen et al. (1978) were the first to conclusively demonstrate transformation of yeast leu-2 - double auxotroph. It is a low-frequency system giving 2-102 transformants per microgram of DNA. These workers used DNA of recombinant plasmid pYE (Zeu-2)10 that carried the yeast Zeu-2 gene. This yeast leu-2 gene was identified by complementation of an E. coli leu-2 auxotroph. Plasmid pYE (leu-2)10 did not autonomously replicate but integrated in yeast chromosome at several sites including the leu-2 locus. Leu-2 gene fused to a yeast plasmid and to an E . coli plasmid provides a second type of vector. Such a hybrid plasmid replicates in both E. coli and yeast (Beggs, 1978).This vector is stably inherited when carrying cloned leu-2 DNA and transforming yeast to leu+ at frequencies of 104-105transformants per microgram of DNA (Haber et al., 1980; Shine et al., 1980; Struhl et al., 1979; Hicks et al., 1979a; Gerbaud et al., 1979). Storms et al. (1979)have constructed chimeric plasmids with a unique restriction endonuclease site that transform both Saccharomyces cerevisiae and E . coli with a high frequency. These plasmids carry part or all of the yeast 2 pm circle linked to E . coli plasmid pBR322 and yeast his3 gene or yeast leu-2 gene. Plasmids carrying a 2.4 megadalton EcoRI fragment of 2 pM circle transform yeast with 2- to 10-fold higher frequency than those carrying the 1.5-megadalton EcoRI fragment of the 2 p M circle. A clone bank of yeast genes has been screened and chimeric plasmids that complement the ura-3, tyr-I, and met-2 auxotrophs of yeast have been identified. A third yeast transformation system is based on segments of yeast chromosomal DNA that carry yeast replication origins. Hsiao and Carbon (1979) transformed yeast arg-4 deletion mutant to prototrophy with hybrid ColE1 plasmid containing yeast urg-4 gene. The transforming plasmid pYE (arg-4) replicates autonomously in both yeast and E. coli. About lo3transformants per microgram of pYE (arg-4)DNA were obtained, which is a yield three orders of magnitude higher than that obtained by Hinnen et al. (1978; see also Gafher and Philippsen, 1980; Petes, 1980). The yeast DNA fragments in pYE (arg-4)and yep-7 probably contain the origin of DNA replication, since they autonomously replicate in yeast.
44
VEDPAL SINGH MALIK
Another plasmid containing yeast trp-l gene (yep-7 and pLC544) replicates autonomously in tryptophan auxotrophs of yeast (Struhl et al., 1979; Kingsman et al., 1979). The replicon of these two plasmids can be isolated on a small DNA fragment and ligated to an E. coli plasmid along with a selective marker for yeast cloning. Such a hybrid plasmid can be shuttled between yeast and E. coli. Yeast transformants utilizing nutritional markers such as arginine are genetically unstable and have to be maintained on minimum media lacking the auxotrophic requirement. Since most media for producing industrial metabolites are quite complex, vectors that integrate into chromosome or that would not be lost under nonselective conditions may be preferable for industrial purposes. Yeast ribosomal DNA is on chromosome XI1 between asp-5 and ura-4 as determined by mitotic linkage (Szostak and Wu, 1979). The leu-2+ gene, inserted into the rDNA locus, was used as a genetic marker for mapping rDNA that would be otherwise hard to score. This is analogous to the use of antibiotic resistance transposons in mapping bacterial genes. Yeast rDNA consists of about 140 copies of a tandemly repeated 9-kb segment. When half of the yeast rDNA repeat unit is ligated to pBR322 carrying the yeast leu-2 gene, the frequency of yeast transformation increases up to 200-fold, in proportion to the increased amount of homologous repetitive rDNA available for integration. When the other half of the repeat unit is inserted into a plasmid, the transformation frequency increases by a factor of lo4, but the transformants are highly unstable. This segment of rDNA contains a yeast origin of replication (Szostak and Wu, 1979).
E. PLANTCELLS Crowngall is a neoplastic disease of plants caused by the gram-negative bacterium Agrobacterium (Moore et al., 1979). Agrobacterium harbors Ti plasmids, which are responsible for tumor induction in plants. Modified Ti plasmids may be used as vectors for introducing genes into plants that can be propagated vegetatively (Aerts et al., 1979; G . Melchers et al., 1978). When Agrobacterium infects plants, a part of the Ti plasmid called tDNA is transferred to plant cells. tDNA contains genes for opine synthesis and infection. It consists of three functional units. The central unit is present in all Ti plasmids (Thomashow et al., 1980). These plasmids are large, with molecular weights ranging from 150 to 230 kb (Drummond, 1979). They are extensively cleaved by restriction enzymes. As a result, unnecessary segments and restriction sites of these plasmids must be deleted before they can be useful as vectors. Use of an enzyme such as HphI, which cleaves at some distance from its recognition site, is another
RECOMBINANT DNA TECHNOLOGY
45
possibility for inserting DNA sequences in Ti plasmid. The unique sticky ends generated at each cut allow accurate plasmid assembly. The DNA could be inserted into an isolated tDNA fragment before the whole vector is assembled. Schell and associates avoided manipulating DNA in vitro altogether (Schell et al., 1979). They obtained transposition of streptomycin resistance (Tn7) into tDNA of a nopaline plasmid before introducing it into tobacco genome. It should be possible to construct a plasmid that would have an insertion sequence at either end of the DNA sequence to be cloned and then the whole unit could be transposed into the tDNA.
F. MAMMALIANCELLS Even though the first demonstration of recombinant DNA methodology was the introduction of galactose operon of E . coli into simian virus 40 (Jackson et al., 1972), the cloning of genes in higher eukaryotes has been slow. This is owing to the primitive state of knowledge of the genetics of both mammalian cells and their viruses. Tightly blocked mutants and selectable markers are few, and methods for cell-to-cell genetic exchange are poorly developed. In mammalian cells, there are no equivalents of F’ factors, plasmids, and bacteriophage X for E . coli. The mammalian genome contains a thousandfold more DNA than E . coli, and is therefore very complex. This tremendous complexity of the mammalian genome and the lack of strong selection pressure makes it hard to isolate specific genes by selecting for their functional expression. On top of all this, tumor viruses have been the most promising vectors, and development of these genomes as vectors has been significantly impeded by the National Institutes of Health (NIH) guidelines on recombinant DNA technology. Simian virus 40 DNA has been used as a vector for cloning many prokaryotic genes into mammalian cells. However, linking the origin of replication of SV40 to the thymidine kinase gene of Herpes simplex virus type I or the dihydrolate reductase gene derived from the methotrexate resistant AT-3000 line of murine sarcoma 180 cells could yield a suitable vector, one that would grow as a plasmid in permissive cells and have a selectable marker. By joining the SV40 vector to some of the repeated sequences such as histone genes, ribosomal RNA genes, or satellite DNA, homology of the vector with the cellular DNA could be increased. Such a vector would be useful for introducing new genetic information into mammalian chromosomes. Viruses serve as natural vectors for intercellular transmission of DNA. As do transducing bacteriophages, some mammalian viruses recombine with host chromosomal DNA and incorporate host DNA in their chromosomes. Such transducing particles, when they carry their origin of replication, can
46
VEDPAL SINGH MALIK
be propagated in the presence of helper viruses that complement the missing function of the transducing particle. Infection of nonpermissive mouse cells by a hybrid molecule, SV40 joined to phage h DNA, yielded transformants containing h and SV40 sequences (Muzyezka, 1979). Transformed clones were positive for SV40 T-antigen. The DNA linked to the transforming segment of SV40 DNA was integrated into the chromosome, and cyclization of the hybrid linear DNA preceded integration. Purchio et al. (1979) inserted the ornithine transcarbamylase gene of E. co2i into the late region of SV40 DNA. This hybrid molecule was propagated in monkey kidney cells. Hamer and Leder (1979) infected cultured monkey kidney cells with a recombinant plasmid in which the complete genomic mouse p-maj globin gene replaced the SV40 late gene region. Transcription from the SV40 late region promoter generates the globincoding sequence. Production of a substantial amount of mouse p-maj globin by such infected cells suggests that the mouse globin signals for RNA splicing, polyadenylation, and translation are recognized in the monkey cells. Therefore, the SV4O-monkey cell system can be used to clone and study many eukaryotic genes (Berg, 1979). There are several advantages of using SV40 as a vector: 1. The small size of SV40 makes localized biochemical mutagenesis easy. 2. Replication of SV40 is very efficient. Late in infection, up to 100,000 copies of SV40 per infected monkey cell are present, which facilitates detection of gene products. 3. Strong viral late region promoter can be used to direct the transcription of the inserted foreign DNA. However, not more than 2500 base pairs of foreign DNA can be inserted into the late region of SV40 if it is to be packaged into virions. Propagation of hybrid plasmid in persistently infected monkey cells can be used to bypass this limitation. Tissue cultures of mammalian cells have been transformed with DNA coding for selectable biochemical markers (Wigler et al., 1977; Minsen et al., 1978).The thymidine kinase (TK) gene from Herpes simplex virus type 1 can transform mouse L cells deficient in thymidine kinase, yielding clones with TK+ phenotype. Genes that do not code for a selectable marker can be introduced in these cells by cotransformation with the TK gene (Wigler et al., 1979). Large DNA fragments can also be first joined with the Herpes simplex virus TK gene and then transformed into mouse thymidine kinase negative cells. Mouse thymidine kinase negative L cells have been transformed with cloned rabbit chromosomal P-globin gene linked to the cloned
RECOMBINANT DNA TECHNOLOGY
47
TK gene of Herpes simplex virus type 2 (Mantei et al., 1979; Wigler et al., 1979). Most TK+ cells contained rabbit P-globin DNA and produced up to 2000 copies of rabbit P-globin RNA per cell. The human genes for thymidine kinase (TK), galactokinase, and pro collagen type 1 located on chromosome have been transferred to cultured (TK-) mouse cells (Perucho et al., 1980; Klobutcher et al., 1980; Wigler et al., 1980; Franche and Taggart, 1980). Catterall et al. (1979) transformed mouse cells with a chimeric plasmid containing the natural genes for chicken ovalbumin and the viral TK gene. The entire 12 kb chicken DNA containing the ovalbumin gene integrated into mouse cellular DNA and was expressed into the production of ovalbumin. The site of integration of chicken ovalbumin into mouse cell chromosomes could be important for expression of chicken ovalbumin gene, since not all ovalbumin gene-containing mouse transformants synthesize ovalbumin. Similarity between the junction sequences in the genes for ovalbumin and P-globin suggests that ovalbumin gene transcript should be correctly spliced in mouse L cells (Konkel et al., 1978). By improving the efficiency with which the incoming DNA is integrated into the cellular DNA, the efficiency of transformation is increased. When restriction enzyme digests of the TK+-transformedmouse cell DNA are used to retransform TK - mouse cells, the transformation frequency is significantly higher than with the 3.4 kb restriction enzyme fragment carrying the TK gene isolated from HSV-I DNA. Integration is increased owing to homology of the mouse cell DNA bracketing thymidine kinase gene (Minson et al., 1978; Pellicer et al., 1978). VII. Utility of New Technology Les combinaisons de la nature sont a la fois plus simples et plus variees que celles de notre imagination. L. PASTEUR(1880)
The understanding of the structure, organization, and function of genes of E. coli and its phages has progressed far beyond the knowledge of other organisms. This is owing to the availability of techniques of genetic manipulations using F' episomes, phage A, and many translocatable elements. Small segments of DNA can be moved to make merodiploids for any part of the chromosome, which allows the analysis of operons and their regulation by study of the interaction between different alleles of the same regulatory genes and controlling elements in the same cell (Beckwith and Zipfer, 1970; Stent and Calender, 1978; Miller and Reznikoff, 1978; Calos and Miller, 1980). Study of the chemistry, physiology, and genetics of lactose metabolism in E. coli has been easily elucidated owing to a simple enzyme
48
VEDPAL SINGH MALIK
assay. Induction with the gratuitous inducers and availability of noninducing substrates such as X-G have been used to distinguish constitutive from inducible strains.
A. MERODIPLOIDSCONSTRUCTION COMPLEMENTATION TEST
AND
Knowledge of the genetics and biochemistry of industrially important microorganisms is much less advanced than it is in E. coli. Even though many phages infect microorganisms of industrial importance, knowledge of the regulatory biology of these phages is primitive compared with that of coli phages. Also, little is known about the biology of plasmids in such microorganisms. Gene amplification and in vivo merodiploid formation has not yet been achieved by specialized transducing phages or by plasmids for strains of organisms that are being used in industry. Recombinant DNA technology can now be used to ligate small pieces of genomes of industrially important organisms to appropriate vectors that replicate in such organisms as well as in E. coli, which allows application of complementation test for understanding regulatory mechanisms. Such vectors that replicate in E. coli, as well as in some other organism such as B . subtilis or yeast, are already being used to shuttle genes between two different host organisms. B. OPERONFUSIONS Another application of this technology emerges because fusion of any two pieces of DNA is now possible. Genes of any organism can now be fused to the well-studied E. coli promoters with the expectation of efficient expression (Franklin, 1978). Elegant experiments from Beckwith's laboratory have provided the pioneering methodology for in vivo fusing of the P-galactosidase genes into foreign regulatory elements (Bassford et al., 1979; Bassford and Beckwith, 1979; Brickman et al., 1979). Such gene fusions allow exploitation of a simple P-galactosidase assay to probe complex regulatory systems (Cassadaban, 1976). Similarly recombinant DNA technology could be used to create fusions in which the P-galactosidase gene is controlled by promoters of other genes that are functional in industrial organisms. The type of genetic analysis that has been used for lac and phage A repressors could now be applied to other proteins. Point mutations were used to define the regions of the repressors responsible for binding to operator, and to inducer, and aggregation. Thus, it was shown that the operator binding site of lac repressor is restricted to 59 N-terminal residues and the first 92 N-termind residues are sufficient to bind X repressor to A operator
RECOMBINANT DNA TECHNOLOGY
49
(Miller and Reznikoff, 1978). Negative dominance can be used as a tool to study function of any protein that carries two different enzyme activities on one polypeptide chain such as threonine-deaminasekhreoninekinase. Mutants lacking one of the activities can show which end of the polypeptide chain is responsible for each activity. Nonsense fragments of lac repressor are destroyed effectively by proteolytic enzymes. Chimeras that add different pieces of repressor to active P-galactosidase can be isolated and many regions of repressor can be added to P-galactosidase without destroying its enzymic activity. Some chimeras are active both as repressor and P-galactosidase. In one of them the repressor lost the last 4 residues and P-galactosidase, the first 24. It may be that the first 24 amino acids of P-galactosidase can be easily replaced by any protein sequence that does not interfere with the folding and aggregation of P-galactosidase. DNA segments coding for N-terminal regions of A repressor and A-cro have been fused in vitro to other genes. The importance of N-terminal region for DNA binding is supported by the fact that repressor or cro activity is recovered in vivo (Ptashne et al., 1980). The knowledge, gained from repressor P-galactosidase fusions, that certain peptides that are degraded in E. coli can be stabilized by fusing them to high-molecular-weight proteins has already been exploited to make somatostatin hormone in E. coli. Somatostatin was found to be stable in E. coli when it was fused to P-galactosidase protein (Itakura et al., 1977). Similarly, insulin is not destroyed when it is fused to the P-lactamase gene (Villa-Komaroff et al., 1978). Both insulin and somatostatin were fused to the carboxylterminal ends of protein and were transcribed from the promoters of the E. coli gene. Backman et al. (1976)constructed a plasmid in which the A repressor gene was fused to the promoter of the lac operon. The plasmid bore two copies of lac promoter, and synthesis of A repressor in strains bearing this fused plasmid was regulated by lac repressor. Since several translational stop signals immediately precede C gene, repressor synthesized in these strains was not a fused product initiated at the lac2 translational start point. About 3 to 35 times more A repressor was produced as compared to single lysogens. The source of variation in repressor level is not known. These A repressor levels are 10- to 25-fold lower than expected on the basis of the known strength of lac promoter. This inefficient expression could be due to frequent attenuation of transcription beginning at the lac promoter, since A repressor could bind to the A operator, which is situated between the repressor structural gene and the lac promoter. Strains carrying 20 copies of recombinant plasmids in which level of A repressor is controlled by its own promoter produce about five times more repressor than does a single lysogen. These strains exemplify autogenous regulation of repressor synthesis.
50
VEDPAL SINGH MALIK
c. DIRECTEDSECRETION OF PROTEINS To gain insight into the mechanisms by which proteins are secreted from the cytoplasm to the cell membranes, genetic recombination was used to replace the amino-terminus of P-galactosidase (a cytoplasmic enzyme) with the amino-terminal sequence of membrane proteins such as the maltosebinding protein (Silhavy et al., 1976) or phage A receptor lam B protein (Silhavy et aZ., 1977). Owing to the lack of convenient assay for secretory proteins, P-galactosidase was used as a reporter enzyme. In both cases, P-galactosidase activity became associated with membranes, which suggested that addition of a signal sequence to a nonsecreted protein will cause it to be secreted (Davis and Tai, 1980). On the basis of these results, Villa-Komaroff et al. (1978) fused in uitro rat insulin gene cDNA to the P-lactamase gene of pBR322. The hybrid insulin P-lactamase protein was found to be secreted, which protected the insulin from proteolytic degradation by cellular enzymes. Using a very sensitive radioimmunoassay, these workers detected about 100 molecules of insulin per cell. The insertion of a viral DNA sequence coding for surface antigen into a carrier protein gene could result in the secretion of a fused protein that could be used as a vaccine even though no correct virus product is synthesized (Enouye and Halegou, 1980; Koshland and Botstein, 1980). Various genes that determine the synthesis of enzymes secreted by industrial organisms might be fused to appropriate vectors. For example, yeast invertase gene could first be inserted in a vector (Hackel and Khan, 1978; Lampen, 1978). Genes directing synthesis of peptides could then be inserted in this vector in such a manner that the amino-terminal end of invertasa facilitates the secretion of fused protein. Invertase would also be helpful to the yeast while growing on molasses, a cheap industrial carbon source (G. Melchers et al., 1978). D. In Vitro LOCALIZED MUTAGENESIS Recombinant DNA technology can be used to isolate, amplify, and determine the structure of any DNA segment. The functional significance of a specific region of DNA can be explored by generating localized modifcation in the DNA molecule and then studying the resulting effects on the biological properties of the molecule in uiuo or in uitro (Humayun and Chambers, 1979; Gillam and Smith, 1979a,b). I n uitro mutagenesis offers the possibility of mutating isolated purified DNA sequences to obtain enzymes with altered properties (Muller et al., 1978; Paterson and Clarke, 1979; Hibner and Albert, 1980). Analogs of peptide hormones could also be produced by their genes that have been altered in predetermined base sequences. DNA sequences of regulatory elements (operator, promoter, attenuator) can be sub-
RECOMBINANT DNA TECHNOLOGY
51
jected to in uitro localized mutagenesis, and mutated sequences can be used to study how corresponding proteins interact with them (Taniguchi et al., 1979). Such studies have provided insight into the types of interaction between lac operator and repressor (Siebenlist et al., 1980) and promoter and RNA polymerase (Taylor and Burgess, 1979; Johnstrud, 1978; Taniguchi et al., 1979; S . J. Chan et al., 1979). Scherer and Davis (1979) have developed a general method for replacing Sacchromyces cereuisiae chromosome segments with altered DNA sequences. Any isolated gene, deleted or altered by in uitro mutagenesis, can be propagated by attaching it to a vector with a selective chromosomal marker. Upon transformation, the composite DNA molecule, consisting of vector, selective marker, and altered DNA, recombines with the homologous DNA sequence in the chromosome, yielding a direct nontandem duplication separated by the vector and the marker DNA. The vector and marker DNA are lost owing to the second recombinational event on the other side of the altered sequence relative to the first. This replaces the altered sequence with the wild-type DNA segment of the untransformed cell. Homologous sequences on both sides of the mutant DNA sequences must be present in the transforming DNA. The composite molecule does not have to replicate autonomously in the recipient host where altered DNA sequences are to be replaced. An internal deletion mutant of his3 gene and a transposition of a galactose-inducible region into chromosome XV were generated by using the ura-3 gene as a selective marker. Scherer and Davis’ method has general application and relies on the ability to transform cells to achieve integration by homologous recombination and on the availability of selective markers as cloned DNA fragments. The expected phenotype of the organism after insertion of foreign DNA is not known in advance. The desired strain can be identified by restriction enzyme analysis of the clones with the selective marker, which allows deletion or alteration of genes with no known functions. If a good, nonreverting mutation for the selective marker is not available, such a mutation can be transplated into the organism of interest after its creation in uitro. This technique could help the manipulation of the chromosomes of industrially important organisms, since it can provide well-characterized sequence variants of any genetic locus.
E. GENOMEORGANIZATION
1. Gene Mapping Restriction mapping is increasingly being used for gene mapping. The positions of about 350 genes on human chromosomes have been localized and the major part of the human gene map may be constructed in the next
52
VEDPAL SINGH MALIK
few decades. Availability of cloned probes will speed up chromosome mapping (Little et al., 1980; Orkin et al., 1980). Labeled probes add speed and resolution to restriction mapping, an advantage over in situ hybridization. Using labeled probes of complementary RNA prepared from cloned sea urchin genes, five human histone genes have been localized to the long arm of chromosome VII (Gusella et al., 1979). Scott et al. (1979)and Haigh et al. (1980)have precisely localized p-globin gene on the short arm of human chromosome XI. DNA was isolated from hybrid clones that contain Chinese hamster genome together with a section of human chromosome XI. The DNA was treated with restriction endonucleases and fragments resolved on agarose gels. The separated fragments were transferred onto nitrocellulose filters and hybridized to a radioactively labeled human P-globin DNA probe. The pattern of hybridization as revealed by autoradiography was used to conclude that the gene for P-globin is carried on a section of the short arm of human chromosome XI (Scott et al., 1979). 2. Gene Structure
a. Intervening Sequences. The availability of homogeneous purified chromosomal DNA fragments has allowed the determination of their exact base sequence. This information has resulted in the unexpected discovery of intervening sequences (introns) within many genes of higher organisms (eukaryotes)and their cytoplasmic organelles (mitochondria). The diversity, complexity, and size of genes with introns was unexpected (Fedoroff, 1979; Abelson, 1979; Darnell, 1978; Schechter et al., 1979; Long and Dawid, 1980; Crick, 1978; Cory et al., 1980). Including its intervening sequences, the gene that codes for the enzyme dihydrofolate reductase in mammalian cells is about one million nucleotides long. About 10% of these nucleotides code for amino acids in the enzyme. The chick ovomucoid gene contains seven intervening sequences (Catterall et al., 1979; O’Hare et al., 1979). The entire gene is transcribed into a large RNA transcript that is subsequently spliced to yield mature mRNA. The mRNA coding portion (exons) of the chicken conalbumin genes is in 17 pieces (Cochet et al., 1979).
b. Overlapping Genes. The total genomes of several small viruses have now been sequenced. Analysis of these sequences has confirmed that certain genes overlap and some pieces of DNA direct synthesis of more than one protein (Fiddes and Godson, 1979; Shaw and Murialdo, 1980; Yang and Wu, 1979). Overlapping genes have gone undetected for a long time, but DNA sequencing now can aid in their discovery. c. Promoters in the Middle of the Gene. Promoters are sequences of nucleotides in a genome where RNA polymerase first binds before transcrib-
RECOMBINANT DNA TECHNOLOGY
53
ing a gene into mRNA. In bacteria, such RNA polymerase binding sites are at the beginning of a gene. However, sequencing of the DNA of several higher organisms suggests that promoters might be in the middle of the gene (Korn et al., 1979; Moss and Birnsteil, 1979; Bogenhagen et al., 1980; Hentschel et al., 1980).
d . Regulation by Inversion of Promoter and Chromosomal Rearrangement. Salmonella possess two distinct flagella antigens. In general, however, only one of the antigens is expressed at a given time. This phenomenon, called phase variation, has recently been understood through the application of recombinant DNA technology. Transition from expression of one antigen to another results from an inversion in a region containing a promoter-like DNA sequence that controls initiation of gene transcription. In one orientation, transcription occurs. However, inversion of the sequence produces reverse orientation of the promoter contained within that region, so that transcription of genes that direct synthesis of flagellin subunits is interrupted (Silverman and Simon, 1977; Zieg et al., 1978).The mechanism for regulating the inversion of the promoter DNA sequence is not known. Transposition of structural genes as a developmental regulatory mechanism may be involved in the life cycle of homothallic bakers’ yeast (Kushner et al., 1979). Yeast haploid cells of one mating type (a or a) produce progeny of the opposite mating type during mitotic growth. A diploid phase (da)is established by conjugation between siblings of opposite mating types. Switches between mating types occur by transposition of a genetic element that carries genes for the mating type. By using a copy of the Q mating-type gene as a probe for Southern hybridization (Hicks et al., 1979b), the conclusion was reached that the mating type interconversion process in yeast involves genetic rearrangement. Silent copies of the mating type genes are located at the H M L and H M R loci on chromosome 111. Translocation of the replicas of these silent sequences to the mating-type locus affects the switch between mating types. Genome rearrangement, e.g., inversion and translocation, may be involved in the regulation of functions that are not essential for survival of the organism and are subjected to catabolite repression (Williams et al., 1979). Enzymes involved in antibiotic production by Streptomyces may be controlled by such a regulatory system. F. ORIGIN(Om) OF DNA REPLICATION Plasmids have been constructed that contain DNA replication origin (ori) of B . subtilis (Seiki et al., 1979; Niaudet and Ehrlich, 1979), E . coli (Sugimoto et al., 1979), phage G4 (Kaguni aad Ray, 1979), Salmonella typhimurium (Zyskind et al., 1979), yeast (Stinchomb et al., 1979), and
54
VEDPAL SINGH MALIK
Drosophila mitochondrial DNA (Sugino, 1979). A nonreplicating EcoRI fragment conferring Km resistance was used for selecting two different EcoRI fragments containing the replication origin from the F factor and the S. typhimurium chromosome. Owing to incompatibility with the E. co2i chromosome, E. coli and S. typhimurium origin plasmids are not stably maintained in E. coli in the absence of selective pressure. The stability increases with decreased plasmid size, perhaps because genes whose products are detrimental to cell growth have been eliminated. This possibility is supported by the observation that a disruption of the nucleotide sequence at the PstI site in the uncB gene, a site outside the S. typhimurium Ori region, increases plasmid stability by preventing the production of functional uncB gene product (Zyskind et al., 1979). Recombinant DNA technology is being used for the analysis of plasmid structure and function (Timmis et al., 1978a,b). Segments of any plasmid can be inserted in ColE1. The hybrid plasmids are used to transform Poly(A) E. coli that is deficient in DNA polymerase I. Since the ColE1 plasmid component requires DNA polymerase I for replication, only those recombinant plasmids that have inserted a fragment with origin of replication will replicate in Poly(A) Escherichia. This approach has been used to construct hybrid plasmid replicons that harbor the origin of replication of pSCl01 and ColEl plasmids. An autononously replicating 850-base pair sequence has been isolated from yeast (Stinchomb et al., 1979).This sequence has no detectable homology to other yeast sequences. Such replicator-containingplasmids are used for cloning foreign genes and for understanding DNA replication. G. HUMAN PROTEINS The only hope of obtaining proteins such as human interferon, human insulin, and human growth hormone in good amounts is recombinant DNA technology. The microbial production of some human proteins of importance to medicine has already been achieved using recombinant DNA technology (Bylinsky, 1980; Secher and Berke, 1980; Goeddel et al., 1979b; Shine et al., 1980; Talmadge et al., 1980; Vamvakopoulos et aZ., 1980). Recombinant DNA technology has added a new dimension to applied microbiology and has already been used to produce ovalbumin (The Upjohn Company), human interferon (Genentech Inc., Biogen Inc.), human insulin (Eli Lilly and Co., Genentech Inc., Biogen Inc.), human growth hormone, somatostatin, thymosin, and many other products in E. coli (Genentech Inc.). An outstanding example of the benefit to be derived from the application
RECOMBINANT DNA TECHNOLOGY
55
of the new technology would be the production of the highly desirable interferon. Fibroblast and leukocyte interferon genes have been cloned and expressed in E. coli by Genentech scientists. Induced leukocytes were used to make cDNA. Amino acid sequence of tryptic peptide of interferon was used to synthesize mRNA probe. Transformants fall into six classes as analyzed by restriction mapping and nucleotide sequencing. One class that may be similar to interferon was independently cloned by C. Weismann collaborating with the Biogen Laboratory. Two hundred and fifty million units of leukocyte interferon per liter of E. coli culture were produced. Nonglycosylated interferon appears to be biologically active. Cloning of the human insulin gene in E. coli and commitment to commercialize microbially produced human insulin by Eli Lilly and Company further supports the notion that industry is doing its best to insure that the results of research are reaching the market place. H. VACCINES Hepatitis B virus infects man and can cause severe complications such as cirrhosis, hepatitis, and hepatocarcinoma. One hundred and twenty million chronic carriers of hepatitis virus have been estimated worldwide. This virus cannot be propagated in cell cultures, and human serum is the only viral source. However, cloning of this virus in E. coli now allows the purification and determination of the complete nucleotide sequence of hepatitis B virus genome (Gilbert et al., 1979). Since high titers of hepatitis B virus are not produced in tissue culture cells, Valenzuela et al. (1979) used recombinant DNA technology to obtain large quantities of viral genome. Hepatitis B virus DNA was cloned in E. coli using plasmid pBR322 as vector. Restriction endonuclease analysis of full-length hepatitis virus genome and the nucleotide sequence of an 892-base pair fragment encoding for hepatitis B surface antigen has been reported. The portion of the gene coding for surface antigen has no intervening sequences. The DNA sequence suggests that the surface antigen consists of 226 amino acids of MW 25.398. This information combined with the availability of large amount of viral genome will help in the development of antiviral vaccines. Segments of viral genome may be used to produce appropriate viral antigens in alternative hosts like Saccharomyces cerevisiae or B . subtilis. The core antigen gene is expressed in E. coli and, when injected into rabbits, the antigen produced by E. coli induces antibody that reacts with human serum core antigen (Pasek et al., 1979a,b). Recombinant DNA technology can be used to identify the genes that code for a surface protein of foot and mouth disease virus. Such genes can be introduced in the appropriate host to produce the protein that may be an effective vaccine. Emtage et al. (1980)
56
VEDPAL SINGH MALIK
have inserted a DNA sequence from fowl plaque virus into an E. coZi plasmid. The recombinant plasmid directs the synthesis of a protein that is 0.756 of total cell protein and reacts with antisera to FPV hemagglutinin. Transcription of the inserted fragment is from a tryptophan promoter.
I.
IMPROVEMENT OF INDUSTFUAL ORGANISMS
There was the door to which I found no key. There was the veil through which I might not see. OMARKHAYYAM (TWELFTH CENTURY)
For commercial production of recombinant DNA products, some organisms may prove better than E. colt Groomingof organisms already being used in the fermentation industry could be highly beneficial. Even though experiments with industrial organisms have not received as much fanfare as have the unraveling of secrets of nature using E. coli, industrial organisms harbor metabolic pathways that are specific to them. For example, pathways that lead to the biosynthesis of antibiotics, gibberellins, and alkaloids exist in only a few microorganisms. Regulation of general metabolism in such organisms is not well coordinated. The lack of fine regulation of primary cellular metabolism leads to accumulation of many branch point intermediates and end products. These elevated levels of intermediates are the precursors of many commercial metabolites (Malik, 197%) that are produced in significant quantities. For example, penicillin and glutamic acid are accumulated in concentrations of up to 50 and 120 gm/liter of growth medium, respectively. Efficient and economical processes for the industrial production of these microbial metabolites can now utilize the tools of recombinant DNA technology and make even further improvement.
1. Gene Ampl@cation From what has already been demonstrated, you can plainly see the impossibility of increasing the size of structures to vast dimensions either in art or in nature; likewise the impossibility of building ships, palaces or temples of enormous size in such a way that their oars, yards, beams, iron bolts, and, in short, all their other parts will hold together; nor can nature produce trees of extraordinary size because the branches would break down under their own weight, so also it would be impossible to build up the bony structures of men, horses, or other animals so as to hold together and perform their normal functions if these animals were to be increased enormously in height; for this increase in height can be accomplished only by employing a material which is harder and stronger than usual, or by enlarging the size of the bones, thus changing their shape until the form and appearance of the animals suggest a monstrosity. This is perhaps what our wise poet had in mind, when he says, in describing a huge giant: “Impossible it is to reckon his height So beyond measure is his size” CALILEO CALILEI
(FIFTEENTHCENTURY)
RECOMBINANT DNA TECHNOLOGY
57
Many molecules such as insulin, interferon, and growth hormone are active in very minute amounts. Such molecules that are not needed in thousands of pounds and can be sold at a good price may very well be commercially produced in E. coli (Shepard et al., 1979). Many multicopy plasmid and phage vectors can be used to ampllfy genes in E. coli (Malik, 1979d; Collins, 1977). Foreign genes on a multicopy plasmid are easy to isolate and purify in relatively large amounts. The products of such genes can be made in significant quantities if they are inserted in such a manner that their transcription is initiated by a strong promoter (Backman and Ptashne, 1978; Twigg and Sherratt, 1980; Gelfand et al., 1978; Teather et al., 1978). Gene cloning is an effective means of amplifying the number of copies of a specific gene (Malik, 1979d). A pertinent demonstration of this is the construction of a hybrid bacteriophage A into which an E . coli gene coding for DNA ligase has been inserted. Upon infection of E. coli with this chimera, a 500-fold increase in concentration of DNA ligase over that produced by uninfected E. coli is generated. DNA ligase accounts for about 5% of the total E. coli protein and is easy to purlfy in large amounts from such strains (Panasenko et al., 1977). DNA polymerase I was amplified 100-fold following infection of E. coli with X polA QS phage (Kelley et al., 1977). Enhancement of yields of any protein could be achieved by fusing the respective gene to an eficient promoter and inserting it into a multicopy plasmid containing heatinducible A regulatory system. A copy number mutant of plasmid ColE1 exists that produces 210 plasmid copies per E. coli chromosome (Shepard et al., 1979).Tenfold amplification of the lactose carrier protein in E. coli using a recombinant plasmid carrying the y gene of the lac operon has been achieved (Teather et al., 1978). Weisblum and co-workers (1979a,b) have isolated a high copy number mutant of the S . aureus plasmid pE194 that is replicated and maintained in B. subtilis. It is not known if this plasmid will be maintained in other grampositive organisms such as Streptomyces. The mutant plasmid is present up to 100 copies per cell and determines resistance to macrolides, lincosamide, and streptogramin type B antibiotics. This plasmid could be used to clone and ampllfy genes in B. subtilis, which is a source of many commercial enzymes. Yeast and many streptomycetes are known to harbor plasmids. The size of these plasmids can be decreased by available techniques. Decreasing the size of the plasmid sometimes elevates the copy number. 2. Novel Genes
With the increasing prices of media constituents for microbial fermentations, naturally abundant substrates such as cellulose might someday replace expensive carbon sources. Genes for the efficient utilization of cellulose and other substrates are not present in all organisms. Such genes
58
VEDPAL SINGH MALIK
might be isolated and cloned into organisms of commercial interest. Using such genetically tailored microbes that utilize cheap media constituents, more and more natural products might be made by fermentation, thereby replacing their expensive chemical synthesis. Single genes that direct the synthesis of enzymes involved in the modification of functional groups may be isolated. Such genes (for example hydroxylation, chlorination, amination, acetylation, adenylation, phosphorylation, and glycosylation) can be introduced into industrial organisms to obtain altered metabolites. Genes determining the synthesis of a chlorinating enzyme, for example, could be isolated from chloramphenicol-producing Streptomyces venezulae and introduced in corynecin-producing Corynebacterium. Corynecin is analogous to chloramphenicol but lacks chlorine. If the gene is expressed, Corynebacterium possessing the chlorinating enzyme may produce chloramphenicol if it is resistant to excreted chloramphenicol and does not inactivate it.
3. Novel Partial Metabolic Pathways Recombinant DNA technology can be used to transfer genes for partial metabolic pathways to organisms that do not have genes for such pathways.
a. Catabolic Pathway. Many organisms possess catabolic pathways that are usehl in microbial transformation programs. Sometimes mutants blocked in a catabolic pathway are used to accumulate valuable intermediates. Genes for a portion of a catabolic pathway that direct transformation of substrate to the desired intermediate can now be isolated and introduced into a new organism. This could allow accumulation of the desired metabolite and avoid undesirable additional transformations. This strategy might have immediate application in the biotransformations of steroids (Atrat et al., 1979a,b; Tenneson et al., 1979).
b. Anabolic Pathways. Many secondary metabolites, e.g., antibiotics, alkaloids, and gibberellins, consist of subunits that are present in several unique biologically active compounds produced by unrelated organisms (Table IV). Genes for some of the unusual moieties, e.g., sugars with side chains, could be isolated and introduced into a suitable organism to obtain hybrid molecules. Fusion of various macrolide and aminoglycoside antibiotics may now be possible and may yield a superior antibiotic. Fusing two natural products with no biological activity could also yield an active metabolite. In Penicillium chysogenum, a transacylase exchanges the L-a-amino adipyl side chain of isopenicillin N for nonpolar-substituted acetic acid esters. This transacylase gene could be cloned and subjected to in vitro mutagenesis. A mutant gene may be obtained that will direct the synthesis of
59
RECOMBINANT DNA TECHNOLOGY TABLE IV SUBUNITSCOMMON TO SEVERALANTIBIOTICS Antibiotics that share the unit
Subunit ~
D-Oleandrose D-Desosamine L-Mycarose 2-Deoxystreptamine a-,P-Diaminopropionic acid P-Methyl-L-lanthionine Butyric acid Ribostamycin P-Lactam ring
~~~~~
~~
~~
Oleandomycin, oleandrin Macrolide antibiotics (methymycins, erythromycins, picromycin, oleandomycin, narbomycin, megalomicin) Megnamycins, leucomycins, erythromycin, megalomicin A, tylosin, niddamycin, spiramycins, relomycin Aminoglycosides (neomycin, kanamycin A, gentamicin, butirosin) Edeine A, viomycin Nisin, subtilin Butirosin, 2-amino-4,4-dichlorobutyricacid Butirosin, neomycin Penicillins, cephalosporins, cephamycin, nocardicin, thienamycin, wildfue toxin
an enzyme that could exchange the D-a-aminoadipyl side chain of cephalosporins for nonpolar-substituted acetic acid esters. If the suitable mutant gene is introduced and expressed in the appropriate p-lactam producing host, cephalosporins with nonpolar-substituted acetic acid side chains may be produced. Such side chain precursors and their analogs have to be added to the growth medium of the tailored microbe. Hybridization among P-lactam-producing streptomycetes does, indeed, offer many attractive possibilities. Expression of Streptomyces genes determining synthesis of hydroxylases and methylases in cephalosporin might allow cephamycin production utilizing highly efficient strains and technology already in use in fermentation industry. Benzylpenicillin acylase of E. coli hydrolyses benzyl penicillin to 6-aminopenicillanic acid and phenylacetic acid (Gang and Shaikh, 1976). At low pH, it catalyzes the synthesis of new penicillins from 6-aminopenicillanicacid and different side chain precursors. Several semisynthetic penicillins that are sold commercially have already been prepared by this method. Mayer et al. (1979)used the cosmid-packaging method of cloning to isolate the gene that contains the penicillin acylase segment from the total E. coli genome without positive selection pressure. This fragment was further shortened by cleavage with endonucleases and cloned into a plasmid. E. coli strains carrying the penicillin-acylase gene produced high constitutive levels of enzyme. This gene can be brought under the control of stronger promoters to obtain increased enzyme levels. The penicillin-acylase gene can also be subjected to site-directed in uitro mutagenesis to alter the specificity of the enzyme. The benzylpenicillin-acylase gene as well as in uitro-isolated
60
VEDPAL SINGH MALIK
mutant genes of these commercially important enzymes could be ligated to appropriate promoters and then introduced into penicillin-producing organisms. If the gene is expressed, then 6-aminopenicillanic acid instead of penicillin could be produced. A novel two step process for the conversion of cephalosporin C into 7-aminocephalosporanicacid has been reported. D-Amino acid oxidase of the yeast Trigonopsis uariabilis, converts cephalosporin C into glutaryl-7aminocephalosporanicacid, which is further deacylated by a mutant of Comamonus. If the genes determining the synthesis of these two enzymes could be introduced and expressed in the cephalosporin C-producing organisms, direct production of 7-ACA may be possible. Alternatively, novel penicillins might be produced in one step by introducing penicillin acylase of a different specificity into the penicillin producers and incorporating the appropriate side chains of penicillin in the fermentation medium. Many enzymes may be used in the industrial hydrolysis of cephalosporin and penicillins and acylation of 7-aminocephalosporanic acid as well as 6aminopenicillanic acid (Brodelius, 1979).The genes for these enzymes can be isolated and planted in appropriate organisms to make the process of preparing penicillin and cephalosporin analogs economical (Serizawa et al., 1979). Many streptomycetes produce several antibiotics of different chemical structure. These antibiotics are sometimes produced during various phases of growth. Self-cloning in streptomyces could result in increased levels of antibiotic production. Furthermore, clones that harbor amplified operators involved in antibiotic synthesis could neutralize the repressors, resulting in the constitutive production of antibiotics and thus altering the relationship between various growth phases and antibiotic production. Alteration of this relationship could also result in production of novel coupling of antibiotic moieties that were never linked in the parent culture because various moieties were not produced during the same phase of growth. A genome library of any streptomycete harboring various segments of its chromosome ligated to a multicopy plasmid or ribosomal RNA genes could be generated and screened for antibiotics that have not been seen before owing to lack of production or low yield. Thus self-cloning, which is essentially creation of merodiploids using recombinant DNA technology, offers also the possibility of doing complementation tests for gene functions and regulatory studies. Some of the DNA sequences could be ligated to a vector whose replication is temperature-sensitive, and then amplified during any growth phase by manipulating growth temperature. The realization of all the aforementioned possibilities hinges upon the development of vectors with selectable markers that could be used to transport, maintain, and faithfully replicate various segments of the Streptomyces
RECOMBINANT DNA TECHNOLOGY
61
genome into novel Streptomyces that produce many secondary metabolites of intricate chemical structures.
J. VANISHINGORGANISMS Every year many species of plants and animals vanish and a source of genetic information is lost from nature. Making banks of genes of endangered species in E. coli and then storing them may offer a way to salvage the genes of organisms facing extinction.
K. RESOURCERECOVERYAND WASTEDISPOSAL Microbes can be used to recover valuable minerals such as uranium and silver from low grade ores (Manchee, 1979; Charley and Bull, 1979). Many bacteria harbor plasmids that cany genes for transformation of metals, aromatics, and other hydrocarbons (Chakrabarty, 1976). Since they are located on plasmids, such genes can be easily isolated and then introduced into organisms like Azotobacter. Azotobacter can fN nitrogen and utilize the excessive carbon present in municipal sewage. The microbially treated sewage can be used as fertilizer (Domino, 1979). Use of microorganisms as a source of protein has been widely advocated (Kharatyan, 1978). Genes directing the synthesis of proteins that are enriched in essential amino acids can be incorporated into organisms to improve the nutritional value of their protein. Such tailored organisms, grown on sewage and other garbage material, can be used as feed for poultry and cattle. Genes responsible for dehalogenase can be introduced into organisms that grow in sewage polluted with halogenated chemicals (Slater et al., 1979; Weightman et al., 1979). Soil microflora play a very important role in soil fertility. Many microbes could be improved so that they could easily establish themselves in plant rhizospheres (Hirota et al., 1978; Newman, 1978). For example, most of the phosphorus in the soil is fixed in insoluble form. Many phosphorussolubilizing organisms such as Bacillus megatherium var phosphaticum could potentially be modified to enhance their activity, resulting in increased crop yield (Malik, 1964).
L. IMPROVED CROPS Recombinant DNA technology can be used to mod* and characterize the genetic makeup of plants (Seshadri and Ranjekar, 1979; Nasyrov, 1978; Hoffmann, 1980; Gleba and Hoffmann, 1980). Many plant proteins are defi-
62
VEDPAL SINGH MALIK
cient in amino acids that are essential for human health. Genes determining the synthesis of a superabundant protein that is rich in essential amino acids could be introduced to improve the quality of plant protein. It also might be possible to move genes for resistance to pests, herbicides, microbial toxins, and nitrogen fuation. If nitrogen-fuing enzyme genes (dflwere to be introduced into a plant such as corn, their expression would have to be subjected to eukaryotic control unless they were planted in mitochondria or chloroplast genome. Also, some way would have to be found to protect nitrogenase from oxygen poisoning (Brill, 1979; Mortenson, 1978; Mortenson and Thorneley, 1979; Shanmugam and Valentine, 1975). Some strains of Rhizobium form nodules only on a very narrow range of plants, while other promiscuous Rhizobium form nodules on many different plants, such as cowpea, soybean, peanut, and mungbean (Goodchild, 1977; Beringer et al., 1979). Rhizobium also forms nodules on a nonleguminous plant called Trema. Many nitrogen-fuing trees, such as Alnus, possess nodules formed by an actinomyces-Frankia (Callaham et al., 1978). These bacteria may be tailored for nodule formation on nonlegume plants (Neyra and Dobereiner, 1977). Nitrogen fuation capability could also be conferred on many free-living bacteria that are abundant in soil and plant rhizospheres. Their excretion products and cellular material upon death could enrich soil. One of the limiting factors in symbiotic nitrogen fixation is the availability of energy rich bonds (ATP)that are synthesized during photosynthesis in the green part of the plant. By increasing the efficiency of the photosynthetic process, the symbiotic nitrogen fixation may be simultaneously enhanced. Resistance to plant pests and diseases is often conferred by a single gene known as a major gene (Russell, 1978). Resistance based on a single major gene or a few such genes becomes ineffective against new races of pathogens and pests after a few years of its introduction into a crop plant (Simons, 1979; Lacy and Leary, 1979). Therefore, novel strategies are needed for obtaining crops resistant to pests and pathogens. Breeding of resistant varieties is one solution to crop diseases. An integrated approach involving resistant cultivars, presticides, fungicides, herbicides, biological control, and agronomical methods is usually the most effective approach. The photosynthetic enzyme ribulose bisphosphate carboxylase/oxygenase is probably the most abundant protein in nature. This highly soluble protein occurs in the stromal compartment of chloroplast and represents up to 65% of the total soluble protein in leafextracts. A similar enzyme constitutes 40% of the soluble protein in the photosynthetic autotroph Rhodospirillum rubrum. It catalyzes the carbon dioxide-fixing step in photosynthesis. C02
-
+ ~-ribulose-l,5-bisphosphate + H 2 0 Mg'+
2,3-phospho-~-glycerate
RECOMBINANT DNA TECHNOLOGY
63
This enzyme catalyzes another reaction involving molecular oxygen, which is the first step in the process of photorespiration (Heber and Krause, 1980). 0 2
+ D-ribulose-l,5-bisphosphateMg2+ + 3-phospho-~-glycerate+ 2-phosphoglycolate
This important oligomeric enzyme consists of two subunits. The cistron that codes for the large subunit is located on chloroplast DNA. The small subunit is encoded in the nuclear genome and is synthesized as a high-molecularweight precursor. While entering the chloroplast, this precursor is processed so that it can combine with the large subunit in the stroma of the chloroplast to yield holoenzyme. Both microbial and plant ribulose bisphosphate carboxylase enzymes are very inefficient. At the saturating level of carbon dioxide, the turnover number for the carboxylase activity is lo00 moles of carbon dioxide fHed per mole of enzyme per minute. In nature, where the substrate concentration is limiting, the turnover number drops to 200. Another metabolic constraint on plant productivity is the oxygenase activity of this enzyme that produces glycolate, which is lost from the plant via photorespiration. Alteration of the activity in favor of carboxylase at the expense of oxygenase could enhance crop yield. No chemical that would stimulate carboxylase activity or inhibit oxygenase activity under conditions of agricultural production is known. Ribulose bisphosphate carboxylase from tetraploid varieties of rye grass has a higher affinity for carbon dioxide than does the same enzyme from diploid varieties. Diploid leaves have a higher photorespiration rate than do tetraploid leaves. Because of the tremendous importance of decreasing photorespiration in agriculture, many wild plants should be screened for this enzyme with desired properties. Naturally occurring genes coding for efficient ribulose bisphosphate carboxylase could be isolated and introduced into plants of agronomic value. Cloning of the large subunit gene from chlamydomonasand maize and the small subunit gene from pea have already been achieved. I n uitro mutated versions of cloned gene can be put back into plant cells when such technology becomes available. Mutant genes that determine the synthesis of proteins stored in seeds could be selected to increase protein lysine content. Synthetic nucleotide sequences that will code for essential amino acids can also be fused to natural genes and inserted into plants. The nutritional value of plant protein could be improved this way (Ellis, 1979). Biomass could be used as a source of energy if photosynthetic efficiency could be increased, as basic processes of photosynthesis are fully understood (Kjaergaard, 1978).They can be mimicked to provide energy-like hydrogen, fixed carbon, and nitrogen (Ladha and Kumar, 978). The red photosynthetic bacterium Thiocapsa roseopersicina contains a thermostable hydrogenase
64
VEDPAL SINGH MALIK
that has a temperature optimum of 75°C and is stable in air. These hydrogenases can be used in biophotolytic systems that evolve hydrogen gas (I. N. Gogotov, personal communication). Application of recombinant DNA technology can speed up the genetic analysis of such useful organisms. A promiscuous sex factor has already been used to mobilize segments of the Rhodopseudomonas capsulata chromosome that codes for photopigment synthesis, reaction centers, and tryptophan synthetase (B. Marrs, personal communication). These R- prime plasmids can now be isolated and the photo pigment genes can then be cloned for use in studies of gene structure, function, and regulation. R. Haselkorn (personal communication) identified fragments of cyanobacterial DNA containing nif genes by hybridization with recombinant plasmids containing defined segments of the nif region of Klebsiella DNA (Puhler et al., 1979) and found a 10 kb fragment that contains DNA sequences complementary to Klebsiella nitrogenase genes. Plasmids of several Cyanobacteria can be used to mobilize chromosomal pieces in these organisms. Nuti et al. (1979) have documented hybridization between restriction fragments of plasmids from Rhizobium leguminosarum and nitrogenase gene DNA sequences from Klebsiella pneumoniae. These results suggest that some of the Rhizobium nif genes are plasmid-borne (Nuti et al., 1979). Genes required for nodulation are also carried on plasmids that are widespread among Rhizobium species (Zurkowski and Lorkiewicz, 1979). Klebsiella nif DNA-encoding nitrogenase can now be used to clone Rhizobium nif genes. A combined molecular and' genetic analysis of Rhizobium nif genes will now facilitate the study of symbiotic nitrogen fixation (Andersen, 1980).
VIII. A Postscript Lastly, the innermost causes and reasons for the creations of these various elemental beings is hidden from our understanding and knowledge. But at the end, all things shall be revealed to us, the greatest and the least, and.the reayn for all things. THEOPHRASTUS VON HOHENHEIM (PARACELSUS) (SIXTEENTH CENTURY)
Recombinant DNA technology has already uncovered many mysteries, for example, overlapping genes and intervening sequences. Several polypeptides of human origin have already been produced in E. coli and their commercialization in the near future is possible. The yield of other single gene products such as enzymes can definitely be improved by this approach and the technology could have impact on all microbial processes. Owing to the availability of many nucleic acid-modifying enzymes (Table V), rapid progress in gene isolation and gene sequencing makes possible exper-
TABLE V DNMRNA MODIFYING ENZYMES”
Application
Enzyme
Other intrinsic activities
Molecular weight
Most efficient substrate
Cofactors Mg2+ Mg2+
Nick translation Sequencing of DNA
3’,5’-Exonuclease 3’-Exonuclease
109,000 76,000
Synthesis of second strand of single-stranded DNA DNA synthesis
3’-Exonuclease
110,000
None
3’-Extensions
None
110,000220,OOO 32,460
cDNA copies of mRNA
RNase H
160,OOO
Poly(rA) oligo(dT)
Mgz+
Ligation
None
Poly(dAdT)
T4 DNA kinase
”P labeling of 5‘-end of RNMDNA
3’-Phosphatase
60,00068,000 140,000
Mg2+ Mn Mg2+
E . coli RNA Pol.
RNA copy of DNA
None
E . coli Pol. 1 E . coli large fragment of Pol. 1 T4 DNA Pol. Calf thymus a-DNA Pol. Terminal deoxynucleotidyl transferase AMV reverse transcriptase T4 DNA ligase
Poly(dA-dT) Activated calf thymus DNA Heat-denatured calf thymus DNA Poly(dT)oligo(rA)
Mgzi MgZi Mg2+ co 2+
Micrococcal nuclease-treated CNA Native calf thymus DNA
’+
Mg2+
(Continued)
TABLE V (Continued )
Enzyme
Other intrinsic activities
Application
3’-Phosphatase RNase H apurinic endonuclease None
Exo 111
Removal of 3’- and 5’-mononuclee tides of DNA
S, -Nuclease
Single-stranded-specificnuclease
Tobacco acid pyrophosphatase Bacterial alkaline phosphatase
Removes the cap structure from 5’end of mRNA Dephosphorylation of 5‘-RNA/ DNA
RNase Phy I
Sequence analysis of RNA
None
RNase H ( E . coli)
Degradation of RNA in RNA:DNA hybrid; removal of poly(A) from mRNA site-specificcleavage of RNA Analysis of RNA processing
None
RNase 111 (E. coU)
a Reproduced with permission of Bethesda Research
None None
None
Laboratories, Inc., RockviUe, Maryland.
Molecular weight
32,00036,000 270,000280,000 m000 86,000 89,000 25,000
50
Most efficient substrate
Cofactors
Sonicated H-E. coli DNA
Mg2+
Heatdenatured DNA Hydrolysis of ATP
ZnZ+
Hydrolysis of ATP
None
Cytosinedeficient RNA RNA:DNA hybrid
None
Poly(A,U)
Mkf+
None
Me+
RECOMBINANT DNA TECHNOLOGY
67
iments that could not be imagined before. Almost any piece of DNA can now be ligated to ribosomal (Schwarz and Kossel, 1980) or any other genes that should integrate into the chromosome of the host. The replication origin of many self-replicating genomes have already been well-characterized and provide another type of vector that can be used to autonomously replicate genes of interest. In the near future, E. coli will continue to be the Romeo of the molecular biology theater for unraveling the molecular basis of life. However, commercial aspects of the technology will definitely be realized in the years ahead by commitment of application of this new technology to the improvement of organisms currently being used in industry. Hybrid organisms can be obtained also by protoplast fusion. However, fusion of taxonomically different strains may produce very unstable strains owing to poorer genome homology than is desirable for recombination. This will further add to the already prevalent instability of industrial strains (Malik, 1979a). Furthermore, protoplast fusion does not offer the possibility of introducing and ampllfyingpredefined DNA sequences with known biological functions in an organism and is therefore not a viable substitute for recombinant DNA technology. REFERENCES Abelson, J. (1979). Annu. Rev. Biochem. 48, 1035. Adam, R. E., and Zimm, B. H. (1977). Nucleic Acids Res. 4, 1513. Aerts, M., Jacobs, M., Hemalsteens, J . P., Montagu, M. V., and Schell, J. (1979). Plant Sci. Lett. 17, 43. Alt, F. W., Kellems, R. E., Bertins, J. R., and Schimke, R. T. (1978). J . B i d . Chem. 253, 1357-1370. An, G., and Friesen, J . D. (1979). J . Bacteriol. 140, 400. Andersen, K. (1980). Trends Biochern. Sci. 5, (2) 35. Arnheim, N. (1979). Gene. 7, 83. Atrat, P., Deppmeyer, V., and Horhold, C. (1979a). Z. Allg. Mikrobiol. 19, 315. Atrat, P., Deppmeyer, V., Groh, H., and Horhold, C. (197913). Z. AZZg. Mikrobiol. 19, 375. Bach, M. L., Lacroute, F., and Botstein, D. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 386. Backman, K., and Ptashne, M. (1978). Cell 13, 65. Backman, K., Ptashne, M., and Gilbert, W. (1976). Proc. Natl. Acad. Sci. U.S.A. 73, 41744178. Bahl, C. P., Wu, R., Stawinski, J., and Narang, S. A. (1976a). Gene 1, 81. Bahl, C. P., Wu, R., Itakura, K., Katagiri, N., andNarang, S. A. (197613).Proc. Natl. Acad. Sci. U.S.A. 73, 91. Bahl, C . P., Wu, R., Stawinski, J., and Narang, S. A. (1977). Proc. Natl. Acad. Sci. U.S.A. 74, 966.
Bahl, C . P., Wu, R., Brousseau, R., Sood, A. K., Hsiung, H. M., and Narang, S. A. (1978). Biochem. Biophys. Res. Commun. 81, 95. Baldacci, P., Royal, A., Cami, B., Perrin, F.,Krust, A., Garapin, A., and Kourilsky, P. (1979). Nucleic Acids Res. 6, 2683.
68
VEDPAL SINCH MALIK
Barnes, W. M. (1070). Gene 5, 127. Barrell, B. G., Bankier, A. T., and Drouin, J, (1070). Nature (London)282, 180. Bassford, P., and Beckwith, J. R. (1070). Nature (London) 277, 538. Bassford, P., Silhavy, T. J., and Beckwith, J. (1070).J . Bacterfol. 130, 10. Bastia, D. (1078). J . Mol. Btol. 124, 601. Bauer, W. R. (1078). Annu. Reo. Biophys. Bioeng. 1, 287. Bazetoux, S., Jouanin, L., and Huguet, T. (1078). Nuckic Ad& Res. 5, 751. Beck, C. F. (1070). Proc. Natl. Acad. Sci. U.S.A. 76, 2376. Beckwith, J. R., and Zipfer, D., eds. (1070). “The Lactose Operon.” Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Beebee, T. J. C., and Carty, D. S. (1080). Anal. Biocha. 101,7. Beggs, J. D. (1078). Nature (London)275, 164. Behrens, B., Luder, G., Behncke, M.,Trautner, T. A,, and Ganesan, A. T. (1070). Mol. Gen. Genet. 175,351. Bell, G. I., Swain, W. F., Pictet, R., Cordell, B., Goodman, H. M.,and Rutter, W. J. (1070). Nature (London) 282,525. Belliard, G., Vedel, F.,and Pelletier, G. (1070). Nature (London)281, 401. Bennett, G. N., and Yanofsky, C. (1078).J . Mol. Biol. 121, 170. Benton, W. D., and Davis, R. W. (1077). Science 196, 180. Benzinger, R. (1078). Mtcrobiol. Reo.42, 194. Beremand, M. N., and Blumenthal, T. (1070). Cell 18, 257. Berg, P. (1070). CRC Crft. Reo. Biochem. 7, 75. Berg, P. E., Gayda, R., Avni, H., Zehnbauer, B., and Markovitz, A. (1076). Proc. Natl. Acad. Sci. U.S.A. 73, 607. Beringer, J. E., Brewin, N., Johnston, A. W. B., Schulman, H. M.,and Hopwood, D. A. (1070). Proc. R. SOC.London 204, 251. Berman, M. L., and Beckwith, J. (1970).J . Mol. Biol. 10, 303. Bernard, H. U.,Remaut, E., Hershfield, M.V., Das, H., Helinski, D. R., Yanofsky, C., and Franklin, N. E. (1070). Gene 5, 50. Bernhard, K., Schrempf, H., and Goebel, W. (1978). 1.Bncteriol. 133, 807. Beyreuther, K., and Gronenborn, B. (1076). Mol. Gen. Genet. 147, 115. Beyreuther, K., Adler, K., Geisler, N., and Klemm, A. (1073). Proc. Natl. Acad. Sci. U.S.A. 70,3576. Bibb, M.J., Ward, J., and Hopwood, D. A. (1078). Nature (London)274,308. Bingham, A. H. A., Bruton, C. J., and Aktinson, T. (1070). J . Gen. Mtcrobiol. 114,401. Birky, C. W. (1078). Annu. Reo. Genet. 12, 471. Blakesley, R. (1080). Focus 2, (6), 1. Bulletin of Bethesda Research Laboratories, Inc. Blattner, F. R., Williams, W. G., Blechl, A. E.,Denniston-Thompson, K., Faber, H. E., Furlong, L. A., Grunwald, D. J., Kiefer, D. O., Moore, D. D., Schumm, J. W., Sheldon, E. L.,and Smithies, 0. (1077). Sdence 196, 161. Bogenhagen, D. F., Sakonju, S., and Brown, D. D. (1060). Cell 10, 27. Boliver, F., Rodriquez, R. L., Green, P. J., Betlach, C., Heyneker, H. L., Boyer, H. W., Crosa, J. H., and Falkow, S. (1077). Gene 2,95. Bollum, F. J, (1074). Ado. Enzymol. 47, 347. Bollum, F. J. (1078). “Mechanisms in the Control of Neoplasia” (P. Chandra, ed.), p. 157. Plenum, New York. Bortrand, K., Korn, L.,Lee, F., Platt, T., Squires, C. L., Squires, C., and Yankofsky, C. (1957). Science 180,227. Bostian, K. A., Lee, R. C., and Halvorson, H. 0. (1070). Anal. Biochem. 05, 174.
RECOMBINANT DNA TECHNOLOGY
69
Boyer, H. W., Crosa, J. H., and Fakow, S. (1977).Gene 2, 95. Brack, C., and Tonegawa, S. (19n). Proc. Natl. Acad. Sci. U.S.A. 74, 5652. Brammar, W.J. (1977).Bfochem. SOC.Trans. 5, 1633. Brandt, A., and Ingversen, J. (1978).Carlsberg Ree. Commun. 43, 451. Breiner, A., Gusella, J. F., Keys, C., and Hbusman, D. E. (1979).Gene 1, 317. Brickman, E., Silhavy, T. J., Bassford, P. J., Shuman, H. A., and Beckwith, J. R. (1979).J . Bacteriol. 139, 13. Brill, W. J. (1979).Am. Sci. 67,458. Broach, J. R., Strathem, J. N., and Hicks, J. N. (1979).Gene 8, 121. Brodelius, P. (1979).Adu. Biochem. Eng. 10, 75. Broome, A., and Gilbert, W. (1978).Proc. Natl. Acad. Sci. U.S.A. 75, 2746. Brown, B. J., and Carlton, B. C. (1980).J . Bacteriol. 142, 508. Brown, K. D., Bennett, G . N., Lee, F., Schweingruber, E., andyanofsky, C. (1978).J . Mol. B b l . 121, 153. Brown, T. D. K., and Balmain, A. (1979).Nucleic Acids Res. 7,2357. Buchel, D. E., Gronenborn, B., and Muuer-Hill, B. (1980).Nature (London)283, 541. Bull, A. T., Ellwood, D. C.,and Radedge, C. (eds.). “Microbial Technology: Current State, Future Prospects.” Cambridge Univ. Press, London and New York. Burrell, C. J.. Mackay, P., Greenaway, P. J., Hofschneider, P. H., and Murray, K. (1979). Nature (London)270, 43. Bylinsky, G. (1980).Fortune, June 16,p. 144. Cdaham, D.,Tredic, P. D., andTorrey, J. G. (1978).Sdence 199, 899. Cdos, M. P., and Miller, J. H. (1980).CeU 20, 579. Cami, B., and Kourilsky, P. (1978).Nucbic Adds Res. 5, 2373. Canosi, U.,Morelli, G., and Trautner, T. A. (1978).Mol. Gen. Genet. 166,259. Carbon, J., Ratzkin, B., Clarke, L.,and Richardson, D. (1977).Miomi Winter Symp. 12,59. Case, M. E., Schweizer, M., Kushner, S. R., and Giles, N. H. (1979).Proc. Natl. Acad. Sci. U.S.A. 76,5259. Cassadaban, M. J. (1976).J . Mol. Biol. 104, 557. Casse, F., Boucher, C., Julliott, J. S., Michel, M., and Denarie, J. (1979).J . Gen. Microbiol. 113, 229. Catterall, J. F., Stein, J. P., Lai,E. C., Woo,S. L. C., Dugaiczyk, A,, Mace, M. L., Means, A. R.,and O’Malley, B. W. (1979).Nature (London)278, 323. Cech, T. R., and Rio, D. C. (1979).Proc. Natl. Acad. Sd. U.S.A. 76,5051. Chakrabarty, A. L. (1976).Annu. Reu. Genet. 10, 7. Chakrabarty, A. M. (1978).“Genetic Engineering.” CRC Press, Boca Raton, Florida. Chan, P. T., Lebowitz, J., and Bastia, D. (1979).Nucbic A& Res. 7, 1247. Chan, S. J., Noyes, B. E., Aganval, K. L., and Stein, R. (1979). Proc. Natl. Acad. Sd. U.S.A. 76,5036. Chandler, P. M., Rimkus, D., and Davidson, N. (1979).Anal. Bfochem. 99,200. Chang, A. C. Y., Lansman, R. A., Clayton, D. A,, and Cohen, S. N. (1975).CeU 6, 231. Chang, A. C. Y., Nunberg, J. H., Kauhan, R. J., Erlich, H. A., Schimke, R. T., andCohen, S. N. (1978).Nature (London)275,617. Chang, S., and Cohen, S. N. (1979).Mol. Gen. Genet. 168, 111. Charley, R. C., and Bull, A. T. (1979).Arch. Microbiol. 123,239. Chater, K. F., and Carter, A. T. (1978).J . Cen. Microbiol. 109, 181. Chater, K. F., and Carter, A. T. (1979)./. Gen. Microbiol. 115,431. Chevallier, M. R., and Aigle, M. (1979).FEBS Lett. 108, 179. Chi, N. W.,Ehrlich, S. D., and Lederberg, J. (1978).J . Bacteriol. 133, 816.
70
VEDPAL SINGH MALIK
Chinault, A. C., and Carbon, J. (1979). Gene 5 , 111. Chirgwin, J. M., Przybyla, A. E., MacDonald, R.J., and Rutter, W. J. (1979). Biochemistry 18, 5294. Chou, J., Casadaban, M. J., Lemaux, P. G., and Cohen, S. N. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 4020. Citron, B. A., Feiss, M., and Donelson, J. E. (1979). Gene 6, 251. Clarke, L., and Carbon, J. (1976). Cell 9, 91. Clarke, L., and Carbon, J. (1978). J . Mol. Biol. 120, 527. Clewell, D. B. (1972). J . Bacteriol. 110, 667. Clewell, D. B., Yagi, Y., Dunny, G. M., and Schultz, S. K. (1974).J . Bacteriol. 117, 383. Cochet, M., Gannon, F., Hen, R., Maroteaux, L., Perrin, F., and Chambon, P. (1979). Nature (London) 282,567. Cockburn, A. F., Newkirk, M. J., and Firtel, R. A. (1976). Cell 9, 605. Cohen, G., Zimmer, Z., Gurevich, R., and Yanofsky, S. (1978). Mol. Gen. Genet. 166, 305. Cohen, S. N. (1975). Sci. Am. 233,24. Cohen, S. N., and Cbang, A. C. Y. (1973). Proc. Natl. Acad. Sci. U.S.A. 70, 1293. Cohen, S. N., Chang, A. C. Y., and Hsu, L. (1972). Proc. Natl. Acad. Sci. U.S.A. 69, 2110. Cohen, S. N., Chang, A. C. Y., Boyer, H. W., and Helling, R. B. (1973). Proc. Natl. Acad. Sci. U.S.A. 70, 3240. Collins, C. J., Jackson, D. A,, and deVries, F. A. J. (1976). Proc. Natl. Acad. Sci. U.S.A. 73, 3838. Collins, J. (1977). C u r . Top. Microbiol. Zmmunol. 78, 122. Collins, J. (1979). Gene 6, 29. Collins, J., and Bruning, H. J. (1978). Gene 4, 85. Collins, J., and Hahn, B. (1978). Proc. Natl. Acad. Sci. U.S.A. 9, 4242. Colman, A., Byers, M. J., Primrose, S. B., and Lyons, A. (1979). Eur. J. Biochem. 91, 303. Commerford, S. L. (1971). Biochemistry 16, 1993. Cooper, J. A., and Moss, B. (1979). Nuleic Acids Res. 6, 3599. Cordell, B., Bell, G., Tischer, E., Denoto, F. M., Ullrich, A., Pictet, R.,Rutter, W. J., and Goodman, H. M. (1979). Cell 18, 533. Cory, S., Jackson, J., and Adams, J. M. (1980). Nature (London) 285, 450. Cosloy, S. D., and Oishi, M. (1973). Proc. Natl. Acad. Sci. U.S.A. 70, 84. Coutelle, Ch., Ioannou, P., and Williamson, R. (1978). Gene 3, 117. Crabeel, M., Charlier, D., Weyens, G., Feller, A., Pierard, A., and GlansdorE, N. (1980). 1. Bacteriol. 143, 921. Crawford, G. P., and Stauffer, D. V. (1980). Annu. Reo. Biochem. 49, 163. Crea, R.,Kraszewski, A., Hirose, T., and Itakura, K. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 57655769. Creighton, T. E. (1979). J . Mol. Biol. 128, 235. Crick, F. H. C. (1978). Eur. J. Biochem. 83, 1. Currier, T. C., and Nester, E. W. (1976). Anal. Biochem. 76, 431. Dagert, M., and Ehrlich, S. D. (1979). Gene 6,23. Dale, R. M. K., and Ward, D. C. (1975). Biochemistry 14, 2458. Dale, R. M. K., Martin, E., Livingston, D. C., and Ward, D. C. (1975). Biochemistry 14,2447. Darnell, J . E. (1978). Science 202, 1257. Davis, B. D. (1977). Jpn. J. Antibiot. 30, 262. Davis, S. B. D., and Tai: P. C. (1980). Nature (London) 283,433. Dawid, I. B., and Wahli, W. (1979). Dew. Biol. 68, 305-328. Debarbouille, M., and Schwartz, M. (1979). J . Mol. Biol. 132, 521. Deddish, P. A., and Ravin, A. W. (1979). J . Bacteriol. 138, 94.
RECOMBINANT DNA TECHNOLOGY
71
Delisle, A. L., Nauman, R. K., and Minah, G. E. (1978). Infect. Immun. 20, 303. Denhardt, D. T., Dressler, D., and Ray, D. S. (1979). “The Single-Stranded DNA Phages. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. DeVries, F. A. J., Collins, C. J., and Jackson, D. A. (1976). Biochim. Biophys. Acta 435,213. Dickson, R. C., and Martin, J. S. (1978). Cell 15, 123. Dimitriadis, G. J. (1978). Nucleic Acids Res. 5 , 1381. Dimitriadis, G. J. (1979). Nucleic Acids Res. 6, 2697. Din, N., and Engberg, J. (1979). J . Mol. B i d . 134, 555. Dodgson, J. B., Strommer, J., and Engel, J. D. (1979). Cell 17, 879. Domino, F. A. (1979).“Energy from Solid Waste.” Noyes Data Corporation, Park Ridge, New Jersey. Donoghue, D. J., and Sharp, P. A. (1978). J. Bacteriol. 138, 1192. Driesel, A. J., Crouse, E. J.. Gordon, K., Bohnert, H. J., and Herrmann, R. G. (1979). Gene 6, 285. Drurnmond, M. (1979). Nature (London) 281,343. Dudits, D., Hadlaczky, G . , Bajszar, G. Y.,Koncz, C., Lazar, G., and Horvath, G . (1979). Plant Sci. Lett. 15, 101. Dugaiczyk, A., Boyer, H. W., and Goodman, H. M. (1975). 1.Mol. Biol. 96, 171. Dunn, R., Delaney, A. D., Gillam, I. C., Hayashi, S., Tener, G. M., Grigliatti, T., Misra, V., Spurr, M. G., Taylor, D. M., and Miller, R. C. (1979). Gene 1, 197. Eckhardt, T. (1978). Plasmid 1, 584. Ehrlich, S. D. (1977). Proc. Natl. Acad. Sci. U.S.A. 74, 1680. Ehrlich, S. D. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 1433. Ehrlich, S. D., Burstyn-Pettegrew, H., Stroynowski, I., and Lederberg, J. (1976). Proc. Natl. Acad. Sci. U.S.A. 72, 4145. Ellis, J. G., Kerr, A., Tempe, J., and Petit, A. (1979). Mol. Gen. Genet. 173, 263. Ellis, R. J. (1979). Trends Biochem. Sci. 11, 241. Emtage, J. S., Tacon, W. C. A., Catling, H., Jenkins, B . , Porter, A. G . , and Carey, N. H. (1980). Nature (London) 283, 171. Enouye, M., and Halegou, S. (1980). CRC Crit. Reo. Biochem. 7, 339. Enquist, L., Tiemeier, D., Leder, P., Weisberg, R., and Sternberg, N. (1976). Nature (London) 259,596. Evans, G . A., and Rosenfeld, M. G. (1979). J . Biol. Chem. 245, 8023. Farabaugh, P. J., and Fink, G. R. (1980). Nature (London) 286, 352. Farrell, R., Gunsalus, I. C., Crawford, I. P., Johnson, J. B., and Ito, J. (1978). Biochem. Biophys. Res. Commun. 82, 411. Fedoroff, N. V. (1979). Cell 16, 697. Fiddes, J . C., and Godson, G . N. (1979). J . Mol. Biol. 133, 19. Fiddes, J . C., and Goodman, H. M. (1979). Nature (London) 281, 351. Fiddes, J. C., Seeburg, P. H., Denoto, F. M., Hallewell, R. A., Baxter, J. D., andGoodman, H. M. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 4294. Firtell, R. A., Cockburn, A., Frankel, G., and Hershfield, V. (1976). J . Mol. Biol. 102, 831. Fischer, S. G., and Lerman, L. S. (1979). Cell 16, 191. Fischer, R. A., and Turner, N. C. (1978). Annu. Reo. Microbial. 29, 277. Flavell, R. A., Bernards, R., Kooter, J. M., deBoer, E., Little, P. F. R., Annison, G . , and Williamson, R. (1979). Nucleic Acids Res. 6, 2749. Fonty, G., Goursot, R., Wilkie, D., and Bernardi, G. (1978). J . Mol. Biol. 119, 213. Fonty, G., Culard, F., Baldacci, G., Goursot, R., Prunell, A,, and Bernardi, G. (1979).J . Mol. Biol. 134,493. Fraley, R. T., Fornari, C. S., and Kaplan, S. (1979). Proc. Natl. Acad. Sci. U.S.A. 66,3348.
72
VEDPAL SINGH MALIK
Franche, U., and Taggart, R. T. (1980). Proc. Natl. Acad. Sci. U.S.A. 77,3595. Franklin, N. C. (1978). Annu. Reo. Genet. 12, 193. Fraser, T. H., and Bruce, B. J. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 996. Fritsch, E. F., Lawn, R., and Maniatis, T. (1979). Nature (London) 279,598. Fuchs, P. G., and Dobmnski, W. T. (1978). J . Bacterbl. 136, 295. Fujii, T., Shibuya, T., and Matsumoto, K. (1979). C h a . SOC.Spec. Publ. Gafner, J., and Philippsen, P. (1980). Nature (London) 286, 414. Gang, D. M., and Shaikh, K. (1976). Biochim. Biophys. Acta 425, 110. Gantotti, B. V.,Patil, S. S., and Mandel, M. (1979). Mol. Gen. Genet. 174, 101. Garapin, F., Chousterman, S., Horodniceanu, F., Kourilsky, P., and Garapin, A. C. (1979). Proc. Natl. Acad. Sci. U.S.A. 76,3755. Gardner, J. F. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 1706. Gelfand, D. H., Shepard, H. M., O’Farrell, P. H., and Polisky, B. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 5869. Gerbaud, C., Fournier, P., Blanc, H., Aigle, M., Heslt, H., and Guernequ, M.’(1979). Gene 5, 233.
Gergen, J. P., Stem, R. H., and Wensink, P. C. (1979). Nucleic A& Res. 7, 2115. Ghangas, G., and Wu, R. (1975). J . B w l . Chem. 18, 387. Gilbert, F., Mandart, E., Fitoussi, F., Tiollais, P., and Charnay, P. (1979). Nature (London) 281,646.
Gilbert, W., and Maxam, A. (1973). Proc. Natl. Acad. Sci. U.S.A. 70, 3581. Gilbert, W., and Villa-Komaroff, L. (1980). Sd.Am., May. Gillam, S., and Smith, M. (1979a). Gene 8, 81. Gillam, S., and Smith, M. (1979b). Gene 8, 99. Gillam, S., Jahnke, P.,Astell, C., Phillips, S., Hutchison, C. A., and Smith, M. (1979). Nucleic AcidP Res. 6, 2973. Glaser, G., Enquist, L., and Cashel, M. (1977). Gene 2, 159. Gleba, Y. Y., and H o h a n n , F. (1980). Planta 149, 112. Glover, D. M., and Hogness, D. S. (1977). Cell 10, 167. Goeddel, D. V., Kleid, D. G., Bolivar, F., Heyeneker, H. L.,Yansura, D. G., Crea, R., Hirose, T., Kraszewski, A., Itakura, K., and Riggs, A. D. (1979a). Proc. Natl. Acad. Sd. U.S.A. 76, 106. Goeddel, D. V., Heyneker, H., Hozumi, T., Arentzen, R.,Itakura, K., Yansura, D. G., Ross, M. J., Miozzari, G., Crea, R.,and Seeburg, P. H. (1979b). Nature (London) 281, 544. Goff, S. P., and Berg, P. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 1763. Goff, S. P., and Berg, P. (1979). J . Mol. Biol. 133, 359. Gonzalez, J. M., and Carlton, B. C. (1980). Plasmid 3, 171. Goodchild, D. J. (1977) Znt. Reo. Cytol. 6, 235-288. Goodman, H. M., Olson, M. V.,and Hall, B. D. (1977). Proc. Natl. Acad. Sci. U.S.A. 74,5453. Graf, L., Kossel, H.,and Stutz, E. (1980). Nature (London) 286, fN8. Graham, M. Y., and Weisblum, B. (1979). J . Bacterlol. 13, 1464. Graham, S., Yoneda, Y., and Young, F. E. (1979). Gene 7,69. Gromkova, R., and Goodgal, S. (1979). Biochem. Biophys. Res. Commun. 88, 1428. Gronenborn, B., and Messing, J. (1978). Nature (London) 272,375. Gross, D. C., Vidaver, A. K., and Klucas, R. V. (1979). J . Cen. Microbtol. 114, 257. Grossmann, M. K., and Zimmermann, F. K. (1979). Mol. Gen. Genet. 175, 223. Grunstein, M., and Hogness, D. S. (1975). Roc. Natl. Acad. Sci. U.S.A. 72, 3961-3965. Gryczan, T. J., and Dubnau, D. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 1428. Gryczan, T. J., Contente, S., and Dubnau, D. (1978). J . Bocteriol. 134, 318. Guarente, L., Lauer, G., Roberts, T. M., and Ptashne, M. (1980). Cell 20,543.
RECOMBINANT DNA TECHNOLOGY
13
Gueny, P., LeBlanc, D. J., and Fakows (1973). J . Bacteriol. 116, 1064. Gunsalus, R. P., Zurawski, G., and Yanofsky, C. (1979). J . Bacteriol. 140, 106. Curskaya, G. V., Grokhovsky, S. L., Zhuze, A. L., and Gottiks, B. P. (1978). Biochim. Biophys. Acta. 563,336. Gusella, J., Breiner, A,, Kaot, P. J . , Jones, C., Puck, T. T., Keys, C., Orkin, S., and Housman, D. (1979). Proc. Natl. A d . Sci. U.S.A. 76, 5239. Haber, J., Mascioli, D. W., and Rogers, D. T. (1980). Cell 20, 519. Hackel, R. A., and Khan, N. A. (1978). Mol. Gen. Genet. 164, 295. Haigh, L. S., Anderson, W. F., and Francke (1980). Nature (London) 263,683. Haldenwang, W. G., and Losick, R. (1979). Nature (London) 282,256. Hamer, D. H., and Leder, P. (1979). Nature (London) 281,35. Hansen, J., and Olsen, R. (1978). J . Bacteriol. 135, 227. Hardies, S. C., and Wells, R. D. (1976). Proc. Natl. Acad. Sci. U.S.A. 73,3117. Hardies, S. C., and Wells, R. D. (1979). Gene 7, 1. Hardies, S. C., Patient, R. K., Klein, R. D., Ho, F., Reznikoff, W. S., and Wells, R. D. (1979). J . Biol. Chem. 254, 5527. Harpold, M. M., Dobner, P. R.,Evans, R. M., and Bancroft, F. C. (1978). N u c k Acids Res. 5, 2039. Harris, C. C., Yolken, R. H., Krokan, H., and Hsu, I. C. (1979). Proc. Natl. Acad. Sci. U.S.A. 76,5336. Hautala, J. A,, Schweizer, M., Giles, N. H., andKushner, S. R.(1979). Mol. Gen. Genet. 172, 83. Hayakawa, T., Otake, N., Yonehara, H., Tanaka, T., and Sakaguchi, K. (1979)./. Antibiot. 32, 1348. Heber, V., and Krause, G. H. (1980). Trends Biochem. Sci. 5 (2), 32. Hedden, P., MacMillan, J., and Phinney, B. 0. (1978). Annu. Reo. Plant Physiol. 29, 149. Helinski. D. R. (1979). CRC Crit. Reo. Biochem. 7, 83. Helling, R. B., Goodman, H. M., and Boyer, H. W. (1974). J . Virology 14, 1235. Henning, V., Royer, H., Teether, R. M., Hindennach, I., and Hollenberg, C. P. (1979). Proc. Natl. Acad. Sci. U.S.A. 76,4360. Hentschel, C., Irminger, J. C., Bucher, P., and Birnstein, M. (1980). Nature (London) 285, 147-151. HersMeld, V., Boyer, H. W., Yanofsky, C., Lovett, M. A., and Helinski, D. R. (1974). Proc. Natl. Acad. Sci. U.S.A. 71, 3455. Herson, D., Schmidt, A., Seal, S., Marcus, A., and Doting, L. (1979). J . Biol. Chem. 254, 8245. ‘Heyneker, H. L., Shine, J., Goodman, H. W., Boyer, H., Rosenberg, J., Dickerson, R. E., Narang, S. A., Itakura, K., Lin, S., and Riggs, A. D. (1976). Nature (London) 263, 748. Hibner, U.,and Albert, 8. M. (1980). Nature (London) 285, 300. Hicks, J. B.,Hinnen, A., and Fink, G. R. (1979a). Cold Spring Harbor Symp. Quant. Biol. 38, 1305. Hicks, J. B., Strathem, J. N., and Klar, A. J. S. (1979b). Nature (London) 282,478. Hinnen, A., Hicks, J. B., and Fink, J . R. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 1929. Hirota, Y., Fujii, T., Sano, Y., and Iyama, S. (1978). Nature (London) 276, 416. Hoch, J. A. (1976). Ado. Genet. 18, 69. Hoffmann, F. (1980). Natutwissenschafen 67,301. Hofstetter, H., Schambock,A., VandenBerg, J., and Weissmann, C. (1976). Biochim. Biophys. Acta. 454, 587. Hollaender, A. ed. (197‘7). “Genetic Engineering for Nitrogen Fixation.” Plenum, New York. Hooykaas, P. J. J., Roobol, C., and Schilpemrt, R. A. (1979). J . Gen. Mhobiol. 110, QQ.
74
VEDPAL SINGH MALIK
Horinouchi, S., Vozumi, T., Hoshino, T., Ozaki, A., Nakajima, S., Beppu, T., and Arima, K. (1978).Mol. Gen. Genet. 157, 175-182. Howley, P. M., Israel, M. A., Law, M., and Martin, M. A. (1979).J . B i d . Chem. 254,4876. Hranueli, D., Pigac, J., and Vesligaj, M. (1979).J . Gen. Microbiol. 114,295. Hsiao, C., and Carbon, J. (1979).Proc. Natl. Acad. Sci. U.S.A. 76,3829. Hsiung, H. M., Brousseau, R., Michniewicz, J., and Narang, S. A. (1979).Nucleic Acids Res. 6 ,
1371. Hull, R., Covey, S. N., Stanley, J., and Davies, J. W. (1979).N u c k Acids Res. 1, 669. Humayun, M. Z., and Chambers, R. (1979).Nature (London) 278, 524. Humphries, P., Old, IT..,Coggins, L. W., Meshane, T., Watson, C., and Paul, J. (1978). Nucleic Acids Res. 5, 905. Iordanewu, S. (1975).J . Bacteriol. 124,597. Itakura, K., Bahl, C. P., Katagiri, N., Michniewicz, J. J., Wightman, R. H., and Narang, S. A. (1973).Can. J. Chem. 51,3649. Itakura, K., Hirose, T., Crea, R., Rigs, A. D., Heyneker, H. L., Boliver, F., and Boyer, H. W. (1977).Science 198, 1056. Jackson, D. A., Symons, R. H., and Berg, P. (1972).Proc. Natl. Acad. Sci. U.S.A. 69,29042909. Johnson, J. B., and Gunsalus, I. C. (1977).Biochem. Biophys. Res. Commun. 75, 13. Johnston, A. W. B., Setchell, S. M., and Berringer (1978).J . Gen. Microbiol. 104,209. Johnstrud, L. (1978).Proc. Natl. Acad. Sci. U.S.A. 75,5314. Jovin, T. M., Geisler, N., and Weber, K. (1977).Nature (London) 269, 668. Kaguni, J., and Ray, D. S. (1979).J . Mol. B i d . 135,863. Kania, J., and Brown, D. T. (1976).Proc. Natl. Acad. Sci. U.S.A. 73,3529. Kania, J., and Muller-Hill, B. (1977).Eur. J. Biochem. 79,381. Katagiri, N., Itakura, K., and Narang, S. A. (1975).J . Am. Chem. Soc. 97, 7332. Kato, K., Umeda, Y., Suzuki, F., Hayashi, D., and Koska, A. (1979).Clin. C h m . Winston Salem N.C. 25, 1306. Kedes, L. H., Chang, A. C. Y., Houseman, D., and Cohen, S. N. (1975).Nature (London)255, 533. Keggins, K. M., Duvall, E. J., and Lovett, P. S. (1978a).J . Bacteriol. 134,514. Keggins, K. M., Lovett, P. S., and Duvall, E. J. (197813).Proc. Natl. Acad. Sci. U.S.A. 75, 1423. Keggins, K. M., Lovett, P. S., Marrero, R., and Hoch, S. (1979).J . Bacteriol. 139, 1001. Kelley, W. S., Chalmers, K., and Murray, N. E. (1977).Proc. Natl. Acad. Sci. U.S.A.74,5632. Kemp, D.J., Cory, S., and Adams, J. M. (1979).Proc. Natl. Acad. Sci. U.S.A. 76,4627. Kenerley, M. E.,Morgan, E. A., Post, L., Lindahl, L., and Nomura, M. (1977).J . Bacteriol. 132, 931-949. Kharatyan, S. G . (1978).Annu. Reo. Microbiol. 32, 301. Khorana, H. (1978).Biourg. C h m . 7, 351. Khorana, H. G . (1979).Science 203,614. Khorana, H. G.,Aganval, K. L., Bresmer, P., Buchi, H., Caruthers, M. H., Cashion, P. J., Fridkin, M., Jay, E., Kleppe, K., Kleppe, R.,Kumar, A., Loewen, P. C., Miller, R. C., Minamoto, K., Panet, A,, RajBhandary, U. L., Ramamoorthy, B., Sekiya, T., Takeya, T., and van de Sande, J. H. (1976).J . Biol. C h a . 251,565. Kingsman, A. J., Clarke, L., Motrimer, R. K., and Carbon, J. (1979).Gene 1, 141. Kjaergaard, L. (1978).Biotechnol. Bioeng. 20, 1691. Klaus, S . , Suss, F., Juch, C., and Hauck, A. (1978).2. All. Mikrobiol. 18,375. Klaus, S., Triebel, H., Hartmann, M.,Walter, A., Walter, F., Zopel, P., Bar, H., and Hradecna, 2.(1979).Mol. Gen. Genet. 172,312.
RECOMBINANT DNA TECHNOLOGY
75
Klein, B., and Murray, K. (1979). J. Mol. Biol. 133, 289. Klein, R. D., Selsing, E., and Wells, R. D. (1980). Plasmid 3, 88. Kleinkauf, H., and Koischvitz, H. (1980). In “Multifunctional Proteins” (H. Bisswanger and E. Schmincke-Ott, eds.), p. 217. Wiley, New York. Klier, A. F., Kunst, F., and Rapoport, G. (1979). Nucleic Acids Res. 1, 997. Klobutcher, L. A., and Ruddle, F. H. (1979). Nature (London)280, 657. Klobutcher, L. A., Miller, C. L., and Ruddle, F. H. (1980). Proc. Natl. Acad. Sci. U.S.A. 77, 3610. Knopf, U. C. (1979). Sub-cell. Biochem. 6, 143. Kochert, G. (1978). Annu. Reo. Plant Physiol. 29, 461. Koekman, B. P., Ooms, G., Klapwijk, P. M., and Schilperoort, R. A. (1979). Plasmid 2,347. Komeda, Y.,and Iino, T. (1979). J . Bacteriol. 139, 721. Konkel, D. A., Tilghman, S. M., and Leder, P. (1978). Cell 150, 1125. Kom, L. J., Birkenmeier, E. H., and Brown, D. D. (1979). Nuckic Acids Res. 7, 947. Koshland, D., and Botstein, D. (1980). Cell 20, 749. Kourilsky, P., and Chambon, P. (1978). Trends Biochern. Sci. 2, 244. Kretschmer, P. J . , Chang, A. C. Y., and Cohen, S. N. (1975). J . Bacteriol. 124, 225. Kreuzaler, F., Ragg, H., Heller, W., Tesch, R.,Witt, I., Hammer, D., and Hahlbrock, K. (1979). Bur. J . Biochern. 99, 89. Kronenberg, H. M., McDevitt, B. E., Majzoube, J. A . , Nathans, J., Sharp, P. A., Potts, J . T., and Rich, A. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 4981. Kushner, P. J., Blair, L. C., and Herskowitz, I. (1979). Proc. Natl. Acad. Sci. U.S.A. 76,5264. Kushner, S. R. (1978). Genet. Eng. 17, 178. Lacy, G. H., and Leary, J. V. (1979). Annu. Reo. Phytopathol. 17, 181. Ladha, J. K., and Kumar, H. D. (1978). B i d . Reo. 53, 355. Lampen, J. 0. (1978). Syrnp. Soc. Gen. Microbiol. 28, 283. Langley, K. E., Villarejo, M. R., Fowler, A. V., Zamenhof, P. J., and Zabin, I. (1975). Proc. Natl. Acad. Sci. U.S.A. 72, 1254. Latrou, K., Tsitilou, S. G., Goldsmith, M. R.,and Kafatos, F. C. (1980). Cell 20, 659. Lau, P. B., Yu, S. H., Spring, T. G., and Gray, H. B. (1979). Biochirn. Biophys. Acta. 560,313. LeBlanc, D. J., and Lee, L. N. (1979). J . Bacteriol. 140, 1112. Lederberg, E. M., and Cohen, S. (1974). J . Bacteriol. 119, 1072. Lehman, I. R. (1974). Science 186, 790. Levings, C. S., and Pring, D. R. (1976). Science 193, 156. Little, P., Curtis, P., Coutelle, Ch., Van Den Berg, J., Dalgleish, R.,Malcolm, S., Courtney, M., Westaway, D., and Williamson, R. (1978). Nature (London) 273, 640. Little, P. F. R., Annison, G., Darling, S., Williamson, R., Camba, L., and Modell, B. (1980). Nature (London) 285, 144. Liu, C. P., Slate, D. L., Gravel, R.,and Ruddle, F. H. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 4503. Livingston, D. M. (1977). Genetics 86, 73. Livingston, D., and Hahne, S. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 3727. Lobban, P. E., and Kaiser, A. D. (1973). J . Mol. Biol. 78,453. Locker, J. (1979). Anal. B i o c h a . 98, 358. Lofdahl, S., Sjostrom, J. E., and Philipson, L. (1978a). Gene 3, 161. Lofdahl, S., Sjostrom, J. E., and Philipson, L. (1978b). Gene 3, 149. Lomax, M. I., Helling, R. B., Hecker, L. I., Schwartzbach, D. S., and Barnett, W. E. (1977). Science 196, 202. Lomedico, P., Rosenthal, N., Efstratiadis, A., Gilbert, W., Kolodner, R., andTizard, R. (1979). CeU 18, 545.
76
VEDPAL SINGH MALIK
Lomovskaya, N. D., Chater, K. F., and Mkrtumian, N. M. (1980). Mfcrobfol. Reu. 44,206. Long, E. O., and Dawid, I. V. (1980). Annu. Reu. Biochem. 49,727. Longacre, S., and Mach, B. (1979). Nuclefc Acids Res. 6, 1241. Longacre, S., Rougeon, F., and Mach, B. (1977). Experenttu 33,823. Losick, R.,and Chamberlin, M., eds. (1976). “RNA Polymerase.” Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Lovett, P. S.,and Burdick, B. D. (1973). Biochem. Biophys. Res. Cmmun. 54,365. Lovett, P. S., Duvall, E. J., and Keggins, K. M. (1976). J . Bacterfol. 127, 817. Lurquin, P. F. (1979). Nuclefc Acids Res. 6, 3773. McFarland, G. D., and Borer, P. N. (1979). Nuclefc A& Res. 7, 1067. McReynolds, L., O’MaUey, B. W., Nisbet, A. D., Fothergill, J. E., Givol, D., Fields, S., Robertson, M., and Brownlee, G. G.(1978). Nature (London) 273,723. Maizels, N. (1976). CeU 9, 431. Malik, V. S. (1964). “The Effect of Phosphobacterin and an Indian Culture on the Uptake of Nitrogen and Phosphorus by Sorghum Crop under Different Fertilizer Treatments.” Indian Agriculture Research Institute, New Delhi. Malik, V. S. (1972). Ado. Appl. Mfcrobiol. 15, 297. Malik, V. S. (1977). J . Antibiot. 30, 897. Malik, V. S. (1978). Nature (London)274, 844. Malik, V. S. (1979a). Ado. Genet. 20, 37. Malik, V. S. (1979b). Ado. Appl. Microbiol. 25,75. Malik, V. S. (197%). A.S.M. News45, 25. Malik, V. S. (1979d). A.S.M. N m 4 5 , 602. Malik, V. S. (1980). Trends Biochem. Sd. 37, 431. Malik,V. S., and Reusser, R. (1979). Plasmid 2, 627. Malik, V. S., and Vining, L. C. (1970). Can. J . Mfcrobtol. 16, 173. Malik, V. S.,and Vining, L. C. (1971). Can. J . Mfcrobiol. 17, 1287. Malik, V. S., and Vining, L. C. (1972a). Can.J . Microbfol. 18, 137. Malik, V. S., and Vining, L. C. (1972b). Can. J . Mfcrobiol. 18,583. Malnoe, P., Rochaix, J . D., Chua, N. H., and Spahr, P. F. (1979). J . Mol. Biol. 133,417. Manchee, R. (1979). Trends Btochem. Sci. 4, 77. Mandel, M., and Higa, A. (1970). J . Mol. Biol. 93, 159. Maniatis, T. (1980). I n “Cell Biology: A Comprehensive Treatise” (L. Coldstein and D. M. Prescott, eds.), Vol. 3, p. 606.Academic Press, New York. Maniatis, T., Sim, G. K., Efstratiadis, A., and Kafatos, F. C. (1976). Cell 8, 163. Maniatis, T., Hardison, R. C., Lacy, E., Lauer, J., O’Connell, C., Quon, D., Simm, G.K., and Efstratiadis, A. (1978). CeU 15, 687. Mansson, P. E., Carter, D. B.,Silverberg,A. B., Tuly, D. B., and Harris,S.E. (1979). Nucletc Acids Res. 7, 1553. Mantei, N., Boll, W., and Weissmann, C. (1979). Nature (London) 281, 40. Marians, K., Wu, R., Stawinski, J., Hozumi, T., and Narang, S. A. (1976). Nature (London) 263,744. Martens, P. A., and Clayton, D. A. (1977). Nuclefc Acids Res. 4, 1393. Martial, J. A., Hdewell, R. A., Baxter, J. D., and Coodman, H. M. (1979). Sdence 205,602. Marton, L., Wullems, G. J., Molendijk, L., and Schilperoort, R. A. (1979). Nature (London) 277, 129. Manola, D. L., and Bartholomew, D. P. (1979). Sdence 205,555. Maxam, A., and Gilbert, W. (1977). Froc. Natl. Acad. Sct. U.S.A. 74,560. Mayer, H., Collins, J., and Wagner, F. (1979). I n “The Environmental, Medical, and Commerc d Importance of Plasmids.” Elsevier-North Holland, Amsterdam.
RECOMBINANT DNA TECHNOLOGY
77
Mama, G., and Zalizzi, A. (1978). Microbbbgica 1, 111. Melchers, F., Potter, M., and Warner, N. L. (1978). Cum Top. Microbiol. Zmmunol. 81, 187. Melchers, G., Sacristan, M. D., and Holder, A. A. (1978). Carlsberg Res. C m m u n . 43,203. Mercer, A. A., and Loutit, J. S. (1979). J . Bacteriol. 140, 37. Mercereau-Puijalon, 0.. and Kourilsky, P. (1979). Nature (London)279,647. Mercereau-Puijalon, O., Royal, A., Cami, B., Garapin, A., Krust, A., Cannon, F., and Kourilsky, P. (1978). Nature (London) 275, 505. Mertz, J. E., and Davis, R. W. (1972). Proc. Natl. Acad. Sci. U.S.A. 69, 3370. Messing, J., Gronenborn, B.,Mullerhill, B., and Hofschneider, P. H. (1977). Proc. Natl. Acad. S c i . U.S.A. 74, 642. Mevarech, M., Noyes, B. E., and A g d , K. L. (1979). J . Biol. Chem. 245, 7472. Meyerink, J. H., Klootwijk, J., Planta, R. J., Ende, A., and Bruggen, F. (1979). Nucleic Acidp Res. 7, 69. Miller, J. H. (1972). “Experiments in Molecular Genetics,” p. 398. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Miller, J. H., and Reznikoff, W. S. (1978). “The operon.” Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Miller, L. (1980). Anal. Biochem. 100, 166. Mills, D. R., and Kramer, F. R. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 2232. Minson, A. C., Wildy, P., Buchan, A., and Darby, G. (1978). Cell 13, 581-587. Miozzari, G. F., and Yanofsky, C. (1978). Nature (London) 276,684. Mishra, A. K., Roy, P., and Bhattacharya, S. (1979). J . Bacteriol. 137, 1425-1427. Mishra, N. C. (1979). J . Gen. Microbiol. 113, 255. Miura, K., Law, S. W. T., Nishi, S., and Tamaoki, T. (1979). J . Biol. Chem. 254,55153521. Miwa, T., Takanami, M., and Yamagishi, H. (1979). Gene 6, 319-330. Molholt, B., and Doskocil, J. (1978). Biochm. Biophys. Res. Commun. 82, 477. Moore, L., Warren, G., and Strobel, G. (1979). Plasmid 2, 617. Moore, S. K., and James, E. (1979). Gene 5, 159. Moran, C. P., and Bott, K. F. (1979). J . Bacteriol. 140, 99-105. Morrison, D. A. (1977). J . Bacteriol. 132, 3494.51. Morrison, D. A., and Baker, M. F. (1979). Nature (London) 282, 215-217. Morrison, D. A,, and Mannarelli, B. (1979). /. Bacteriol. 146, 655-665. Morrow, J. F., Cohen, S. N.,Chang, A. C. Y., Boyer, H. W., Goodman, H. M., and Helling, R. B. (1974). Proc. Natl. Acad. Sci. U.S.A. 71, 1743-1747. Mortenson, L. E. (1978). Curr. Top. Cell. Regul. 13, 179-232. Mortenson, L. E., and Thorneley, R. (1979). Annu. Rev. Biochm. 48, 387. Moss, T., and Birnsteil, M. L. (1979). Nuckic Acids Res. 6, 3733. Mottes, M.,Morandi, C., Cremaschi, S., and Sgaramella, V. (1977). Nuckic Acids Res. 4, (7) 2467-2476. Mottes, M., Grandi, M., Sgaramella, V., Canosi, V., and Morelli, G. (1979). Mol. Gen. Genet. 174, 281-286. Muller, W., Weher, H., Meyer, F., and Weissmann, C. (1978). J . Mol. B i d . 124, 343. Muller-Hill, B. (1975). Prog. Biophys. Mol. Biol. 30, 227. Mufier-Hill, B., Heidecker, G., and Kania, J. (1976). Proc. John Znnes Symp. 3r4 1976. p. 167. Muuer-Hill, B., Gronenborn, B., Kania, J., Schlotmann, M., and Beyreuther, K. (1977). In “Nucleic Acid Protein Recognition” (H. J. Vogel, V. Bryson, and J . 0. Lampen, eds.) p. 219. Academic Press, New York. Mulligan, R. C., Howard, B. H., and Berg, P. (1979). Nature (London) 277, 108-114. Murphy, E., and Novick, R. P. (1979). Mol. Gen. Genet. 175, 19-30. Murray, K. (1976). Endeaoow 35, 129.
78
VEDPAL SINGH MALIK
Murray, M. G., Palmer, J . D., Cuellar, R. E., andThompson, W. F. (1979).Biochemistry 18,
5259. Murray, N. E., and Murray, K. (1974).Nature (London) 251, 476. Murray, N. E., Brammer, W. J., and Murray, K. (1977). Mol. Gen. Genet. 150, 53. Murray, N. E., Bruce, S. A,, and Murray, K. (1979).J . Mol. Biol. 132,493-505. Muzyczka, N. (1979).Gene 6, 107-122. Mylroie, J. R.,Friello, D. A., and Chakrabarty, A. M. (1978).Biochem. Biophys. Res. Commun. 82, 281. Nakamura, K., and Inouye, M. (1979).Cell 18, 1109. Nakanishi, S.,Inoue, A,, Kita, T., Nakamura, M., Chang, A. C. Y., Cohen, S. N., and Numa, S. (1979).Nature (London) 278,423427. Narang, S. A., Bahl, C. P., and Wu, R. (1977).Can. J . Biochem. 55, 1125. Narang, S. A,, Hsiung, H. M., and Brousseau, R. (1979).In “Methods in Enzymology” (R. Wu, ed.), Vol. 68, pp. 90-98. Nasyrov, Y. S. (1978).Annu. Reo. Plant Physiol. 29, 215. Nathans, D. (1979).Science 206, 891. Newman, E. I. (1978).B i d . Reo. 53, 511. Neyra, C. A., and Dobereiner, J . (1977).Ado. Agron. 29, 9. Niaudet, B., and Ehrlich, S. D. (1979).Plasmid 2, 4858. Nojiri, C., Watanabe, H., Katsumata, K., Yamada, Y., Murakami, T., and Kumata, Y. (1980).J . Antibiot. 33, 118. Norgard, M. V., Keem, K., and Monahan, J. J. (1978).Gene 3, 279. Norgard, M. V.,Emigholz, K., and Monahan, J. J. (1979).J . Bacteriol. 138,270-272. Norris, K. E., Iserentant, D., Contreras, R., and Fiers, W. (1979).Gene 1, 355. Nosikov, V. V., Braga, E. A., Karlishev, A. V., Zhuze, A. L., and Polyanovsky, 0. L. (1976). Nucleic Acids Res. 3, 2293. Noyes, B. E., Mevarech, M., Stein, R., and Agarwal, K. L. (1979).Proc. Natl. Acad. Sci. U.S.A. 76, 1770. Nuti, M. P., Lepidi, A. A., Prakash, R. K., Schilperoort, R. A,, and Cannon, F. C. (1979). Nature (London) 282,533. Ochi, K., Hitchcock, M. J. M., and Katz, E. (1979).J. Bacteriol. 139, 984-992. Ogata, R. T., and Gilbert, W. (1979).J . Mol. Biol. 132, 709-728. O’Hare, K., Breathnach, R., Benoist, C., and Chambon, P. (1979).Nucleic Acids Res. 7 (2),
305-320. Ohlsson, R., Hentschel, C. C., and Williams, J . G. (1978).Nucleic Acids Res. 5, 583. Okanishi, M., Manome, T., and Umezawa, H. (1980).J . Antibiot. 33, 88. Olson, M. V., Loughney, K., and Hall, B. D. (1979).J. Mol. Biol. 132,387410. Ooyen, A. V., Berg, J., Mantel, N., and Weissman, C. (1979).Science 206, 337. Orkin, S. H., Kolodner, R., Michelson, A., and Husson, R. (1980).Proc. Natl. Acad. Sci. U.S.A. 77,3558. O’SuUivan, M. J., Bridges, J. W., and Marks, V. (1979).Ann. Clin. Biochem. 16, 221. Page, W. J.. and Tigerstorm, M. (1979).J . Bacteriol. 139, 1058-1061. Palchaudhuri, S.,and Chakrabarty, A. (1976).J . Bacteriol. 126, 410416. Panasenko, S. M., Cameron, J . R., Davis, R. W., and Lehman, I. R. (1977).Science 196,
188. Panayatotos, N., and Wells, R. D. (1979).J . Biol. Chem. 254, 55555561. Pasek, M., Goto, T., Gilbert, W., Zink, B., Schaller, H., MacKay, P., Leadbetter, G., and Murray, K. (1979a).Nature (London) 282, 55. Pasek, M., Goto, T., Gilbert, W., Zink, B., Schaller, H., MacKay, P., Leadbetter, G., and Murray, K. (1979b).Nature (London) 282,575. Paterson, A., and Clarke, P. H. (1979).1. Gen. Microbiol. 114, 75-86.
RECOMBINANT DNA TECHNOLOGY
79
Paterson, B. M., Roberts, B. E., and Kuff, E. W. (1977). Proc. Natl. Acad. Sci. U.S.A. 74, 4370. Payvar, F., and Schimke, R. T. (1979). Eur. J. Biochem. 101, 271. Pellicer, A., Wigler, M., Axel, R., and Silverstein, S. (1978). Cell 14, 133-141. Pemberton, J. M., and Fisher, P. R. (1977). Nature (London) 268, 732-733. Perlak, F. J., Mendelsohn, C. L., and Thome, C. B. (1979).J . Bacteriol. 146, 699. Pemn, F., Cochet, M., Gerlinger, P., Cami, B., LePennec, J. P., and Chambon, P. (1979). Nucleic Acids Res. 6, 2731-2748. Persson, H., Perricaudet, M., Tolun, A , , Philipson, L., and Petersson, V. (1979). J . Biol. Chem. 245, 7999-8003. Perucho, M., Hanahan, D., Lipsich, L., and Wigler, M. (1980). Nature (London) 285, 207. Peterson, B. M., Roberts, B. E., and Kuff, E. L. (1977). Proc. Natl. Acad. Sci. U.S.A. 74,4370. Petes, J. D. (1980). Annu. Reu. Biochem. 49, 845. Petes, T. D. (1979). Proc. Natl. Aca. Sci. U.S.A. 76, 410414. Petes, T. D., and Botstein, D. (1977). Proc. Natl. Sci. U.S.A. 74, 50915095. Pfahl, M., Stockter, C., and Gronenbom, B. (1974). Genetics 76, 669. Polisky, B., Greene, P., Garfin, D. E., McCarthy, B. J., Goodman, H. M., and Boyer, H. S. (1975). Proc. Natl. Acad. Sci. U.S.A. 72, 3310. Poonian, M. S., Schlabach, A. J., and Weissbach, A. (1971). Biochemistry, 10, 424. Porter, A. G., Barber, C., Carey, N. H., Hallewell, R. A,, Threlfall, G . , and Emtage, J. S. (1979). Nature (London) 282, 471. Ptashne, M., Jeffrey, A., Johnson, A. D., Maurer, R., Meyer, B. J.. Pabo, C. O., Roberts, T. M . , and Sauer, R. T. (1980). Cell 19, 1. Puhler, A., Burkardt, H. J., and Klipp, W. (1979). Mol. Gen. Genet. 176, 17. Puijalon, 0. M., and Kourilsky, P. (1979). Nature (London) 279, 647-649. Purchio, A., James, E., and Fareed, G. C. (1979). Gene 7, 15. Radloff, R., Bauer, W., and Vinograd, J. (1967). Proc. Natl. Acad. Sci. U.S.A. 57, 1514-1520. Rambach, A., and Tiollais, T. (1974). Proc. Natl. Acad. Sci. U.S.A. 71, 3927. Rao, R. N., and Rogers, S. G. (1978). Gene 3, 247-263. Rao, R. N., and Rogers, S. G. (1979). Gene 7, 79-82. Rapoport, G., Klier, A,, Billault, A , , Fargette, F., and Dedonder, R. (1979). M o ~ .Gen. Genet. 176, 239. Ratzkin, B., and Carbon, J . (1977). Proc. Natl. Acad. Sci. U.S.A. 74,487. Reddy, V. B., Thimmappaya, B., Dhar, R., Subramanian, W., Zain, B. S., Pan, J., Ghosh, P. K., Celma, M. S., and Weissman, S. M. (1978). Science 200, 494. Ricciatdi, R. P., Miller, J. S., andRoberts, B. E. (1979).Proc. Natl. Acad. Sci. U.S.A. 76,4927. Rigby, P. W. J., Dieckman, M., Rhodes, C., and Berg, P. (1977).J. Mol. Bid. 113,237-251. Roberts, J. L., Seeburg, P. H., Shine, J., Herbert, E., Baxter, J. D., and Goodman, H. M. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 2153. Roberts, R. J. (1976). CRC Crit. Reo. Biochem. 4, 123. Roberts, R. J. (1978). Gene 4, 183. Roberts, T. M., Kacich, R., and Ptashne, M. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 760, 1979. Rodriquez, R. L., Bolivar, F., Goodman, H. M., Boyer, H. W., and Betlach, M. C. (1976). In “Molecular Mechanisms in the Control of Gene Expression” (D. P. Nierlich, W. J. Rutter, and C. F. Fox, eds.), pp. 471-477. Academic Press, New York. Rodriquez, R. L., West, R. W., Heyneker, H. L., Boliver, F., and Boyer, H. W. (1979). Nucleic Acids Res. 6, 3267. Roskam, W. G., and Rougeon, F. (1979). Nucleic Acids Res. 7,305-320. Roychoudhury, R., Jay, E., and Wu, R. (1976a). Nucleic Acids Res. 3, 101. Roychoudhury, R., Jay, E., and Wu, R. (1976b). Nucleic Acids Res. 3, 863.
80
VEDPAL SINCH MALIK
Rudkin, G. T., and Stollar, B. D. (1977). Nature (London) 265,472. Russell, G. E.(1978).“Plant Breeding for Disease Resistance.” Butterworth, London. Ryan, M. J., Brown, E.L.,Sekiya, T., Kupper, H., and Khorana, H. G. (197Qa).J . Biol. Chem. 2!54 (3),5871. Ryan, M. J., Belagaje, R.,Brown, E. L., Fritz, H., and Khorana, H. G . (1979b)./. B i d . C h a . 254,10,944. Sadler, J. R., Tecklenburg, M., Betz, J. L.,Goeddel, D. V., Yansura, D. G., and Caruthers, M. H. (1977). Gene 1,305. St. John, T. P.,and Davis, R. W. (1979).Cell 16,443. Sanger, F., and Coulson, A. R. (1975).J. Mol. Biol. 94,441. Sanger, F., Air, G. M., Barrell, B. G., Brown, N. L., Coulson, A. R.,Fiddes, J. C., Hutchinson, C. A., IH, Slocombe, P. M., and Smith, M. (1Q77a).Nature (London) 265, 687. Sanger, F., Nicklen, S., and Coulson, A. R. (1977b).Proc. Natl. Acad. Sci. U.S.A. 74,5463. Sarthy, A., Fowler, A., Zabin, I., and Beckwith, J. R. (1979).J . Bacterfol. 139,832-839. Sauer, R. T., Pabo, C. O., Meyer, B. J., Ptashne, M., and Backman, K. C. (1979).Nature (London) 279,3964. Schechter, I., Wolf, O., Zemell, R.,and Burstein, V. (1979).Fed. Proc. Fed. Am. SOC. Erp. Biol. 38, 1839-1846. Schell, M. A., and Wilson, D. B. (1979).Gene 5, 291. Scheller, R. H., Thomas, T., Lee, A., Niles, W., Klein, R., Britton, R., and Davidson, E. (1977).Sdence 196,197. Scherer, S., and Davis, R. W. (1979).Proc. Natl. Acad. Sd.U.S.A. 76, 4951. Schmitz, A., Schmeissner, U., and Miller, J. H. (1976).J . Biol. C h m . 251,3359. Schrempf, H.,Bujard, H., Hopwood, D. A., and Goebel, W. (1975).1.Bacterlol. 121,416. Schroeder, J. L.,and Blattner, F. R. (1978).Gene 4, 167-174. Schwan, Z.,and Kossel, H. (leS0).Nature (London) 283, 739. Schweitzer, S. M., and Matzura, H. (1977).Mol. Gen. Genet. 155,213. Scott, A. F., Philips, J. A., and Migeon, B. (1979).Proc. Natl. Acad. Sd. U.S.A. 76, 4563. Secher, D., and Berke, D. C. (1980).Nature (London) 285, 446. Seeburg, P. H., Shine, J., Martial, J. A., Baxter, J. D., and Goodman, H. M. (1977).Nature (tondon) 270,486. Seeburg, P. H., Shine, J., Martial, J. A., Ivarie, R. D., Morris, J. A., Ullrich, A., Baxter, J. D., and Goodman, H. M. (lQ78a).Nature (London) 276,795. Seeburg, P. H., Shine, J., Martial, J. A., Ivarie, R. D., Morris, J. A., Ullrich, A,, Baxter, J. D., and Goodman, H. M. (1978b).Sdence 276,5690. Segall, J., and Losick, R. (1977). Cell 11, 751. Seiki, M., Ogasawara, N., and YoShikawa, H. (1979).Nature (London) 281, 699. Serizawa, N.,Nakagawa, K., Kamimura, S., Miyadera, T., and Arai, M. (1979).J . Antibiot. 32, 1016. Seshadri, M., and Ranjekar, P. K. (1979).ZndianJ. Biochm. Btophys. 16,15. Setlow, 1. K., and Hollaender, A. (1979).“Genetic Engineering.” Plenum, New York. Sgaramella, V. (1972).Proc. Natl. A d . Sci. U.S.A. 69,3389. Sgaramella, V., VandeSande, J. H., and Khorana, H. G. (1970).Proc. Natl. Acad. Sd.U.S.A. 67, 1468. Shanmugam, K. T., and Valentine, R. C. (1975).Science 187,919. Shanmugam, K . T..O’Gara, F., Anderson, K., andvalentine, R. C. (1978).Annu. Reo. Plant Physiol. 29,263. Shaw, D. M.,and Langley, C. H. (1979).Nature (London)281,696-699. Shaw, J. E.,and Murialdo, H. (1980).Nature (London)283,30. Shenk, T.(1978).Cell 13, 791.
RECOMBINANT DNA TECHNOLOGY
81
Shepard, H. M., Gelfand, D. H., and Polisky, B. (1979). Cell 18, 267-275. Shih, T. Y.,and Martin, M. A. (1974). Biochemistry 13,3411. Shine, J., Seeburg, P. H., Martial, J. A., Baxter, J. D., and Goodman, H. M. (1977). Nature (London) 270,494. Shine, J., Fettes, I., Lan, N. C. Y., Roberts, J. L., and Baxter, J. D. (1980).Nature 285,456. Shoyab, M., and Sen, A. (1978).J . Biol. Chem. 253, 6654. Siebenlist, U., Simpson, R. B., and Gilbert, W. (1980). Cell 20,269. Silhavy, J. J., Casadaban, M. J., Shuman, J. A., and Beckwith, J. R. (1976). Proc. Natl. Acad. Sci. U.S.A. 73,342.3. Silhavy, T. J., Shuman, H. A., Beckwith, J., and Schwartz, M. (1977). Proc. Natl. Acad. Sci. U.S.A. 74, 5411. Silverman, M., and Simon, M. I. (1977). Annu. Reo. Microbiol. 31, 397419. Simons, M. D. (1979). Annu. Reo. Phylopathol. 17, 75. Simpson, J. S. A., Campbell, A. K.,Ryall, M. E. T., and Woodhead, J. S. (1979). Nature (London) 279,646-647. Sinsheimer, R. L. (1977). Annu. Reo. Biochem. 46,415. Sisco, K. L.,and Smith, H. 0. (1979). Proc. Natl. Acad. Sci. U.S.A. 76,972-977. Sjostrorn, J. E., Lindberg, M., and Philipson, L. (1972).J . Bacteriol. 109, 285. Sjostrom, J., Lofdahl, S., and Philipson, L. (1979). Plasmid 2, 529-535. Skalka, A. (1978). Gene 3,39. Skalka, A., and Shapiro, L. (1976). Gene 1 , G . Sladkova, 1. A., Chinenova, T. A., Lomovskaya, N. D., and Mkrtumian, N. M. (1979). Genetika 15, 1953. Slater, J. H., Lovatt, D., Weighhnan, A. J., Senior, E., and Bull, A. T. (1979). J . Cen. Microbiol. 114, 125. Smith, H. 0. (1979). Science 205,455461. Sodja, A., and Davidson, N. (1978). Nuclejc Acids Ree. 5, 385. Soni, G. L., and Bhatia, I. S. (1979). ZndianJ. Biochem. Biophys. 16, 223. Sood,A. K., and N m g , S. A. (1977). Nucleic Acids Ree. 4,2757. Southern, E. M. (1975). J. Mol. Biol. 98, 503. Southern, E. M. (1979a). Anal. Biochem. 100,304. Southern, E. M. (1979b). Anal. Biochem. 100,319. Stawinski, J., Hozumi, T., and Narang, S. A. (1976). Can. J. Chem. 54,670. Stawinski, J,, Hozumi, T., Narang, S. A,, Bahl, C. P., and Wu, R.(1977). Nuckic AddsRes. 4,
353. Stent, G. S.,and Calender, R. (1978). “Molecular Genetics.” Freeman, San Francisco. Sternberg, N., Tremeier, D., and Enquist, L. (1977). Gene 1, 255. Stinchomb, D. T., Struhl, K., and Davis, R. W. (1979). Nature (London)282,39. Storms, R. K., McNeil, J. B., Khandekar, P. S.,An, G., Parker, J., and Friesen. (1979).J . Bacteriol. 140,73. Strike, P., Humphreys, G. O., and Roberts, R. J. (1979).J . Bacteriol. 138, 1033. Struhl, K., and Davis, R. W. (1977). Proc. Natl. Acad. Sci. U.S.A. 74, 51555259. Struhl, K.,Cameron, J. R., and Davis, R. W. (1976). Proc. Natl. Acad. Sci. U.S.A. 73, 1471. Struhl, K.,Stinchcomb, D. T., Scherer, S., and Davis, R. W. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 1035-1039. Suarez, J. E., and Chater, K. F. (1980). Nature (London)286, 527. Sugimoto, K.,Oka, A., Sugisaki, H., Takanami, M., Nishimura, A., Yasuda, S.,and Hirota, Y. (1979). Proc. Natl. Acad. Sd. U.S.A. 76, 575579. Sugino, A. (1979). Biochem. Biophys. Res. Commun. 91, 1321.
82
VEDPAL SINGH MALIK
Sugino, A., Goodman, H. A., Heyneker, H. L., Shine, J., Boyer, H. W., andcoyzarelli, N. R. (1977). J . Biol. Chem. 252, 2987. Sung, W. L.,Hsiung, H. M., Brousseau, R., Micniewicz, J., Wu, R., and Narang, S. A. (1979). Nucleic Acids Res. 7, 2199. SutcliEe, J. G. (1978a). Cold Spring Harbor Symp. Quant. Biol. 43, 77. SutcliEe, J. G. (1978b). Nucleic Acids Res. 5, 2721. Szostak, J. W., and Wu, R. (1979). Plasmid 2, 536. Szybalski, E., and Szybalski, W. (1979). Gene 7,217. Tait, R. C., and Boyer, H. W. (1978). Mol. Gen. Genet. 164, 285. Taketa, A. (1972).J . Biochem. 72, 973. Talmadge, K., Stahl, S., and Gilbert, W. (1980). Proc. Natl. Acad. Sci. U.S.A. 77, 3369. Tanaka, T. (1979). Mol. Gen. Genet. 175,235. Tanaka, T., and Weisblum, B. (1975).J. Bacteriol. 121, 354. Taniguchi, T., O’Neill, M., and Crombrugghe, B. D. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 5090. Taylor, J . M. (1979). Annu. Rev. Biochem. 48, 681. Taylor, W. E., and Burgess, R. R. (1979). Gene 6,331365. Teather, R. M., Muller-Hill, B., Abrutsch, U.,Aichele, G., and Overath, T. (1978). Mol. Gen. Genet. 159, 239-248. Templeton, G. E., Tebeest, D. O., and Smith, R. J. (1979). Annu. Reo. Phytopathol. 17,301. Tenneson, M. E., Bilton, R. F., Drasar, B. S., and Mason, A. N. (1979). FEBS Lett. 102,311. Thayer, R. E. (1979). Anal. Biochem. 98, 60. Thomas, M., and Davis, R. W. (1975). J . Mol. B i d . 91, 315. Thomas, M., Cameron, J. R., and Davis, R. W. (1974). Proc. Natl. Acad. Sci. U.S.A. 71,4579. Thomas, M., White, R. L., and Davis, R. W. (1976). Proc. Natl. Acad. Sci. U.S.A. 73,2294. Thomashow, M. F . , Panagopoulos, C. S., Gordon, M. P., and Nester, E. W. (1980). Nature (London) 283, 794. Thompson, C. J., Ward, J. M., and Hopwood, D. A. (1980). Nature (London) 286, 525. Thompson, J. P., and Skerman, V. D. (1979).“Azotobacteraceae.” Academic Press, New York. Tiemeier, D., Enquist, L., and Leder, P. (1976). Nature (London)263, 526. Tiemeier, D. C., Tilghman, S. M., and Leder, P. (1977). Gene 2, 173. Tilghman, S. M., Tiemeier, D. C., Peterlin, B. M., Sullivan, M., Maize], J. V., and Leder, P. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 775. Timko, J., and Zelinka, J. (1977).J. Antibiot. 30, 644-648. Timmis, K., and Winkler, V. (1973). J . Bactm’ol. 113, 508-509. Timmis, K. N., Cabello, F., and Cohen, S. N. (1974). Proc. Natl. Acad. Sci. U.S.A. 71,4556. Timmis, K., Cabello, F., and Cohen, S. N. (1975). Proc. Nad. Acad. Sci. U.S.A. 72, 2242. Timmis, K. N., Cabello, F., andCohen, S. N. (1978a). Mol. Gen. Genet. 162, 121-138. Timmis, K., Cabello, F., and Cohen, S. N. (1978b). Prog. Mol. Subcell. B i d . 6, 1. Timothy, D. H., Levings, C. S., Pring, D. R., Conde, M. F., and Kermicle, J. L. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 4220. Tonegawa, S., Brack, C., Hozain, N., and Schuller, R. (1977).Proc. Natl. Acad. Sci. U.S.A. 74, 3518. Trinick, M. J . (1973). Nature (London)244, 459. Troost, T. R., Danilenko, V. N., and hmovskaya, N. D. (1979).J . Bacteriol. 140, 359. Tu, C. D., Jay, E., Bahl, C. P., and Wu, R. (1976). Anal. Biochem. 74, 73. Twigg, A. J . , and Sherratt, D. (1980). Nature (London) 283, 216. Ucker, D. S., and Signer, E. R. (1978).J . Bacteriol. 136, 1197-1200. Uhlin, B. E., Molin, S., Gustafsson, P., and Nordstrom, K. (1979). Gene 6, 91. Ullrich, A., Shine, J., Chirgwin, J., Pictet, R., Tischer, E., Rutter, W. J., and Goodman, H. M. (1977). Science 196, 1313.
RECOMBINANT DNA TECHNOLOGY
83
Upcroft, P., Skolnick, H., Upcroft, J. A., Solomon, D., Khoury, G., Hamer, D. H., and Fareed, G. C. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 2117-2121. Valenzuela, P., Gray, P., Guiroga, M., zaldivar, J., Goodman, H. M., and Rutter, W. J. (1979). Nature (London) 280, 815-819. Vamvakopoulos, N. C., Monohan, J. J., and Kourides, I. A. (1980). Proc. Natl. Acad. Sci. U.S.A. 77, 3149. Vapnek, D., Hautala, J. A,, Jacobson, J. W., Giles, N. H., and Kushner, S. R. (1977). Proc. Natl. Acad. Sci. U.S.A. 74, 35083512. Venema, G. (1979). Ado. Microb. Physiol. 19, 245. Verdiere, J., and Petrochilo, E. (1979). Mol. Gen. Genet. 175, 209. Villa-Komaroff,L., Efstratiadis, A., Broome, S., Lomedico, P., Tizard, R., Naber, S. P., Chick, W. L., and Gilbert, W. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 37273731. Villarreal, L. P., and Berg, P. (1977). Science 196, 183. Volovitch, M., Drugeon, G., Dumas, J. P., Haenni, A. L., and Yot, P. (1979). Eur. J . Biochem. 100,245. Wade, M., and Albersheim, P. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 4433. Wahl, G. M., Padgett, R. A., and Stark, G. R. (1979a).J . BioE. Chem. 254, 867923689. Wahl, G. M., Stem, M., andstark, G.R. (197913). Proc. Natl. Acad. Sci. U.S.A. 76,36833687. Walker, G. C., Uhlenbec, 0. C., Bedows, E., and Gumport, R. I. (1975). Proc. Natl. Acad. Sci. U.S.A. 72, 122. Walz, A., Ratzkin, B., and Carbon, J. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 6172. Warren, G., and Sherratt, D. (1978). Mol. Gen. Genet. 161, 39. Weare, N. M. (1978). Biochim. Biophys. Acta 502, 486. Weightman, A. J., Slater, J. H., and Bull, A. T. (1979). FEMS Microbiol. Lett. 6, 231. Weinard, U . , Bruschke, C., and Feix, G. (1979). Nucleic Acids Res. 68, 2707-2716. Weisblum, B., Grahm, M. Y., Gryczan, T. J., and Dubnau, D. (1979a). J . Bacteriol. 137, 6354543. Weisblum, B., Holder, S. B., and Halling, S. M. (1979b).J . Bacteriol. 138, 990-998. Weiss, B., and Milcarek, C. (1974). Methods Enzymol. 29, 180-193. Weissman, S. M. (1979). Anal. Biochem. 98, 243. Weisz, P. B., and Marshall, J. F. (1979). Science 206, 24-30. Wensink, P. C., Finnegan, D. J., Donelson, J. E., and Hogness, D. S. (1974). Cell 3,315325. West, R. W., Neve, R. L., and Rodriquez, R. L. (1979). Gene 7,271. White, R. L., and Rosbash, M. (1979). Gene 7, 97. Whitman, W. B., Martin, M. N., and Tabita, F. R. (1979).J . Biol. C h m . 254, 10,329. Wickens, M. P., Buell, G. N., and Schimke, R. T. (1978).J . Biol. Chem. 253, 2483. Wickner, R. B. (1979). Plasmid 2,303322. Widera, G . , Gautier, F., Lindenmaier, W., and Collins, J. (1978). Mol. Gen. Genet. 163, 301305. Widmer, H. J., Jaggi, R. B., Weber, R., Rflel, G. V., and Muellener, D. (1979). Eur. J . Biochem. 99, 23. Wieslander, L. (1979). Anal. Biochem. 98, 305. Wigler, M., Silverstein, S., Lee, L. S., Pellicer, A., Cheng, Y. C., a n d h e l , R. (1977). Cell 11, 223-232. Wigler, M., Sweet, R., Sim, G . K., Wold, B., Pellicer, A., Lacy, E., Maniatis, R., Silverstein, S., and Axel, R. (1979). Cell 16, 777-785. Wigler, M., Perucho, M., Kurtz, D., Dane, L., Pellicer, A., Axel, R., and Silverstein, N. (1980). Proc. Natl. Acad. Sci. U.S.A. 77, 3567. Wilkie, N. M., Clements, J. B., Boll, W., Mantei, N., Lonsdale, D., and Weissmann, C. (1979). Nucbic Acids Res. 1, 859. Williams, R. O., Young, J. R.,and Majiwa, P. A. 0. (1979). Nature (London) 282, 847.
84
VEDPAL SINGH MALIK
Williamson, V. M., Bennetzen, J , , Young, E. T., Nasmyth, K., and Hall, B. D. (1980). Nature (London) 283,214.
Willshaw, G. A,, Smith, H. R.,and Anelerson, E. S. (-1979).J . Gen. Mbobiol. 114, 15-26. Wiseman, A. (1977). “Topics in Enzyme and Fermentation Biotechnology.” Ellis H o w d Ltd., Chichester, England. Wittig, B., and Wittig, S. (1979). Biochem. Biophys. Res. Commun. 01, 554. Wittig, B., Wittig, S.,and Grunz, H. (1979). Nucleic A& Res. 6, 3759. Woo, S. L. C., Chandra, T., Means, A. R.,and O’Malley, B. (1977a). Biochemisty 16,5670. Woo, S. L. C., Monahan, J. J., and O’Malley, B. W. (1977b). J . Biol. Chem. 252,5789. Wovcha, M. G., Antosz, F. J., Knight, J. C., Kominek, L. A., and Pyke, T.R.(1978). Biochim. Biophys. Acta 531, 308. Wovcha, M. G., Brooks, K.,and Kominek, L. A. (1979). Biochim. Biophys. Acta 574,471479. Wu, R. (1978). Annu. Reo. Biochem. 47, 607. Wu, R.,and Bahl, C. P. (1978). Prog. Nucleic Acid. Res. Mol. Biol. 21, 101-141. Wu, R.,Bahl, C. P., and Narang, S. A. (1978). Currents Top. Cell. Regul. 13, 137-178. Yagisawa, M., Huang, R. T. S.,and Davies, J . E. (1978). J . Antibiot. 31, 809. Yalow, R. S. (1978). Science 200, 1236-1245. Yang, R. C. A,, and Wu, R. (1979). Science 206,456-462. Yoneda, Y., Graham, S., and Young, F. E. (1979). Gene 7,5148. Young, F. E., Duncan, C., and Wilson, G. A. (1977). I n “Recombinant Molecules” (R.F. Berrs and E. G. Bassett, eds.), p. 33. Raven, New York. Zakian, V. A., Brewer, B. J., and Fangman, W. L. (1979). Cell 17,923-834. Zamecnik, P. C., and Stephenson, M. L. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 280. Zasloff, M., Ginder, G. D., and Felsenfeld, G. (1978). Nucleic A& Rer. 5, 1139-1152. Zieg, J.. Silverman, M., Hilmm, M., and Simon, M. (1978). In “The Operon” 0. H. Miller and W. S. Reznikoff, eds.). Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Zubay, G. (1977). Annu. Reo. Genet. 7,267-287. Zurkowski, W., and Lorkiewicz, Z. (1979). Arch. Microbid. 123, 195. Zyskind, J. W., Deen, L. T., and Smith, D. W. (1979). Proc. Natl. Acad. Sci. U.S.A. 76, 30973101.
A. HURST Microbiology Research Division, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, Canada I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11. Biology ............................... A. Cult , and Media.. ....................... 87 B. Genetic Control of Nisin Synthesis.. . . . . . . . . . . . . . . . . . . 89 90 C. Function of Nisin to the Producer Organism . . . . . . . . . . . D. Mode of Action 111. Chemistry. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98 A. Historical.. . . . . . . . . . . . . . . . . . . . . . . . . . 98 B. Units of Measurement and Metho . . . . . . 98 C. Preparation of Nisin D. Occurrence of Sever . . . . . . . . . . . . . . . . . 101 G. Enzymic Inactivation of Nisin ........................ IV. Biosynthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Use ofNisin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Introduction
E. Fully Heat-Processed Foods . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
104 105 108
119
I. Introduction Nisin has been acknowledged for about 40 years and continues to be of interest to food microbiologists. Nisin is a polypeptide that, together with acids and peroxides, is among the biological inhibitors produced by the lactic streptococci. These organisms belong to serological group N; the name was coined by Mattick and Hirsch (1947) from the letters N Inhibitory Substance. A number of reviews have been published, some emphasizing the applied aspects and others the basic microbiology and chemistry (Berridge, 1953; Hawley, 1957, 1962; Marth, 1966; Jarvis and Morisetti, 1969; Hurst, 1972, 1978; Lipinska, 1977). This article represents an attempt to produce a comprehensive account covering all these aspects, but, because of the long history and widely scattered references, a coverage of all the literature has not been achieved. Hence, some work has been wholly or partially omitted but no slight is intended by this selection. 85 ADVANCES IN APPLIED MICROBIOLOGY, VOLUME 27 Copyright @ 1981 by Academic Press, Inc. All rights of reproduction In any form reserved. ISBN 0-12-002627-9
86
A. HURST
The chemistry and biosynthesis of nisin offer interesting and d8icult challenges. A pronisin has been postulated but not isolated; a substance that could be pronisin has been isolated from non-nisin-producing streptococci, and enzyme(s)that convert this into nisin have been found but not yet purified or studied. The function of nisin for the producer cell also poses interesting questions. In the case of Bacillus peptide antibiotics, a function in the growth cycle of the organism can readily be hypothesized because of the overt differentiation that occurs among spore-formers. This process is not so obvious among gram-positive cocci, but it is possible that a more cryptic cellular differentiation does take place. One can speculate that nisin and other antibiotics, as well as peptides not recognized as antibiotics (Hurst, 1967), may play a role in this aging or differentiation process. Subtilin produced by Bacillus subtilus and nisin produced by Streptococcus lactis are extremely unusual yet very similar substances (Gross et al., 1969). It is astonishing that such different microorganisms should produce such similar substances. Nisin-like substances are commonly produced by the lactic streptococci (Oxford, 1944; Hurst, 1967). Indeed, nisin-like substances may be widely distributed within the whole genus Streptococcus. For example, an antibiotic-like substance, streptococcin A-F22, was described by Tagg and Wannamaker (1978). This substance is either an antibiotic or a bacteriocin and is formed by the clearly pathogenic member of this genus, Streptococcus p yogenes. The production of bacteriocins by gram-positive bacteria has been reviewed (Tagg et al., 1976). Among antibiotics, nisin has the unique function of being used as a food preservative. There are several reasons for this: It is not used medicinally or in animal feed, and, when eaten, it is nontoxic. Since it is a polypeptide, any residues remaining in foods are digested. In spite of these factors, the application of nisin to food preservation has been slow and is probably still in its infancy. An interesting use of nisin-producing starters is being developed by Lipinska (1977)to replace the use of nitrate in cheese making. As of December 1979, its use was not allowed in North America. In 1966, the United States Food and Drug Administration (FDA)rejected applications for the use of nisin in canned foods, probably for the good reason that some essential information about it was missing, which appears still to be the case. As pointed out elsewhere in this review, the information on cross-resistance is inadequate and perhaps other tests, e.g., tests for mutagenicity, should now be done. Also, more recently, a greater awareness has developed of the risks of feeding antibiotics to farm animals (Anonymous, 1972a). It is a mistake to lump together everything that is called an antibiotic. Nisin is evidently very different from the antibiotics used in medical and veterinary practice and it has not been used for purposes of growth promotion. Progress in the area of food
NISIN
87
preservation will be greatly hampered as long as the popular confusion remains over all substances called antibiotics being kept out of foods. It might be better to call nisin a biological food preservative and class it together with lactic or acetic acid and hydrogen peroxide, the other antibacterial products of the lactic streptococci. Nisin has advantages in food preservation that merit further technological and fundamental research. In the developed countries it can be used as an adjunct to heat-processing. Some evidence exists that spores become “injured” and more heat-sensitive when nisin is present, and spores that survive heating may become more nisin-sensitive, Provided that residual nisin remains in the food after heating, the development of these spores can be prevented. Products thus treated could attain “commercial sterility” (any viable spores that they contained could not outgrow and develop) with less heat treatment than is currently necessary. The consumer would benefit from products that, due to milder heating, would have improved nutritional value, flavor, texture, and appearance, and the savings in energy would be an important consideration to the processor. Authorities charged with regulating the use of food additives have been concerned that such substances might be used to hide sloppy manufacturing practices. However, this type of abuse is not likely with nisin because of its narrow antibacterial spectrum. The effectiveness of nisin is related to the bacterial load, and there is evidence that it is ineffective when poor quality starting materials are used (Gibbs and Hurst, 1964). Developing countries often require imported dried milk products to supplement low-protein diets. However, the water supply of such countries is often unsafe, and dried milk products reconstituted with contaminated water may do more harm than good. Under such circumstances, it would appear sensible to establish reconstituting plants, in which the product would be heat-treated before distribution. The addition of nisin to this milk powder might permit diminished heating with a concomitant gain in nutritional value. The nisin remaining in the product might prolong its shelf-life in areas where refrigeration is not available. The process just described is already being followed in some countries in the Middle East.
11. Biology A. CULTURES, STRAINS AND MEDIA Immediately after their discovery, the “inhibitory streptococci” were known to belong to the group of lactic streptococci. The organism used by Oxford (1944) appears to have been Steptococcus cremoris. Detailed taxonomic tests were first done in 1951by Hirsch and Grimsted. They used
88
A. HURST
serological and physiological tests and investigated 21 nisin-producing strains, all of which were S. Zactis. The only remarkable feature of their results is that 20 of the 21 strains were sucrose fermentors, a property of this species normally regarded as variable (Deibel and Seeley, 1974). The connection, if any, between sucrose fermentation and nisin synthesis has not been followed up. Baribo and Foster (1951)found that both S. Zactis and S . cremoris were able to produce antibiotics. Nisin is formed in milk or in the usual complex organic media in which these fastidious organisms can grow (the culture requires incubation at 2030°C without aeration). Hirsch (1951b)found that in a complex glucose meat extract medium, the usual yield of nisin was about 80 International Units/ milliliter (IUlml). Acidity was the cause for cessation of growth, so that periodic neutralization approximately doubled the yield. Glucose then became limiting; increasing the glucose from 1to 2.5% in the medium, combined with periodic neutralization of the acid, increased the yield from 160 to 460 IU/ml. Pantothenate then became limiting and with this supplement, 620 IU/ml were attained. Replacement of periodic neutralization by a three component buffer system further increased the yield to about 1700 IU/ml. The maximum buffer capacity of this medium was at about pH 5.9-6.1, which thus appeared to be the optimal for nisin synthesis. Increased nisin synthesis always went hand in hand with increased cell mass (Hirsch, 1951b). That maximal nisin synthesis was related to maximal biomass formation was confirmed by Egorov et al. (1971). They optimized the concentrations of various medium ingredients such as corn extract, yeast-autolysate, caseinhydrolysate, glucose, phosphates, and mineral salts and obtained maximum yields of about 2000 IU/ml. Later they reported that thymine, adenine, and hypoxanthine stimulated nisin synthesis (Egorov et al., 1976). However, their own results show no greater yield of the product than that reported by them in 1971. Hirsch (1951b) found no effect that could be ascribed to purines and pyrimidine bases. A minimal synthetic medium was reported by Kozak and Dobrzanski (1977). The minimal requirements for growth were also the minimal requirements for nisin synthesis. About three-four times less nisin was produced in this than in a complex medium. The medium consisted of nine amino acids, four B group vitamins, glucose, and mineral salts. They confirmed that purines and pyrimidines had no effect on nisin synthesis. However, adding four extra amino acids to the minimal medium (serine, proline, cysteine, and cystine) increased nisin synthesis to levels comparable to those found in complex media. Unfortunately, Kozak and Dobrzanski (1977) express their results in ratios of either IU/OD or IU/colony-forming units (CFU) so that a direct comparison of their published results with those of others is impossible.
89
NISIN
Selection of strains for nisin production was mentioned by Mattick and Hirsch (1947). They observed a large strain-to-strain variation and a decline in the inhibitory activity in milk as the culture became “used to” broth. In broth, nisin production appeared to be stable for at least 2 years. Cheeseman and Berridge (1957) describe the selection of a strain from a culture freeze-dried 10 years previously. The yield of nisin from the culture declined with repeated subculturing and it appeared that the strain was becoming nisin sensitive. Cheeseman and Berridge (1957) selected tolerant forms by using a 10%inoculum into 500 IU of added nisirdml of medium and after overnight incubation, plated on agar medium containing 2000 IU/ml. A colony was picked that produced 700 IU/ml, whereas the original culture formed only 250 IU/ml. The variable effect of the number of serial transfers and other early strain selection experiments is also discussed by Hirsch
(1951b).
Lipinska (1977) summarizes experiments concerning the use of industrial wastes for growing the nisin producing streptococci. These wastes include dairy and pancreatin-hydrolyzed wastes from insulin production. The actual yields attained are not mentioned. It appears that with the present strains, 2000 IU/ml is about the maximum that can be attained. The stability of the nisin preparations of English, Polish, and Soviet manufacturers was compared by Goudkov et al. (1973)who found that the English preparation was somewhat more stable than the other two. B. GENETICCONTROLOF NISIN SYNTHESIS Mutants with increased nisin yield following irradiation treatment were reported by Lipinska (1977). Kalra et aZ. (1973) reported the isolation of mutants that formed approximately double the amount of nisin of the parent organism. They used UV irradiation and colonies were isolated when there was 1 4 . 1 %survival. They quote earlier work by others in which similar treatments resulted in 10-fold increases in nisin synthesis. It would seem that more experiments of this kind are needed. Plasmid DNA is known in S. Zactis and 4-6 different sizes have been reported in the strains examined (Larsen and McKay, 1978). Kozak et al. (1973) reported preliminary experiments suggesting that nisin synthesis might be plasmid controlled. They examined 12 untreated strains of S . Zactis and picked 8081 colonies, of which 3 were Nis- (0.004%).After treatment with proflavin, 11,337 colonies were isolated and examined, of which 200 were Nis- (2%);after ethidium bromide treatment, 6392 colonies were isolated and 29 were Nis- (0.5%).This increase in Nis- cultures was mainly owing to one strain. Because proflavine and ethidium bromide treatments are classically believed to “cure” bacteria from plasmids, there was some evidence that nisin synthesis may be plasmid controlled. ’
90
A. HURST
One strain that readily responded to curing also contained more spontaneously formed Nis- clones (35 of 4248 examined). This property was stable: Passaging 120 cultures 10 times through broth did not result in any Nis+ cultures. Cultures cured of a plasmid-controlled property should not be able to regain this property by means of a mutation. Kozak et aZ. (1974) examined two cured cultures after treatment with nitrosoguanine. They examined 30,730 colonies from one of these cultures and 20,115 colonies from the other, but no Nis+ colonies were found. This finding supports the notion that nisin is plasmid regulated. Further experiments were reported in which attempts were made to characterize the plasmid DNA by centrifuging in CsCl gradients (Fuchs et al., 1975). However, no conclusive results were reported: Among eight nisin-producing S. Zactis, two were found not to contain covalently closed circular (ccc) DNA. Two further strains that had been cured of nisin were tested. Compared to the parent strain, only one had lost ccc DNA while the other one had not. OF NISIN TO THE PRODUCER ORGANISM C. FUNCTION
1 . As a Secondary Metabolite
It is possible that nisin has no function for the organism producing it. In batch cultures, it is formed when more than half of the cell mass has been synthesized (Hurst, 1966b). At that time, it is possible that the cell reacts to the exhaustion of a limiting but essential nutrient. Woodruff (1966) suggested that instead of “switching-off’altogether, cells turn to the synthesis of antibiotics as an alternative, which represents a means of using fully formed enzyme systems and available substrates. Hence, antibiotic synthesis may be regarded as an alternative to breakdown of cellular control mechanisms and a means of maintaining a fully functional machinery while awaiting a new source of the limiting metabolite. However, this view seems inappropriate to nisin synthesis, which is an energy-requiring process, and it is energy in particular that may be limiting toward the end of the growth phase. In addition, the enzyme(s) converting pronisin to nisin is not present all the time; on the contrary, it appears to be made only for a brief period toward the end of the growth phase (Hurst and Paterson, 1971). 2. As a Dominance Factor A second view of the function of nisin is that it ensures dominance when its producer organism is in competition with other lactic streptococci. This argument concerns the contest between S . Zactis and S. cremorkr. The natural habitat of these organisms remains uncertain (Sandine et al., 1972),
91
NISIN
F t it is known that they are the organisms that naturally sour raw milk. The argument put forward by Hirsch (1952)can be summarized briefly as follows: "Spilt milk or "milk in a container" is a relatively recent substrate dating back only to the domestication of milk-producing animals. Two species converging on this new substrate are struggling for dominance; hence, they produce antibiotics aimed at each other. Thus, S . lactis produces nisin and S. cremoris is the organism most sensitive to it. Similarly, S . cremoris produces diplococcin and the organism most sensitive to it is S. lactis (Hirsch and Grinsted, 1951).Also in favor of this argument is the fact that lactose fermentation-a basic need for growth in a milk substrate-is plasmid rather than chromosomally controlled (Larsen and McKay, 1978). In industrial practice, strains of lactic acid bacteria are frequently used in mixtures. These strains can be distinguished by phage-typing. After a few transfers, one of the strains becomes dominant and, since the work of Hoyle and Nichols (1948), antibiotic production has been accepted as one of the important causes of strain dominance. Although other causes for dominance have been suggested, the question has remained with us (Reddy et al., 1971). 3. As a Cellular Growth Regulator A third way of looking at the function of nisin is that it has a regulatory action in the growth cycle of the producer organism. Biosynthesis of nisin in batch cultures starts after about 50% of the mass of the organism has been formed (Fig. 1)(Hurst, 1966b). If nisin is added to the medium before the start of its synthesis, it inhibits and lyses the producer organism (Hurst and 200
150
100 50
-
z3 2
0
Hours
FIG. 1. Biosynthetic activities of Streptococcus Zactb growing in batch culture. Dry weight (C--.-); DNA (0-); nisin (e-. .-), protein (0---), RNA, (El--). After Hurst, 1966b.
92
A. HURST
I. I.
0. 0. $ 0 0 0 lD
G
0.
>-
t 0, v) Z
w
n-1 o a
$ 0 0 (
MINUTES
FIG. 2. A nisin-producing Streptococcus Zactis grown overnight in a complex organic medium was reinoculated into the same medium. Tube 1 had no added nisin. Tubes 2-5 had nisin added (- 500 IU/ml). Tube 2 nisin added before inoculation, tube 3 after incubation for 30 min, tube 4 after incubation for 105 min, and tube 5 after beginning of nisin synthesis at 120 min. After Hurst and Kruse, 1972.
Kruse, 1972). If nisin is added to the medium before inoculation, growth is slightly delayed but then the organism grows at the same rate as the control and attains the same mass (Fig. 2). These results suggest that the growth of the producer organism commences with the inactivation of nisin. To test this possibility, a culture controlled to pH 6.8 was grown to stationary phase (Hurst, 1968). At this pH, nisin remained cell-associated and its concentration increased from 0 (at the time of inoculation) to 1.3%of the dry weight (at stationary phase). At this point, the cells were used as a 1%inoculum to start a new fermentation. The cells were reisolated and nisin was then only 0.13% of the dry weight of these cells (Fig. 3). A nisin-destroying enzyme(s) could not be demonstrated and it was suggested that uptake of calcium was linked to the disappearance of nisin
93
NISIN
12.0
3g
-
I: 10.0 e 3 9.0 I .-CI :. 8.0 11.0
.Q
00
1.0
1
I
I
I
,
Min
FIG. 3. Apparent destruction of nisin by the producer organism. Streptococcus lactis was grown for the time shown in a hatch fermentor at pH 6.8. At time 0 the culture was reinoculated into fresh medium of the same composition. After Hurst, 1968.
(Hurst and Lazarus, 1968). Because uptake of calcium could be expected to alter the optical properties of cell suspensions, this effect was studied (Hurst, 1969). On subculture, the optical density of cell suspension declined. The reaction required salts (e.g., calcium) and glucose, and was temperature dependent. It could be poisoned by p-mercuribenzoate and iodoacetate (Hurst and Kruse, 1970). Electron microscopic observations of stationary phase cells suspended in ammonium molybdate showed clear structures of wall, membranes, adhesions of wall to membrane, septae, and mesosomes. However, 4 minutes after subculture, ammonium molybdate no longer revealed any structures, the interior of the cells being stained solidly black. Presumably, in this short interval, the cells had become permeable to the stain (Hurst and Stubbs, 1969). The events that occur at subculture can be summarized as follows: An optical reaction occurs, indicating a change in cell size. These cells become permeable to ammonium molybdate, incorporate 45Ca2+,and lose bioassayable nisin. Omission of glucose or addition of iodoacetate stops the optical reaction and the 45Ca2+uptake, and nisin is not inactivated. This effect suggests that nisin inactivation results from configurational change of the cell (Hurst and Kruse, 1970).
94
A. HURST
A small survey of “wild’ strains of S. lactis showed that, although most of them produced nisin (35 of 40), some did not (5 of 40). Hence, it was dficult to see how nisin could have a regulatory function if some strains did not produce it (Hurst, 1967). However, these strains produced a basic peptide that had no inhibitory properties, yet was so similar to nisin that it could not be separated from nisin by Sephadex chromatography and behaved as does nisinl in polyacrylamide gel electrophoresis’. It was further found that, in batch cultures, nisin accumulated as growth came to an end. The amount of cell-associated nisin was also strongly correlated with the length of the lag-phase (Hurst and Dring, 1968). As a result, there is speculative evidence that nisin and other basic peptides (and they are largely unknown because they are not antibiotics) may have a function related to the beginning and the ending of growth in batch cultures. A regulatory function concerned with the sporulation of the producer organism has been demonstrated for gramicidin (Mukherjee and Paulus, 1977).
D. MODE OF ACTION 1 . Antibacterial Spectrum Nisin has a narrow spectrum, and it does not inhibit gram-negative organisms, yeasts, or fungi. Neisseria are an exception to this general statement, the three strains reported by Mattick and Hirsch (1947) being quite sensitive. Gram-positive organisms are sensitive to nisin. The activity of nisin is not affected by the presence of milk or serum. Streptococci and the closely allied S. cremoris are especially sensitive and in this respect, nisin resembles a bacteriocin rather than an antibiotic (Tagg and Wannamaker, 1978). Staphylococci are also sensitive (Gowans et al., 1952). Mattick and Hirsch (1947) tested six strains of Mycobacterium tuberculosis and listed them as sensitive organisms. Nevertheless, these strains were about 100 times more resistant than streptococci.
2 . Effect of Nisin on S p o r e f m s The early literature on the effect of nisin on sporeformers has been reviewed by Campbell and O’Brien (1955) and later by Boone (1966). In 1947, Mattick and Hirsch reported that bacilli and clostridia were sensitive to nisin. Andersen et al. (1953) reported that nisin was effective against Clostridium botulfnum. Lewis et al. (1954) tested the complementary action of heat and antibiotics. Nisin was among 67 antibiotics they tested ‘The basic peptides from one of these strains were used to generate an antibiotic that resembled nisin; this is described in Section IV.
NISIN
95
against Clostridium sporogenes (PA 3679); it caused a 55% decrease in the D value (decimal reduction time in the count due to the applied heat). O’Brien et al. (1956) obtained similar results using only subtilin and nisin but a wide range of microorganisms: C . botulinum (PA 3679), C . thermosaccharolyticum, Bacillus coagulans, and B . stearothermophilus. Campbell et al. (1960)used various foods and processing conditions to extend these findings. They confirmed the preservative effectiveness of nisin combined with mild heat. These workers suggested that the reduction in the D value was due to carry-over of nisin into the recovery medium. Campbell and O’Brien (1955) showed that about 0.03 ppm in carry-over was sufficient to inhibit the development of severely heat-treated spores of clostridia or bacilli. Campbell and Sniff (1959a) using B . coagulans showed that the heated spores were not killed by nisin because the counts could be restored to that of the control when trypsin was incorporated into the plating medium. Thorpe (1960)obtained similar results with B . stearothermophilus and suggested that the reduction in heat resistance was due to the adsorption of nisin on the spores. Tramer (1964) also found that trypsin reversed the heat effect of nisin, but he found no evidence for adsorption to spores. Nisin could be diluted out on plating. On the other hand, Hawley (1962) reported that nisin cannot be washed off C. botulinum spores, nor is it clear why trypsin, which does not inactivate nisin (see Section 111, G), should reverse its action. The evidence presented by Hawley (1962) strongly suggests that heated C. botulinum types A and B became injured. At that time, spore injury was not known (for review of injury see Adams, 1978) and Hawley was unable to express his results in modem terms. Nevertheless, he noted that spores of nisin-resistant organisms “will germinate and grow profusely in the presence of high concentrations of nisin if they have not previously been exposed to a sub-lethal heat treatment” (Hawley, 1962). Direct evidence for heated spores becoming increasingly nisin sensitive was provided by Heinemann et al. (1965).They used heat-damaged spores of four species and in every case observed a dramatic increase in nisin sensitivity as the severity of the heating was increased. The results of Heinemann et al. (1965) leave no doubt that heat injury in bacilli and clostridia is expressed by increased sensitivity to nisin. Hirsch and Grinsted (1954) reported that nisin was sporicidal for Clostridium butyricum but not for C. sporogenes and C . bij-ermentans. Ramseier (1960)confirmed the sporicidal effect of nisin on C . butyricum. He suggested that the spores remained unaffected, but once germinated, they were killed by nisin. Campbell and Sniff (1959a) thought that nisin was sporostatic and that it prevented the outgrowth of spores of B. coagulans. Hitchins et al. (1963) and Gould (1964), using spores of bacilli, reported phase darkening and loss of heat resistance in the presence of nisin but they
96
A. HURST
also found prevention of further outgrowth steps. Whether spores of bacilli and clostridia behave in the same way remains to be established.
3. Factors Affecting Effectiveness Ramseier (1960) emphasized the numerous factors that affect nisin activity. The important ones were size and age of inoculum, composition of medium, and p H of the solution in which nisin was dissolved prior to its addition to the broth. The best solvent tested was 0.02 N HCI. At the other extreme, in buffer at pH 10, 80%of the nisin was inactivated within 2 hours. Campbell and Sniff (1959b)used tomato juice adjusted to different pH values and confirmed the increased effectiveness of nisin at low pH. At p H 5.3, all 31 strains of B . coagulans were inhibited by 200 IU of nisin but none were inhibited at p H 7.2 by 560 IU.
4 . Molecular Basis for Nisin Action Although Tramer (1964) reported that nisin is not adsorbed to spores, the weight of the evidence supports the contrary view. Adsorption to the microbe appears to be the first step required for nisin to act (Hirsch, 1954; Ramseier, 1960; Thorpe, 1960). Hirsch (1954), working with Streptococcus agalactiae, reported that 150 IU/ml killed the organism in 10-15 min. However, when culturing was done in broth containing charcoal, 20-30 min were required. This difference is most easily explained by the assumption that a nisin-bacterium complex that can be disrupted by charcoal is formed first; after 2 0 3 0 min, either the reaction becomes irreversible or the cells have been killed. Ramseier (1960) also reported that nisin was strongly adsorbed by sensitive vegetative cells of C . butyricum. Cells that had been made resistant did not adsorb nisin. He also showed that the adsorption by sensitive cells was highly pH-dependent, peaking at pH 6.5. Taking adsorption at p H 6.5 as 100%,69%was adsorbed at pH 5.5 and only 43% at p H 4.5. Ramseier (1960) further reported that treatment of sensitive cells with nisin caused the release of cytoplasmic material and lysis. Similar results were obtained by Hurst and Kruse (1972) when they added nisin to the producer organism in its nisin-sensitive growth phase (see Fig. 2). Ramseier (1960)also reported that anionic soaps neutralized nisin and concluded that it acted as a cationic surface-active detergent. Sack (1952)had earlier reported that the closely allied antibiotic subtilin acted similarly. Nisin may also have other effects. Gross and Morel1 (1967)used it successfully as an antimalarial in mice. They reasoned that the unsaturated amino acids in the molecule would compete for sulfhydryl-containing enzymes, such as coenzyme A. Malarial parasites are known to be sensitive to deficiency in coenzyme A.
97
NISIN
In cell-free systems, nisin-inhibited peptidoglycan synthesis catalyzed by enzymes from B . stearothermophilus or Escherichia coli (Linnett and Strominger, 1973). These authors used 40 puglml (about 1600 IU/ml) to cause a 50%inhibition of peptidogylcan synthesis. This concentration is about loo0 times more than the minimal inhibitory concentration (MIC) for B . stearothemnophilus. It therefore seems unlikely that inhibition of peptidoglycan synthesis could be a primary site of nisin action.
5 . Resistance to Nisin Nisin was bactericidal against S . agalactiae, a group B streptococcus (Hirsch and Mattick, 1949). More than 99% of the inoculum was killed first but the surviving organisms could outgrow in the presence of nisin. These cultures became nisin resistant (Hirsch, 1950). The relationship between the developed resistance and the amount of nisin in the culture medium is shown in Fig. 4. It can be seen that after only one subculture in medium containing 100 IU/ml, the resulting culture displayed a 40-fold increase in resistance. Carlson and Bauer (1957) trained S. pyogenes, B . subtilis, and StaphyZococcus aureus to nisin resistance. The MIC of the latter organism
$3 [ ,
0
, I0
20
,
,
,
,
,
,
,
,
30 40 50 60 70 80 ORGANISM GROWN IN NlSlN IU/rnl
90
100
FIG.4. Streptococcus agalactiae was grown in broth containing the nisin concentrations shown. From each, three colonies were isolated and their nisin resistance tested; their averaged response is shown. Based on the data of Table 2, Hirsch, 1950.
98
A. HURST
increased from 2.5 to 2000 IU/ml after 17 “passages.” The nisin-resistant staphylococcus did not produce a soluble nisinase, but water extracts of acetone-dried cells had a nisin-inactivating property. After 7 “passages” in nisin-free broth, the resistant staphylococcus reverted to its original MIC of 2.5 IU/ml. Ramseier (1960) also used the “training” procedure to obtain resistant C. butyricum. The resistance of the organism increased from 128 to 4096 W m l in the course of 12 passages. Culturing in nisin-free broth resulted in a decrease in resistance from 4096 to 1024 IU/ml in 17 passages. Subculturing for another 14 passages did not result in further increase in sensitivity. The staphylococcus trained by Carlson and Bauer (1957) to resist nisin to 2OOO IU/ml had unchanged sensitivity to penicillin, streptomycin, terramycin, and tetracycline. Carlson and Bauer also tested 14 strains of staphylococci isolated from clinical sources. All were penicillin resistant and some were resistant to as many as four additional antibiotics. Of the 14 penicillin-resistant strains, eight were also nisin resistant. The enzyme nisinase is formed by some lactic acid bacteria and bacilli; this is further discussed in Section 111, G.
111. Chemistry A. HISTORICAL By 1933, Whitehead was aware that nisin was a peptide. The first purified material was obtained from acidified culture fluids by Mattick and Hirsch (1947). It was concentrated into a chloroform gel by the method of Sevag et al. (1938), dissolved in acid alcohol, and finally precipitated at neutral pH. The resulting preparation probably contained only 2 4 % nisin, but Berridge (1947) used it as a starting material to prepare crystalline nisin. The activity of the crystalline material suggested that it was almost pure nisin (Berridge, 1949). Falconer (1952) caused nisin to remain cell associated by maintaining the pH of the fermentation at about 6. After the cells had been collected, nisin was extracted with solvents. Nisin could also be concentrated from culture fluids by frothing, which achieved about a 10-fold increase in concentration of the antibiotic activity (Hirsch, 1951b).
B. UNITS
OF
MEASUREMENTAND METHODS OF ASSAY
1 . Dejlnition of Units Several units have been defined in the past, but more recently, Tramer and Fowler (1964) defined a Reading Unit (RU) in terms of the activity
NISIN
99
exhibited by 1pg of a standard batch of commercial nisin.2 The term Reading Unit was chosen because much of the original work on nisin was done at the University of Reading in England. This standard was accepted by the World Health Organization (WHO) (1969), so that Reading Units are now referred to as International Units (IU). The approximate activity of 1 pg of pure nisin is 40 IU.
2. Assay As early as 1934, Cox recommended the use of methylene blue reduction for the detection of “inhibitory streptococci” in milk. In this test, starter organisms in milk rapidly reduce methylene blue to the colorless compound. If the milk contains nisin-producing streptococci, the time required for reduction is increased. The detection in raw milk of inhibitory streptococci, most being apparent nisin producers, was also described by Chevalier et aZ. (1957).A rich agar medium capable of growing the thermophilic LactobaciZZus Zactis was inoculated simultaneously with the milk under test. Plates were first incubated for 1 day at 20°C, when colonies developed of the nisin-producing organism but not the thermophilic lactobacillus. This procedure was followed by incubation at 30°C. Nisin-producing colonies were then surrounded by clear zones of inhibition. Hirsch (1951b) described a quantitative version of the methylene blue assay and also a more complex assay, the lag-phase method. Streptococcus agaZactiae was the test organism and within the range of 5-50 IU/ml, the length of the lag was linearly related to the concentration of nisin. Growth was estimated by the lowering of pH. A turbidimetric assay was developed by Berridge and Barrett (1952), and was also used in a modified form by Hurst (1966a). This assay method can be used with concentrations of 0.1-1 pg/ml ( 4 4 0 IU/ml). The test organism was S. cremoris, which was grown for 2%-3 hours in broth containing different concentrations of nisin, growth then being stopped with an organic mercurial disinfectant. A standard was then plotted relating OD at 600 nm to nisin concentration. The test required clear solutions but, because of its speed, sterile precautions were unnecessary. A tube method using‘vertical diffusion was suggested by Beach (1952). None of the methods mentioned so far used the conventional horizontal agar diffusion techniques: Nisin usually occurs in a polymeric form (MW a 7000) and therefore, does not readily diffuse through agar. Mocquot and Lefebre (1956) attempted to overcome this limitation by incorporating Tween 80 in the agar medium. The plates were refrigerated overnight to permit nisin to ‘Standardized nisin preparations can be obtained from the manufacturers Aplin and Barrett Ltd., Technical Service Dept., 11 North Street, Beaminster, Dorset DT8 3DZ, England.
100
A. HURST
diffuse into the agar, and then incubated to enable growth of the test organism and to develop the zones of inhibition. Tramer and Fowler (1964) used 1% Tween 20, which eliminates the need for prediffusion and hence permitted a simple diffusion assay of nisin.'This assay was especially useful for the estimation of nisin in foods, because such samples may be cloudy or contain particulate matter. The test organism for this assay is Micrococcus flauus, which grows profusely after overnight incubation at 30°C. The size of the zones of inhibition is linearly related to nisin concentration, in the range of 0.5-10 IU/ml. Many foods contain substances that interfere with the assay either by binding the nisin or by influencing the zones of inhibition so that direct reading off a standard curve can introduce serious error. However, Tramer and Fowler (1964) described the preparation of suitable controls to overcome these problems. Assay techniques not suitable for routine use were described for special applications by a number of authors. For example, Lewis et al. (1954) wanted to test the combined effect of moist heat with antibiotics. They aimed to screen antibiotics that might be useful for canning. They found that subtilin and nisin were the only antibiotics that accelerated death due to heat. Stumbo et al. (1964) developed a micromethod for testing traces of residual nisin that may be present in canned foods after heat processing or after long storage. Their estimation was based on counting colonies that developed and they could estimate as little as 0.005 IU/ml (0.000125 ppm on the standard curve). Ingram (1969) working on the biosynthesis of nisin used incorporation of radioactive amino acids to assay nisin and elucidate the mechanism of its cellular synthesis.
C. PREPARATION OF NISIN Cheeseman and Berridge (1957)described detailed schemes for obtaining nisin of high purity and in good yield. The